GEORGE ACALINGEORGE A CALIN9408CALIN, GEORGE AProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25446899Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA, Kalluri RCancer cellCancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014 Nov 10; 26(5):707-21.Cancer Cell2014-10-23T00:00:002014Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.24747968Li X, Liu Y, Granberg KJ, Wang Q, Moore LM, Ji P, Gumin J, Sulman EP, Calin GA, Haapasalo H, Nykter M, Shmulevich I, Fuller GN, Lang FF, Zhang WOncogeneTwo mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015 Mar 26; 34(13):1619-1628.Oncogene2014-04-21T00:00:002014Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.25713380Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, Hark L, Katz LJ, Witkiewicz A, Rostami A, Jimenez SA, Hollingsworth MA, Yeh JJ, Shaw CA, McKenzie SE, Bray P, Nelson PT, Zupo S, Van Roosbroeck K, Keating MJ, Calin GA, Yeo C, Jimbo M, Cozzitorto J, Brody JR, Delgrosso K, Mattick JS, Fortina P, Rigoutsos IProceedings of the National Academy of Sciences of the United States of AmericaAnalysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A. 2015 Mar 10; 112(10):E1106-15.Proc Natl Acad Sci U S A2015-02-23T00:00:002015Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.1881 East RoadHouston77054-3005TXAuthorship 1685465Authorship 1689514Authorship 1691851Authorship 1713333Authorship 1715585Authorship 1735342Authorship 1736711Authorship 1739233Authorship 1743623Authorship 1757653Authorship 17579411Authorship 1757962Authorship 1766934Authorship 1769957Authorship 17718611Authorship 1775347Authorship 1778561Authorship 1781991Authorship 1788083Authorship 1790684Authorship 1791243Authorship 1793805Authorship 1797383Authorship 1812742Authorship 1818402Authorship 1825876Authorship 1827733Authorship 1829456Authorship 1831714Authorship 1831877Authorship 18331510Authorship 1834143Authorship 1835912Authorship 1839402Authorship 18404344Authorship 1840554Authorship 1849382Authorship 1853032Authorship 1859214Authorship 18815816Authorship 18897114Authorship 1893572Authorship 1910625Authorship 1916972Authorship 19221214Authorship 1927214Authorship 19272714Authorship 1929972Authorship 19331051Authorship 19340512Authorship 19384915Authorship 19516818Authorship 195937169842983Mircioiu C, Perju A, Griu E, Calin G, Neagu A, Enachescu D, Miron DSEuropean journal of drug metabolism and pharmacokineticsPharmacokinetics of progesterone in postmenopausal women: 2. Pharmacokinetics following percutaneous administration. Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep; 23(3):397-402.Eur J Drug Metab Pharmacokinet1998-07-01T00:00:001998Pharmacokinetics of progesterone in postmenopausal women: 2. Pharmacokinetics following percutaneous administration.10749116Schwienbacher C, Angioni A, Scelfo R, Veronese A, Calin GA, Massazza G, Hatada I, Barbanti-Brodano G, Negrini MCancer researchAbnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor. Cancer Res. 2000 Mar 15; 60(6):1521-5.Cancer Res2000-03-15T00:00:002000Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor.10861498Calin GA, Gaf? R, Tibiletti MG, Herlea V, Becheanu G, Cavazzini L, Barbanti-Brodano G, Nenci I, Negrini M, Lanza GInternational journal of cancerGenetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer. 2000 May 20; 89(3):230-5.Int J Cancer2000-05-20T00:00:002000Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGRbetaRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes.11559527Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CMCancer researchCharacterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res. 2001 Sep 15; 61(18):6640-8.Cancer Res2001-09-15T00:00:002001Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene.12011454Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R, Russo G, Hardy RR, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaHuman chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A. 2002 May 14; 99(10):6955-60.Proc Natl Acad Sci U S A2002-05-14T00:00:002002Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.12748281Thakur S, Nakamura T, Calin G, Russo A, Tamburrino JF, Shimizu M, Baldassarre G, Battista S, Fusco A, Wassell RP, Dubois G, Alder H, Croce CMMolecular and cellular biologyRegulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol. 2003 Jun; 23(11):3774-87.Mol Cell Biol2003-06-01T00:00:002003Regulation of BRCA1 transcription by specific single-stranded DNA binding factors.14973191Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaHuman microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004 Mar 02; 101(9):2999-3004.Proc Natl Acad Sci U S A2004-02-18T00:00:002004Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.15701871Sarti M, Sevignani C, Calin GA, Aqeilan R, Shimizu M, Pentimalli F, Picchio MC, Godwin A, Rosenberg A, Drusco A, Negrini M, Croce CMClinical cancer research : an official journal of the American Association for Cancer ResearchAdenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):806-13.Clin Cancer Res2005-01-15T00:00:002005Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo.16009126Croce CM, Calin GACellmiRNAs, cancer, and stem cell division. Cell. 2005 Jul 15; 122(1):6-7.Cell2005-07-15T00:00:002005miRNAs, cancer, and stem cell division.16023281Michaille JJ, Tili E, Calin GA, Garin J, Louwagie M, Croce CMBiochimieCloning and characterization of cDNAs expressed during chick development and encoding different isoforms of a putative zinc finger transcriptional regulator. Biochimie. 2005 Nov; 87(11):939-49.Biochimie2005-11-01T00:00:002005Cloning and characterization of cDNAs expressed during chick development and encoding different isoforms of a putative zinc finger transcriptional regulator.16482530Shi B, Prisco M, Calin G, Liu CG, Russo G, Giordano A, Baserga RJournal of cellular physiologyExpression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells. J Cell Physiol. 2006 Jun; 207(3):706-10.J Cell Physiol2006-06-01T00:00:002006Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells.16549775Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, Volinia S, Bhatt D, Alder H, Marcucci G, Calin GA, Liu CG, Bloomfield CD, Andreeff M, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaMicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A. 2006 Mar 28; 103(13):5078-83.Proc Natl Acad Sci U S A2006-03-20T00:00:002006MicroRNA fingerprints during human megakaryocytopoiesis.16966691Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, Croce CMJournal of clinical oncology : official journal of the American Society of Clinical OncologyMicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol. 2006 Oct 10; 24(29):4677-84.J Clin Oncol2006-09-11T00:00:002006MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.17028600Calin GA, Croce CMOncogeneMicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 2006 Oct 09; 25(46):6202-10.Oncogene2006-10-09T00:00:002006MicroRNAs and chromosomal abnormalities in cancer cells.17071139Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CMTrends in molecular medicineMicroRNA expression and function in cancer. Trends Mol Med. 2006 Dec; 12(12):580-7.Trends Mol Med2006-10-30T00:00:002006MicroRNA expression and function in cancer.17111382Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti ECJournal of cellular physiologyIdentification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol. 2007 Feb; 210(2):370-7.J Cell Physiol2007-02-01T00:00:002007Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.17260024Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, Liu CG, Andreeff M, Croce CMOncogeneMicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007 Jun 14; 26(28):4148-57.Oncogene2007-01-29T00:00:002007MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.17720486Calin GA, Croce CMMethods in enzymologyInvestigation of microRNA alterations in leukemias and lymphomas. Methods Enzymol. 2007; 427:193-213.Methods Enzymol2007-01-01T00:00:002007Investigation of microRNA alterations in leukemias and lymphomas.18021078Caporaso N, Goldin L, Plass C, Calin G, Marti G, Bauer S, Raveche E, McMaster ML, Ng D, Landgren O, Slager SBritish journal of haematologyChronic lymphocytic leukaemia genetics overview. Br J Haematol. 2007 Dec; 139(5):630-4.Br J Haematol2007-12-01T00:00:002007Chronic lymphocytic leukaemia genetics overview.18098138Barbarotto E, Schmittgen TD, Calin GAInternational journal of cancerMicroRNAs and cancer: profile, profile, profile. Int J Cancer. 2008 Mar 01; 122(5):969-77.Int J Cancer2008-03-01T00:00:002008MicroRNAs and cancer: profile, profile, profile.18219318Kulshreshtha R, Davuluri RV, Calin GA, Ivan MCell death and differentiationA microRNA component of the hypoxic response. Cell Death Differ. 2008 Apr; 15(4):667-71.Cell Death Differ2008-01-25T00:00:002008A microRNA component of the hypoxic response.18226107Nicoloso MS, Calin GABrain pathology (Zurich, Switzerland)MicroRNA involvement in brain tumors: from bench to bedside. Brain Pathol. 2008 Jan; 18(1):122-9.Brain Pathol2008-01-01T00:00:002008MicroRNA involvement in brain tumors: from bench to bedside.18392144Tili E, Michaille JJ, Calin GAInternational journal of medical sciencesExpression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci. 2008 Apr 03; 5(2):73-9.Int J Med Sci2008-04-03T00:00:002008Expression and function of micro-RNAs in immune cells during normal or disease state.18521080Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini MOncogeneMiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene. 2008 Sep 25; 27(43):5651-61.Oncogene2008-06-02T00:00:002008MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.18952709Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora SFASEB journal : official publication of the Federation of American Societies for Experimental BiologyDownregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009 Mar; 23(3):806-12.FASEB J2008-10-24T00:00:002008Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke.19096009Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett WBloodSpecific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 2009 Apr 16; 113(16):3744-53.Blood2008-12-18T00:00:002008Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.19160125Fabbri M, Croce CM, Calin GALeukemia & lymphomaMicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma. 2009 Feb; 50(2):160-70.Leuk Lymphoma2009-02-01T00:00:002009MicroRNAs in the ontogeny of leukemias and lymphomas.19219043Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, Villanueva A, Capella G, Schwartz S, Shiekhattar R, Esteller MNature geneticsA TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet. 2009 Mar; 41(3):365-70.Nat Genet2009-02-15T00:00:002009A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.19641226Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen S, Wu Q, Plow EF, Croce CM, Karnik SThe Journal of biological chemistryUnique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem. 2009 Oct 02; 284(40):27487-99.J Biol Chem2009-07-29T00:00:002009Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.19778859Spizzo R, Rushworth D, Guerrero M, Calin GAClinical lymphoma & myelomaRNA inhibition, microRNAs, and new therapeutic agents for cancer treatment. Clin Lymphoma Myeloma. 2009; 9 Suppl 3:S313-8.Clin Lymphoma Myeloma2009-01-01T00:00:002009RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.19789321Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen KClinical cancer research : an official journal of the American Association for Cancer ResearchAn miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res. 2009 Oct 01; 15(19):6292-300.Clin Cancer Res2009-09-29T00:00:002009An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.19850741Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CMBloodMicroRNA 29b functions in acute myeloid leukemia. Blood. 2009 Dec 17; 114(26):5331-41.Blood2009-10-22T00:00:002009MicroRNA 29b functions in acute myeloid leukemia.19925433Crosby ME, Devlin CM, Glazer PM, Calin GA, Ivan MCurrent pharmaceutical designEmerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des. 2009; 15(33):3861-6.Curr Pharm Des2009-01-01T00:00:002009Emerging roles of microRNAs in the molecular responses to hypoxia.20051373Izzotti A, Calin GA, Steele VE, Cartiglia C, Longobardi M, Croce CM, De Flora SCancer prevention research (Philadelphia, Pa.)Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev Res (Phila). 2010 Jan; 3(1):62-72.Cancer Prev Res (Phila)2010-01-01T00:00:002010Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs.20306251Nicoloso MS, Jasra B, Calin GACancer treatment and researchMicroRNAs: new players in AML pathogenesis. Cancer Treat Res. 2010; 145:169-81.Cancer Treat Res2010-01-01T00:00:002010MicroRNAs: new players in AML pathogenesis.20439436Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CMGenome researchReprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010 May; 20(5):589-99.Genome Res2010-05-01T00:00:002010Reprogramming of miRNA networks in cancer and leukemia.20443168Fabbri M, Calin GACurrent opinion in drug discovery & developmentBeyond genomics: interpreting the 93% of the human genome that does not encode proteins. Curr Opin Drug Discov Devel. 2010 May; 13(3):350-8.Curr Opin Drug Discov Devel2010-05-01T00:00:002010Beyond genomics: interpreting the 93% of the human genome that does not encode proteins.20501828Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri LCancer researchMiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2010 Jun 15; 70(12):5184-93.Cancer Res2010-05-25T00:00:002010MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.20832748Jung EJ, Calin GACancer cellThe Meaning of 21 in the MicroRNA world: perfection rather than destruction? Cancer Cell. 2010 Sep 14; 18(3):203-5.Cancer Cell2010-09-14T00:00:002010The Meaning of 21 in the MicroRNA world: perfection rather than destruction?21809359Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson M, Georgiades C, Roberts LR, Gores GJ, Ferguson-Smith A, Almeida MI, Calin GA, Mezey E, Selaru FMHepatology (Baltimore, Md.)MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology. 2011 Dec; 54(6):2089-98.Hepatology2011-12-01T00:00:002011MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint.22085809Bhayani MK, Calin GA, Lai SYMutation researchFunctional relevance of miRNA sequences in human disease. Mutat Res. 2012 Mar 01; 731(1-2):14-9.Mutat Res2011-11-06T00:00:002011Functional relevance of miRNA sequences in human disease.22903157Redis RS, Calin S, Yang Y, You MJ, Calin GAPharmacology & therapeuticsCell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther. 2012 Nov; 136(2):169-74.Pharmacol Ther2012-08-08T00:00:002012Cell-to-cell miRNA transfer: from body homeostasis to therapy.24034421Vasilescu C, Olteanu M, Flondor P, Calin GATheoretical biology & medical modellingFractal-like kinetics of intracellular enzymatic reactions: a chemical framework of endotoxin tolerance and a possible non-specific contribution of macromolecular crowding to cross-tolerance. Theor Biol Med Model. 2013 Sep 14; 10:55.Theor Biol Med Model2013-09-14T00:00:002013Fractal-like kinetics of intracellular enzymatic reactions: a chemical framework of endotoxin tolerance and a possible non-specific contribution of macromolecular crowding to cross-tolerance.24145123Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu XMolecular oncologymiR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Mol Oncol. 2014 Feb; 8(1):83-92.Mol Oncol2013-10-08T00:00:002013miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.24858343Ruvolo PP, Ruvolo VR, Jacamo R, Burks JK, Zeng Z, Duvvuri SR, Zhou L, Qiu Y, Coombes KR, Zhang N, Yoo SY, Pan R, Hail N, Konopleva M, Calin G, Kornblau SM, Andreeff MBiochimica et biophysica actaThe protein phosphatase 2A regulatory subunit B55a is a modulator of signaling and microRNA expression in acute myeloid leukemia cells. Biochim Biophys Acta. 2014 Sep; 1843(9):1969-77.Biochim Biophys Acta2014-05-21T00:00:002014The protein phosphatase 2A regulatory subunit B55a is a modulator of signaling and microRNA expression in acute myeloid leukemia cells.Experimental Radiation OncologyExperimental TherapeuticsGynecological Oncology & Reproductive MedicineLeukemiaMolecular & Cellular OncologyPalliative Care & Rehabilitation MedicineSystems BiologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorGORDON BMILLSGORDON B MILLS8620MILLS, GORDON BProfessorEDUARDOBRUERAEDUARDO BRUERA8804BRUERA, EDUARDOProfessor33.50050.001358481212research areas5.611430.0226823227coauthor of504.392100.77860similar to11727selected publicationsANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorAuthorship 2158714Authorship 2161454Authorship 2172835Authorship 21775610Authorship 2179681Authorship 2185414Authorship 2188743Authorship 2201832Authorship 2205283Authorship 2209371Authorship 2213224Authorship 22150616Authorship 22176111Authorship 2226372Authorship 2231551Authorship 2232322Authorship 22323510Authorship 22338113Authorship 2234907Authorship 2235462Authorship 22368511Authorship 22421116Authorship 22424610Authorship 2242644Authorship 2243594Authorship 2250142Authorship 2250622Authorship 2254863Authorship 2256684Authorship 2257047Authorship 22586313Authorship 22588912Authorship 22611116Authorship 2261902Authorship 2264041Authorship 2268441Authorship 2269203Authorship 2269482Authorship 2269635Authorship 2269921Authorship 22700015Authorship 22727610Authorship 2275285Authorship 2275292Authorship 2277742Authorship 2278822Authorship 22803724Authorship 2281704Authorship 2281712Authorship 2281946Authorship 2284042Authorship 2285077Authorship 2285915Authorship 2287744Authorship 2288864Authorship 2290452Authorship 2290924Authorship 2292703Authorship 2296209Authorship 2305853Authorship 2307554Authorship 2307997Authorship 2310552Authorship 2312995Authorship 2313194Authorship 2316152Authorship 2323333Authorship 2323408Authorship 2324262Authorship 2328729Authorship 23297434Authorship 2332446Authorship 2333795Authorship 2334506Authorship 23351219Authorship 23394511Authorship 23503818055471Stefanescu DT, Colita D, Nicoara S, Calin GCancer genetics and cytogeneticst(1;7)(p36;q32): a new recurring abnormality in primary myelodysplastic syndrome. Cancer Genet Cytogenet. 1994 Jul 15; 75(2):103-5.Cancer Genet Cytogenet1994-07-15T00:00:001994t(1;7)(p36;q32): a new recurring abnormality in primary myelodysplastic syndrome.8221616Stefanescu DT, Colita D, Motoiu I, Calin GCancer genetics and cytogeneticsT-cell malignant lymphoma with a complex unbalanced translocation (8;11;14). Cancer Genet Cytogenet. 1993 Oct 01; 70(1):71-3.Cancer Genet Cytogenet1993-10-01T00:00:001993T-cell malignant lymphoma with a complex unbalanced translocation (8;11;14).9842982Mircioiu C, Perju A, Neagu A, Griu E, Calin G, Miron DSEuropean journal of drug metabolism and pharmacokineticsPharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration. Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep; 23(3):391-6.Eur J Drug Metab Pharmacokinet1998-07-01T00:00:001998Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration.10608267Calin G, Ivan M, Stefanescu DMedical hypothesesThe difference between p53 mutation frequency in haematological and non-haematological malignancies: possible explanations. Med Hypotheses. 1999 Oct; 53(4):326-8.Med Hypotheses1999-10-01T00:00:001999The difference between p53 mutation frequency in haematological and non-haematological malignancies: possible explanations.10713707Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini MOncogeneLow frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene. 2000 Feb 24; 19(9):1191-5.Oncogene2000-02-24T00:00:002000Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.10779553Schwienbacher C, Gramantieri L, Scelfo R, Veronese A, Calin GA, Bolondi L, Croce CM, Barbanti-Brodano G, Negrini MProceedings of the National Academy of Sciences of the United States of AmericaGain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas. Proc Natl Acad Sci U S A. 2000 May 09; 97(10):5445-9.Proc Natl Acad Sci U S A2000-05-09T00:00:002000Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas.11306461Mabuchi H, Fujii H, Calin G, Alder H, Negrini M, Rassenti L, Kipps TJ, Bullrich F, Croce CMCancer researchCloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res. 2001 Apr 01; 61(7):2870-7.Cancer Res2001-04-01T00:00:002001Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia.12649173Sevignani C, Calin GA, Cesari R, Sarti M, Ishii H, Yendamuri S, Vecchione A, Trapasso F, Croce CMCancer researchRestoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res. 2003 Mar 15; 63(6):1183-7.Cancer Res2003-03-15T00:00:002003Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.12719539Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaParkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A. 2003 05 13; 100(10):5956-61.Proc Natl Acad Sci U S A2003-04-28T00:00:002003Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.15169904Prisco M, Maiorana A, Guerzoni C, Calin G, Calabretta B, Voit R, Grummt I, Baserga RMolecular and cellular biologyRole of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells. Mol Cell Biol. 2004 Jun; 24(12):5421-33.Mol Cell Biol2004-06-01T00:00:002004Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.15284443Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaMicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004 Aug 10; 101(32):11755-60.Proc Natl Acad Sci U S A2004-07-29T00:00:002004MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.16103053Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, M?nard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CMCancer researchMicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005 Aug 15; 65(16):7065-70.Cancer Res2005-08-15T00:00:002005MicroRNA gene expression deregulation in human breast cancer.16323427Pekarsky Y, Calin GA, Aqeilan RCurrent topics in microbiology and immunologyChronic lymphocytic leukemia: molecular genetics and animal models. Curr Top Microbiol Immunol. 2005; 294:51-70.Curr Top Microbiol Immunol2005-01-01T00:00:002005Chronic lymphocytic leukemia: molecular genetics and animal models.16330772Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle CProceedings of the National Academy of Sciences of the United States of AmericaMicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A. 2005 Dec 13; 102(50):18081-6.Proc Natl Acad Sci U S A2005-12-05T00:00:002005MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.16365291He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle AProceedings of the National Academy of Sciences of the United States of AmericaThe role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005 Dec 27; 102(52):19075-80.Proc Natl Acad Sci U S A2005-12-19T00:00:002005The role of microRNA genes in papillary thyroid carcinoma.16518686Sevignani C, Calin GA, Siracusa LD, Croce CMMammalian genome : official journal of the International Mammalian Genome SocietyMammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome. 2006 Mar; 17(3):189-202.Mamm Genome2006-03-03T00:00:002006Mammalian microRNAs: a small world for fine-tuning gene expression.16530703Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CCCancer cellUnique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006 Mar; 9(3):189-98.Cancer Cell2006-03-01T00:00:002006Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.16847883Di Leva G, Calin GA, Croce CMBirth defects research. Part C, Embryo today : reviewsMicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res C Embryo Today. 2006 Jun; 78(2):180-9.Birth Defects Res C Embryo Today2006-06-01T00:00:002006MicroRNAs: fundamental facts and involvement in human diseases.16885332Calin GA, Croce CMCancer researchMicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006 Aug 01; 66(15):7390-4.Cancer Res2006-08-01T00:00:002006MicroRNA-cancer connection: the beginning of a new tale.17079447Petrocca F, Iliopoulos D, Qin HR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CMCancer researchAlterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Res. 2006 Nov 01; 66(21):10287-91.Cancer Res2006-11-01T00:00:002006Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer.17178851Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG, Rassenti L, Calin GA, Hagan JP, Kipps T, Croce CMCancer researchTcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006 Dec 15; 66(24):11590-3.Cancer Res2006-12-15T00:00:002006Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.17582223Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davuluri RV, Ivan MCell cycle (Georgetown, Tex.)Regulation of microRNA expression: the hypoxic component. Cell Cycle. 2007 Jun 15; 6(12):1426-31.Cell Cycle2007-05-07T00:00:002007Regulation of microRNA expression: the hypoxic component.17826655Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa RUrologic oncologyMicro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007 Sep-Oct; 25(5):387-92.Urol Oncol2007-09-01T00:00:002007Micro-RNA profiling in kidney and bladder cancers.17890317Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaMicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007 Oct 02; 104(40):15805-10.Proc Natl Acad Sci U S A2007-09-21T00:00:002007MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.17911593Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CMJournal of immunology (Baltimore, Md. : 1950)Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol. 2007 Oct 15; 179(8):5082-9.J Immunol2007-10-15T00:00:002007Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock.18187662Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CMBloodMicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008 Mar 15; 111(6):3183-9.Blood2008-01-10T00:00:002008MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.18230780Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CCJAMAMicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008 Jan 30; 299(4):425-36.JAMA2008-01-30T00:00:002008MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.18362358Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaMiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A. 2008 Apr 01; 105(13):5166-71.Proc Natl Acad Sci U S A2008-03-24T00:00:002008MiR-15a and miR-16-1 cluster functions in human leukemia.18388938Liu CG, Calin GA, Volinia S, Croce CMNature protocolsMicroRNA expression profiling using microarrays. Nat Protoc. 2008; 3(4):563-78.Nat Protoc2008-01-01T00:00:002008MicroRNA expression profiling using microarrays.18459106Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, Croce CM, Ambs SThe ProstateExpression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate. 2008 Aug 01; 68(11):1152-64.Prostate2008-08-01T00:00:002008Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer.18538733Bueno MJ, P?rez de Castro I, G?mez de Cedr?n M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fern?ndez-Piqueras J, Malumbres MCancer cellGenetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 2008 Jun; 13(6):496-506.Cancer Cell2008-06-01T00:00:002008Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression.18691114Barbarotto E, Calin GACurrent pharmaceutical designPotential therapeutic applications of miRNA-based technology in hematological malignancies. Curr Pharm Des. 2008; 14(21):2040-50.Curr Pharm Des2008-01-01T00:00:002008Potential therapeutic applications of miRNA-based technology in hematological malignancies.18719391Deng S, Calin GA, Croce CM, Coukos G, Zhang LCell cycle (Georgetown, Tex.)Mechanisms of microRNA deregulation in human cancer. Cell Cycle. 2008 Sep 01; 7(17):2643-6.Cell Cycle2008-09-01T00:00:002008Mechanisms of microRNA deregulation in human cancer.18768788Lujambio A, Calin GA, Villanueva A, Ropero S, S?nchez-C?spedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller MProceedings of the National Academy of Sciences of the United States of AmericaA microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A. 2008 Sep 09; 105(36):13556-61.Proc Natl Acad Sci U S A2008-09-03T00:00:002008A microRNA DNA methylation signature for human cancer metastasis.19074899Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG, Huang Q, Katsaros D, Calin GA, Weber BL, B?tzow R, Croce CM, Coukos G, Zhang LCancer researchMicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 2008 Dec 15; 68(24):10307-14.Cancer Res2008-12-15T00:00:002008MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.19293341Fabbri M, Valeri N, Calin GACarcinogenesisMicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. Carcinogenesis. 2009 Jun; 30(6):912-7.Carcinogenesis2009-03-17T00:00:002009MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift.19336759Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia AJ, Secreto C, Wellik LE, Lee YK, Mukhopadhyay D, Kay NEBloodAberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood. 2009 May 28; 113(22):5568-74.Blood2009-03-31T00:00:002009Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.19410551Spizzo R, Nicoloso MS, Croce CM, Calin GACellSnapShot: MicroRNAs in Cancer. Cell. 2009 May 01; 137(3):586-586.e1.Cell2009-05-01T00:00:002009SnapShot: MicroRNAs in Cancer.19411171Negrini M, Nicoloso MS, Calin GACurrent opinion in cell biologyMicroRNAs and cancer--new paradigms in molecular oncology. Curr Opin Cell Biol. 2009 Jun; 21(3):470-9.Curr Opin Cell Biol2009-05-04T00:00:002009MicroRNAs and cancer--new paradigms in molecular oncology.19497386Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GAThe international journal of biochemistry & cell biologyMicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol. 2010 Aug; 42(8):1291-7.Int J Biochem Cell Biol2009-06-02T00:00:002009MicroRNAs, ultraconserved genes and colorectal cancers.19498445Aqeilan RI, Calin GA, Croce CMCell death and differentiationmiR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010 Feb; 17(2):215-20.Cell Death Differ2009-06-05T00:00:002009miR-15a and miR-16-1 in cancer: discovery, function and future perspectives.19609760Spizzo R, Calin GAMethods in molecular biology (Clifton, N.J.)Multiple approach to analyzing the role of microRNAs in apoptosis. Methods Mol Biol. 2009; 559:219-45.Methods Mol Biol2009-01-01T00:00:002009Multiple approach to analyzing the role of microRNAs in apoptosis.19630570Garzon R, Calin GA, Croce CMAnnual review of medicineMicroRNAs in Cancer. Annu Rev Med. 2009; 60:167-79.Annu Rev Med2009-01-01T00:00:002009MicroRNAs in Cancer.19671867Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini MClinical cancer research : an official journal of the American Association for Cancer ResearchMicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res. 2009 Aug 15; 15(16):5073-81.Clin Cancer Res2009-08-11T00:00:002009MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.19691821Calin GAGenome medicineMicroRNAs and cancer: what we know and what we still have to learn. Genome Med. 2009 Aug 17; 1(8):78.Genome Med2009-08-17T00:00:002009MicroRNAs and cancer: what we know and what we still have to learn.19730444Spizzo R, Nicoloso MS, Lupini L, Lu Y, Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, Davuluri R, Croce CM, Mills G, Negrini M, Calin GACell death and differentiationmiR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 2010 Feb; 17(2):246-54.Cell Death Differ2009-09-04T00:00:002009miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells.20211135Eiring AM, Harb JG, Neviani P, Garton C, Oaks JJ, Spizzo R, Liu S, Schwind S, Santhanam R, Hickey CJ, Becker H, Chandler JC, Andino R, Cortes J, Hokland P, Huettner CS, Bhatia R, Roy DC, Liebhaber SA, Caligiuri MA, Marcucci G, Garzon R, Croce CM, Calin GA, Perrotti DCellmiR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell. 2010 Mar 05; 140(5):652-65.Cell2010-03-05T00:00:002010miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.20218735Ferdin J, Kunej T, Calin GATechnology in cancer research & treatmentNon-coding RNAs: identification of cancer-associated microRNAs by gene profiling. Technol Cancer Res Treat. 2010 Apr; 9(2):123-38.Technol Cancer Res Treat2010-04-01T00:00:002010Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling.20443818Barbarotto E, Secchiero P, Dasgupta A, Fortina P, Calin GA, Hyslop TClinical and translational scienceMicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci. 2008 May; 1(1):50-6.Clin Transl Sci2008-05-01T00:00:002008MicroRNAs as new players in the genomic galaxy and disease puzzles.20502442Almeida MI, Reis RM, Calin GACell researchMYC-microRNA-9-metastasis connection in breast cancer. Cell Res. 2010 Jun; 20(6):603-4.Cell Res2010-05-25T00:00:002010MYC-microRNA-9-metastasis connection in breast cancer.20560048Edwards JK, Pasqualini R, Arap W, Calin GAJournal of cardiovascular translational researchMicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res. 2010 Jun; 3(3):271-9.J Cardiovasc Transl Res2010-05-05T00:00:002010MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases.20639536Tili E, Michaille JJ, Liu CG, Alder H, Taccioli C, Volinia S, Calin GA, Croce CMNucleic acids researchGAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Res. 2010 Nov; 38(21):7673-88.Nucleic Acids Res2010-07-17T00:00:002010GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials.20823296Iuliano R, Palmieri D, He H, Iervolino A, Borbone E, Pallante P, Cianflone A, Nagy R, Alder H, Calin GA, Trapasso F, Giordano C, Croce CM, de la Chapelle A, Fusco AEndocrine-related cancerRole of PTPRJ genotype in papillary thyroid carcinoma risk. Endocr Relat Cancer. 2010 Dec; 17(4):1001-6.Endocr Relat Cancer2010-10-29T00:00:002010Role of PTPRJ genotype in papillary thyroid carcinoma risk.20827528Fabbri M, Spizzo R, Calin GAMethods in molecular biology (Clifton, N.J.)High-throughput profiling in the hematopoietic system. Methods Mol Biol. 2010; 667:79-91.Methods Mol Biol2010-01-01T00:00:002010High-throughput profiling in the hematopoietic system.20951941Melo SA, Moutinho C, Ropero S, Calin GA, Rossi S, Spizzo R, Fernandez AF, Davalos V, Villanueva A, Montoya G, Yamamoto H, Schwartz S, Esteller MCancer cellA genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell. 2010 Oct 19; 18(4):303-15.Cancer Cell2010-10-19T00:00:002010A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells.20959026Lee SK, Calin GAGenome medicineGenetic control of mammalian T-cell proliferation with a synthetic RNA regulatory system - illusion or reality? Genome Med. 2010 Oct 15; 2(10):77.Genome Med2010-10-15T00:00:002010Genetic control of mammalian T-cell proliferation with a synthetic RNA regulatory system - illusion or reality?21034967Cortez MA, Ivan C, Zhou P, Wu X, Ivan M, Calin GAAdvances in cancer researchmicroRNAs in cancer: from bench to bedside. Adv Cancer Res. 2010; 108:113-57.Adv Cancer Res2010-01-01T00:00:002010microRNAs in cancer: from bench to bedside.21093163Wang Y, Scheiber MN, Neumann C, Calin GA, Zhou DInternational journal of radiation oncology, biology, physicsMicroRNA regulation of ionizing radiation-induced premature senescence. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):839-48.Int J Radiat Oncol Biol Phys2010-11-17T00:00:002010MicroRNA regulation of ionizing radiation-induced premature senescence.21209780Le XF, Merchant O, Bast RC, Calin GACancer microenvironment : official journal of the International Cancer Microenvironment SocietyThe Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade. Cancer Microenviron. 2010 Feb 23; 3(1):137-47.Cancer Microenviron2010-02-23T00:00:002010The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade.21447283Lee SK, Calin GADiscovery medicineNon-coding RNAs and cancer: new paradigms in oncology. Discov Med. 2011 Mar; 11(58):245-54.Discov Med2011-03-01T00:00:002011Non-coding RNAs and cancer: new paradigms in oncology.21602527Zuo Z, Calin GA, de Paula HM, Medeiros LJ, Fernandez MH, Shimizu M, Garcia-Manero G, Bueso-Ramos CEBloodCirculating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood. 2011 Jul 14; 118(2):413-5.Blood2011-05-20T00:00:002011Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome.21948089Bartley AN, Yao H, Barkoh BA, Ivan C, Mishra BM, Rashid A, Calin GA, Luthra R, Hamilton SRClinical cancer research : an official journal of the American Association for Cancer ResearchComplex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res. 2011 Dec 01; 17(23):7283-93.Clin Cancer Res2011-09-23T00:00:002011Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer.22200634Setoyama T, Ling H, Natsugoe S, Calin GAThe Keio journal of medicineNon-coding RNAs for medical practice in oncology. Keio J Med. 2011; 60(4):106-13.Keio J Med2011-01-01T00:00:002011Non-coding RNAs for medical practice in oncology.22303453Zorc M, Skok DJ, Godnic I, Calin GA, Horvat S, Jiang Z, Dovc P, Kunej TPloS oneCatalog of microRNA seed polymorphisms in vertebrates. PLoS One. 2012; 7(1):e30737.PLoS One2012-01-27T00:00:002012Catalog of microRNA seed polymorphisms in vertebrates.22650365Almeida MI, Reis RM, Calin GAExpert opinion on biological therapyDecoy activity through microRNAs: the therapeutic implications. Expert Opin Biol Ther. 2012 Sep; 12(9):1153-9.Expert Opin Biol Ther2012-06-01T00:00:002012Decoy activity through microRNAs: the therapeutic implications.22661538Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu XClinical cancer research : an official journal of the American Association for Cancer ResearchGenetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012 Jul 15; 18(14):3982-91.Clin Cancer Res2012-06-01T00:00:002012Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.22956499Fabbri M, Calore F, Paone A, Galli R, Calin GAAdvances in experimental medicine and biologyEpigenetic regulation of miRNAs in cancer. Adv Exp Med Biol. 2013; 754:137-48.Adv Exp Med Biol2013-01-01T00:00:002013Epigenetic regulation of miRNAs in cancer.23051203Shah MY, Calin GANucleic acid therapeuticsThe mix of two worlds: non-coding RNAs and hormones. Nucleic Acid Ther. 2013 Feb; 23(1):2-8.Nucleic Acid Ther2012-10-10T00:00:002012The mix of two worlds: non-coding RNAs and hormones.23338610Jin L, Wessely O, Marcusson EG, Ivan C, Calin GA, Alahari SKCancer researchProoncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-a in breast cancer. Cancer Res. 2013 May 01; 73(9):2884-96.Cancer Res2013-01-21T00:00:002013Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-a in breast cancer.23377966Rossi S, Calin GAAdvances in experimental medicine and biologyBioinformatics, non-coding RNAs and its possible application in personalized medicine. Adv Exp Med Biol. 2013; 774:21-37.Adv Exp Med Biol2013-01-01T00:00:002013Bioinformatics, non-coding RNAs and its possible application in personalized medicine.23658527Atlasi Y, Noori R, Gaspar C, Franken P, Sacchetti A, Rafati H, Mahmoudi T, Decraene C, Calin GA, Merrill BJ, Fodde RPLoS geneticsWnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation. PLoS Genet. 2013 May; 9(5):e1003424.PLoS Genet2013-05-02T00:00:002013Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation.23750211Li P, Grgurevic S, Liu Z, Harris D, Rozovski U, Calin GA, Keating MJ, Estrov ZPloS oneSignal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia. PLoS One. 2013; 8(6):e64678.PLoS One2013-06-04T00:00:002013Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia.23974796Gumireddy K, Li A, Yan J, Setoyama T, Johannes GJ, Orom UA, Tchou J, Liu Q, Zhang L, Speicher DW, Calin GA, Huang QThe EMBO journalIdentification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J. 2013 Oct 16; 32(20):2672-84.EMBO J2013-08-23T00:00:002013Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step.24018975Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, Bottsford-Miller J, Liu Y, Kim SB, Unruh A, Gonzalez-Villasana V, Huang L, Zand B, Moreno-Smith M, Mangala LS, Taylor M, Dalton HJ, Sehgal V, Wen Y, Kang Y, Baggerly KA, Lee JS, Ram PT, Ravoori MK, Kundra V, Zhang X, Ali-Fehmi R, Gonzalez-Angulo AM, Massion PP, Calin GA, Lopez-Berestein G, Zhang W, Sood AKNature communicationsTumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427.Nat Commun2013-01-01T00:00:002013Tumour angiogenesis regulation by the miR-200 family.24077681Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, Buiga R, Pop V, Irimie A, Fodde R, Bedrosian I, Martens JW, Foekens JA, Berindan-Neagoe I, Calin GAOncotargetCCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013 Oct; 4(10):1748-62.Oncotarget2013-10-01T00:00:002013CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations.24097061Wan G, Hu X, Liu Y, Han C, Sood AK, Calin GA, Zhang X, Lu XThe EMBO journalA novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. EMBO J. 2013 Oct 30; 32(21):2833-47.EMBO J2013-10-04T00:00:002013A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation.24629639Ferreira AF, Moura LG, Tojal I, Ambr?sio L, Pinto-Sim?es B, Hamerschlak N, Calin GA, Ivan C, Covas DT, Kashima S, Castro FABlood cells, molecules & diseasesApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance. Blood Cells Mol Dis. 2014 Jun-Aug; 53(1-2):47-55.Blood Cells Mol Dis2014-03-11T00:00:002014ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.Authorship 2367761Authorship 2398163Authorship 2404351Authorship 2407572Authorship 242884Authorship 2438671Authorship 2445071Authorship 2451294Authorship 2457602Authorship 2464971Authorship 2472314Authorship 2474152Authorship 2475832Authorship 2479371Authorship 24884211Authorship 24890812Authorship 2491331Authorship 2492341Authorship 24923916Authorship 2493377Authorship 2494047Authorship 2499132Authorship 2499506Authorship 2501044Authorship 25047511Authorship 2506996Authorship 2509324Authorship 25111610Authorship 2512606Authorship 2514103Authorship 2514983Authorship 2518535Authorship 2518815Authorship 2519991Authorship 2521182Authorship 2521192Authorship 25248816Authorship 2531701Authorship 25344218Authorship 2534958Authorship 2539593Authorship 2540081Authorship 2541213Authorship 2543072Authorship 25434915Authorship 25456724Authorship 2545914Authorship 25462030Authorship 2549212Authorship 25504128Authorship 2553567Authorship 2555387Authorship 2556332Authorship 2558626Authorship 2558756Authorship 25658914Authorship 25671810Authorship 2569783Authorship 2572012Authorship 2573585Authorship 25803512Authorship 2581389Authorship 2584073Authorship 2584173Authorship 2593093Authorship 2598643Authorship 2605344Authorship 2607108Authorship 26089423Authorship 2608972Authorship 2609915Authorship 26099713Authorship 2611403Authorship 2617754Authorship 26182612Authorship 26192861304831Calin GRoumanian archives of microbiology and immunologyOncogenes and tumor suppressor genes--two different looks of the same gene? Roum Arch Microbiol Immunol. 1992 Oct-Dec; 51(4):271-3.Roum Arch Microbiol Immunol1992-10-01T00:00:001992Oncogenes and tumor suppressor genes--two different looks of the same gene?9450213Maximilian C, Stefanescu D, Calin GEuropean journal of human genetics : EJHGGenetic services in Romania. Eur J Hum Genet. 1997; 5 Suppl 2:145-7.Eur J Hum Genet1997-01-01T00:00:001997Genetic services in Romania.9731483Calin G, Herlea V, Barbanti-Brodano G, Negrini MCancer researchThe coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumors. Cancer Res. 1998 Sep 01; 58(17):3777-81.Cancer Res1998-09-01T00:00:001998The coding region of the Bloom syndrome BLM gene and of the CBL proto-oncogene is mutated in genetically unstable sporadic gastrointestinal tumors.10102634di Iasio MG, Calin G, Tibiletti MG, Vorechovsky I, Benediktsson KP, Taramelli R, Barbanti-Brodano G, Negrini MOncogeneRefinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene. 1999 Feb 25; 18(8):1635-8.Oncogene1999-02-25T00:00:001999Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.10757650Wilkinson ML, Hodgson SHEuropean journal of human genetics : EJHGFAP and marfanoid habitus. Eur J Hum Genet. 2000 Feb; 8(2):153.Eur J Hum Genet2000-02-01T00:00:002000FAP and marfanoid habitus.12606244Calin GA, Vasilescu C, Negrini M, Barbanti-Brodano GMedical hypothesesGenetic chaos and antichaos in human cancers. Med Hypotheses. 2003 Feb; 60(2):258-62.Med Hypotheses2003-02-01T00:00:002003Genetic chaos and antichaos in human cancers.12828073Calin GA, Calin S, Ionescu R, Croitoru M, Diculescu M, Oproiu AHepato-gastroenterologySuccessful local fibrinolytic treatment and balloon angioplasty in superior mesenteric arterial embolism: a case report and literature review. Hepatogastroenterology. 2003 May-Jun; 50(51):732-4.Hepatogastroenterology2003-05-01T00:00:002003Successful local fibrinolytic treatment and balloon angioplasty in superior mesenteric arterial embolism: a case report and literature review.15102676Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CMClinical cancer research : an official journal of the American Association for Cancer ResearchAlterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res. 2004 Apr 15; 10(8):2720-4.Clin Cancer Res2004-04-15T00:00:002004Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.15210942Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaAn oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A. 2004 Jun 29; 101(26):9740-4.Proc Natl Acad Sci U S A2004-06-21T00:00:002004An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.15548679Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gaf? R, Lanza G, Negrini MCancer researchFrequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res. 2004 Nov 15; 64(22):8156-9.Cancer Res2004-11-15T00:00:002004Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.15843669Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK, Ferracin M, Bernardi G, Chatterjee D, Baldassarre G, Rattan S, Alder H, Mabuchi H, Shiraishi T, Hansen LL, Overgaard J, Herlea V, Mauro FR, Dighiero G, Movsas B, Rassenti L, Kipps T, Baffa R, Fusco A, Mori M, Russo G, Liu CG, Neuberg D, Bullrich F, Negrini M, Croce CMThe New England journal of medicineFamilial cancer associated with a polymorphism in ARLTS1. N Engl J Med. 2005 Apr 21; 352(16):1667-76.N Engl J Med2005-04-21T00:00:002005Familial cancer associated with a polymorphism in ARLTS1.16166262Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CMProceedings of the National Academy of Sciences of the United States of AmericamiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):13944-9.Proc Natl Acad Sci U S A2005-09-15T00:00:002005miR-15 and miR-16 induce apoptosis by targeting BCL2.16424025Zanesi N, Aqeilan R, Drusco A, Kaou M, Sevignani C, Costinean S, Bortesi L, La Rocca G, Koldovsky P, Volinia S, Mancini R, Calin G, Scott CP, Pekarsky Y, Croce CMCancer researchEffect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice. Cancer Res. 2006 Jan 15; 66(2):915-20.Cancer Res2006-01-15T00:00:002006Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.16461460Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CMProceedings of the National Academy of Sciences of the United States of AmericaA microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006 Feb 14; 103(7):2257-61.Proc Natl Acad Sci U S A2006-02-03T00:00:002006A microRNA expression signature of human solid tumors defines cancer gene targets.16616063Calin GA, Croce CMSeminars in oncologyGenomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol. 2006 Apr; 33(2):167-73.Semin Oncol2006-04-01T00:00:002006Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.17060945Calin GA, Croce CMNature reviews. CancerMicroRNA signatures in human cancers. Nat Rev Cancer. 2006 Nov; 6(11):857-66.Nat Rev Cancer2006-11-01T00:00:002006MicroRNA signatures in human cancers.17194750Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, Ivan MMolecular and cellular biologyA microRNA signature of hypoxia. Mol Cell Biol. 2007 Mar; 27(5):1859-67.Mol Cell Biol2006-12-28T00:00:002006A microRNA signature of hypoxia.17293455Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CIProceedings of the National Academy of Sciences of the United States of AmericaCD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007 Feb 20; 104(8):2750-5.Proc Natl Acad Sci U S A2007-02-09T00:00:002007CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.17470785Sevignani C, Calin GA, Nnadi SC, Shimizu M, Davuluri RV, Hyslop T, Demant P, Croce CM, Siracusa LDProceedings of the National Academy of Sciences of the United States of AmericaMicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A. 2007 May 08; 104(19):8017-22.Proc Natl Acad Sci U S A2007-04-30T00:00:002007MicroRNA genes are frequently located near mouse cancer susceptibility loci.17616664Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini MCancer researchCyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007 Jul 01; 67(13):6092-9.Cancer Res2007-07-01T00:00:002007Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.17671640Calin GA, Croce CMThe Journal of clinical investigationChromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest. 2007 Aug; 117(8):2059-66.J Clin Invest2007-08-01T00:00:002007Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.17699778Yendamuri S, Trapasso F, Ferracin M, Cesari R, Sevignani C, Shimizu M, Rattan S, Kuroki T, Dumon KR, Bullrich F, Liu CG, Negrini M, Williams NN, Kaiser LR, Croce CM, Calin GACancer researchTumor suppressor functions of ARLTS1 in lung cancers. Cancer Res. 2007 Aug 15; 67(16):7738-45.Cancer Res2007-08-15T00:00:002007Tumor suppressor functions of ARLTS1 in lung cancers.17716371Lanza G, Ferracin M, Gaf? R, Veronese A, Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM, Negrini MMolecular cancermRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer. 2007 Aug 23; 6:54.Mol Cancer2007-08-23T00:00:002007mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer.17875710Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, M?nard S, Croce CMCancer researchMicroRNA signatures in human ovarian cancer. Cancer Res. 2007 Sep 15; 67(18):8699-707.Cancer Res2007-09-15T00:00:002007MicroRNA signatures in human ovarian cancer.17927518Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GAFuture oncology (London, England)miRNAs and their potential for use against cancer and other diseases. Future Oncol. 2007 Oct; 3(5):521-37.Future Oncol2007-10-01T00:00:002007miRNAs and their potential for use against cancer and other diseases.18021085Nicoloso MS, Kipps TJ, Croce CM, Calin GABritish journal of haematologyMicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol. 2007 Dec; 139(5):709-16.Br J Haematol2007-12-01T00:00:002007MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.18303474Fabbri M, Croce CM, Calin GACancer journal (Sudbury, Mass.)MicroRNAs. Cancer J. 2008 Jan-Feb; 14(1):1-6.Cancer J2008-01-01T00:00:002008MicroRNAs.18323801Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GALeukemiaMicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia. 2008 Jun; 22(6):1095-105.Leukemia2008-03-06T00:00:002008MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications.18458333Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, B?tzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos GProceedings of the National Academy of Sciences of the United States of AmericaGenomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A. 2008 May 13; 105(19):7004-9.Proc Natl Acad Sci U S A2008-05-05T00:00:002008Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.18477647Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang WCarcinogenesisPolymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 2008 Jul; 29(7):1306-11.Carcinogenesis2008-05-13T00:00:002008Polymorphisms in microRNA targets: a gold mine for molecular epidemiology.18636290Rossi S, Sevignani C, Nnadi SC, Siracusa LD, Calin GAMammalian genome : official journal of the International Mammalian Genome SocietyCancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications. Mamm Genome. 2008 Aug; 19(7-8):526-40.Mamm Genome2008-07-18T00:00:002008Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications.18676839Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce CMCancer researchGenomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res. 2008 Aug 01; 68(15):6162-70.Cancer Res2008-08-01T00:00:002008Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.18945703Taccioli C, Fabbri E, Visone R, Volinia S, Calin GA, Fong LY, Gambari R, Bottoni A, Acunzo M, Hagan J, Iorio MV, Piovan C, Romano G, Croce CMNucleic acids researchUCbase & miRfunc: a database of ultraconserved sequences and microRNA function. Nucleic Acids Res. 2009 Jan; 37(Database issue):D41-8.Nucleic Acids Res2008-10-22T00:00:002008UCbase & miRfunc: a database of ultraconserved sequences and microRNA function.19372264Calin GABloodMiR-sensing chemotherapy resistance in CLL. Blood. 2009 Apr 16; 113(16):3652-3.Blood2009-04-16T00:00:002009MiR-sensing chemotherapy resistance in CLL.19426115Cortez MA, Calin GAExpert opinion on biological therapyMicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009 Jun; 9(6):703-711.Expert Opin Biol Ther2009-06-01T00:00:002009MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases.19465468Izzotti A, Calin GA, Steele VE, Croce CM, De Flora SFASEB journal : official publication of the Federation of American Societies for Experimental BiologyRelationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 2009 Sep; 23(9):3243-50.FASEB J2009-05-22T00:00:002009Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light.19470431Sampath D, Calin GABloodmiRs: fine-tuning prognosis in CLL. Blood. 2009 May 21; 113(21):5035-6.Blood2009-05-21T00:00:002009miRs: fine-tuning prognosis in CLL.19745066Calin GA, Croce CMBloodChronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood. 2009 Nov 26; 114(23):4761-70.Blood2009-09-10T00:00:002009Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes.19823581Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GAPloS oneMicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One. 2009 Oct 12; 4(10):e7405.PLoS One2009-10-12T00:00:002009MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis.19843580Santarpia L, Nicoloso M, Calin GAEndocrine-related cancerMicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype. Endocr Relat Cancer. 2010 Mar; 17(1):F51-75.Endocr Relat Cancer2010-01-29T00:00:002010MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.19903841Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA, Mukherjee PCancer researchMiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009 Dec 01; 69(23):9090-5.Cancer Res2009-11-10T00:00:002009MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer.20022810Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CMThe Lancet. OncologyRelation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010 Feb; 11(2):136-46.Lancet Oncol2009-12-18T00:00:002009Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.20139721Almeida MI, Reis RM, Calin GACancer biology & therapyMicroRNAs and metastases--the neuroblastoma link. Cancer Biol Ther. 2010 Mar 15; 9(6):453-4.Cancer Biol Ther2010-03-15T00:00:002010MicroRNAs and metastases--the neuroblastoma link.20332227Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GACancer researchSingle-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010 Apr 01; 70(7):2789-98.Cancer Res2010-03-23T00:00:002010Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.20393129Rossi S, Shimizu M, Barbarotto E, Nicoloso MS, Dimitri F, Sampath D, Fabbri M, Lerner S, Barron LL, Rassenti LZ, Jiang L, Xiao L, Hu J, Secchiero P, Zauli G, Volinia S, Negrini M, Wierda W, Kipps TJ, Plunkett W, Coombes KR, Abruzzo LV, Keating MJ, Calin GABloodmicroRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood. 2010 Aug 12; 116(6):945-52.Blood2010-04-14T00:00:002010microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.20428111Zhang S, Chen L, Jung EJ, Calin GAClinical pharmacology and therapeuticsTargeting microRNAs with small molecules: from dream to reality. Clin Pharmacol Ther. 2010 Jun; 87(6):754-8.Clin Pharmacol Ther2010-04-28T00:00:002010Targeting microRNAs with small molecules: from dream to reality.20708159Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AKCancer cellRegulation of tumor angiogenesis by EZH2. Cancer Cell. 2010 Aug 09; 18(2):185-97.Cancer Cell2010-08-09T00:00:002010Regulation of tumor angiogenesis by EZH2.20716963Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, Liu CG, Croce CM, Calin GA, Esteller MEpigeneticsDisrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics. 2010 Oct 01; 5(7):656-63.Epigenetics2010-10-01T00:00:002010Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.20920746Fabbri M, Calin GAAdvances in geneticsEpigenetics and miRNAs in human cancer. Adv Genet. 2010; 70:87-99.Adv Genet2010-01-01T00:00:002010Epigenetics and miRNAs in human cancer.21160526Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AKNature reviews. CancerRNA interference in the clinic: challenges and future directions. Nat Rev Cancer. 2011 Jan; 11(1):59-67.Nat Rev Cancer2010-12-16T00:00:002010RNA interference in the clinic: challenges and future directions.21205967Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CMJAMAAssociation of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA. 2011 Jan 05; 305(1):59-67.JAMA2011-01-05T00:00:002011Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.21266476Shao M, Rossi S, Chelladurai B, Shimizu M, Ntukogu O, Ivan M, Calin GA, Matei DNucleic acids researchPDGF induced microRNA alterations in cancer cells. Nucleic Acids Res. 2011 May; 39(10):4035-47.Nucleic Acids Res2011-01-25T00:00:002011PDGF induced microRNA alterations in cancer cells.21420983Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GAMutation researchEpigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res. 2011 Dec 01; 717(1-2):77-84.Mutat Res2011-03-21T00:00:002011Epigenetic regulation of microRNAs in cancer: an integrated review of literature.21458467Almeida MI, Reis RM, Calin GAMutation researchMicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011 Dec 01; 717(1-2):1-8.Mutat Res2011-03-30T00:00:002011MicroRNA history: discovery, recent applications, and next frontiers.21526983Munker R, Calin GAClinical science (London, England : 1979)MicroRNA profiling in cancer. Clin Sci (Lond). 2011 Aug; 121(4):141-58.Clin Sci (Lond)2011-08-01T00:00:002011MicroRNA profiling in cancer.21647195Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GANature reviews. Clinical oncologyMicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011 Jun 07; 8(8):467-77.Nat Rev Clin Oncol2011-06-07T00:00:002011MicroRNAs in body fluids--the mix of hormones and biomarkers.21888691Shah MY, Calin GAGenome medicineMicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med. 2011 Aug 31; 3(8):56.Genome Med2011-08-31T00:00:002011MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer.22035854Ling H, Zhang W, Calin GAChinese journal of cancerPrinciples of microRNA involvement in human cancers. Chin J Cancer. 2011 Nov; 30(11):739-48.Chin J Cancer2011-11-01T00:00:002011Principles of microRNA involvement in human cancers.22082762Ferracin M, Querzoli P, Calin GA, Negrini MSeminars in oncologyMicroRNAs: toward the clinic for breast cancer patients. Semin Oncol. 2011 Dec; 38(6):764-75.Semin Oncol2011-12-01T00:00:002011MicroRNAs: toward the clinic for breast cancer patients.22228303Rivetti di Val Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, Zhou H, Saintigny G, Dellambra E, Odorisio T, Mah? C, Calin GA, Candi E, Melino GProceedings of the National Academy of Sciences of the United States of Americap63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A. 2012 Jan 24; 109(4):1133-8.Proc Natl Acad Sci U S A2012-01-06T00:00:002012p63-microRNA feedback in keratinocyte senescence.22240480Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gaf? R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GAGastroenterologyStrand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology. 2012 Apr; 142(4):886-896.e9.Gastroenterology2012-01-10T00:00:002012Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.22370716Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E, Buzdar AU, Di Leo A, Le XF, Bast RC, Park ST, Pusztai L, Calin GACancerPlasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer. 2012 May 15; 118(10):2603-14.Cancer2011-10-05T00:00:002011Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.22647358Kunej T, Godnic I, Horvat S, Zorc M, Calin GACancer journal (Sudbury, Mass.)Cross talk between microRNA and coding cancer genes. Cancer J. 2012 May-Jun; 18(3):223-31.Cancer J2012-05-01T00:00:002012Cross talk between microRNA and coding cancer genes.22829924Le XF, Almeida MI, Mao W, Spizzo R, Rossi S, Nicoloso MS, Zhang S, Wu Y, Calin GA, Bast RCPloS oneModulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer. PLoS One. 2012; 7(7):e41170.PLoS One2012-07-19T00:00:002012Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer.23477558Van Roosbroeck K, Pollet J, Calin GAExpert review of molecular diagnosticsmiRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev Mol Diagn. 2013 Mar; 13(2):183-204.Expert Rev Mol Diagn2013-03-01T00:00:002013miRNAs and long noncoding RNAs as biomarkers in human diseases.23485132Spizzo R, Nicoloso MS, Calin GAExpert opinion on medical diagnosticsMicroRNAs as new biomarkers in oncology. Expert Opin Med Diagn. 2008 Feb; 2(2):115-27.Expert Opin Med Diagn2008-02-01T00:00:002008MicroRNAs as new biomarkers in oncology.23762306Godnic I, Zorc M, Jevsinek Skok D, Calin GA, Horvat S, Dovc P, Kovac M, Kunej TPloS oneGenome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken. PLoS One. 2013; 8(6):e65165.PLoS One2013-06-06T00:00:002013Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken.23821659Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, Nouraee N, Ikuo M, Ghosh AK, Lerner S, Rassenti LZ, Xiao L, Hu J, Reuben JM, Calin S, You MJ, Manning JT, Wierda WG, Estrov Z, O'Brien S, Kipps TJ, Keating MJ, Kay NE, Calin GABloodPrognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013 Sep 12; 122(11):1891-9.Blood2013-07-02T00:00:002013Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.23834177Braicu C, Calin GA, Berindan-Neagoe ICurrent medicinal chemistryMicroRNAs and cancer therapy - from bystanders to major players. Curr Med Chem. 2013; 20(29):3561-73.Curr Med Chem2013-01-01T00:00:002013MicroRNAs and cancer therapy - from bystanders to major players.24039846Nouraee N, Van Roosbroeck K, Vasei M, Semnani S, Samaei NM, Naghshvar F, Omidi AA, Calin GA, Mowla SJPloS oneExpression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma. PLoS One. 2013; 8(9):e73009.PLoS One2013-09-10T00:00:002013Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma.24172333Ling H, Fabbri M, Calin GANature reviews. Drug discoveryMicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013 Nov; 12(11):847-65.Nat Rev Drug Discov2013-11-01T00:00:002013MicroRNAs and other non-coding RNAs as targets for anticancer drug development.24475217Crippa E, Lusa L, De Cecco L, Marchesi E, Calin GA, Radice P, Manoukian S, Peissel B, Daidone MG, Gariboldi M, Pierotti MAPloS onemiR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer. PLoS One. 2014; 9(1):e87039.PLoS One2014-01-27T00:00:002014miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.24504363Pichler M, Ress AL, Winter E, Stiegelbauer V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW, Kiesslich T, Gerger A, Bauernhofer T, Calin GA, Hoefler GBritish journal of cancerMiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer. 2014 Mar 18; 110(6):1614-21.Br J Cancer2014-02-06T00:00:002014MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.24910097Liz J, Portela A, Soler M, G?mez A, Ling H, Michlewski G, Calin GA, Guil S, Esteller MMolecular cellRegulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol Cell. 2014 Jul 03; 55(1):138-47.Mol Cell2014-06-05T00:00:002014Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region.24914134Cui B, Chen L, Zhang S, Mraz M, Fecteau JF, Yu J, Ghia EM, Zhang L, Bao L, Rassenti LZ, Messer K, Calin GA, Croce CM, Kipps TJBloodMicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 2014 Jul 24; 124(4):546-54.Blood2014-06-09T00:00:002014MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.25104502Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GACA: a cancer journal for cliniciansMicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014 Sep-Oct; 64(5):311-36.CA Cancer J Clin2014-08-07T00:00:002014MicroRNAome genome: a treasure for cancer diagnosis and therapy.Authorship 2663661Authorship 2664117Authorship 2668945Authorship 2669507Authorship 2675923Authorship 26782513Authorship 2678792Authorship 2678803Authorship 2686289Authorship 26895113Authorship 2692932Authorship 2693375Authorship 2693947Authorship 2695096Authorship 26957416Authorship 2696202Authorship 2700034Authorship 2700578Authorship 2702714Authorship 2706791Authorship 2709222Authorship 2716524Authorship 27183512Authorship 272102215068392Sabbioni S, Miotto E, Veronese A, Sattin E, Gramantieri L, Bolondi L, Calin GA, Gaf? R, Lanza G, Carli G, Ferrazzi E, Feo C, Liboni A, Gullini S, Negrini MMolecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biologyMultigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol Diagn. 2003; 7(3-4):201-7.Mol Diagn2003-01-01T00:00:002003Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood.16061637Zanesi N, Mancini R, Sevignani C, Vecchione A, Kaou M, Valtieri M, Calin GA, Pekarsky Y, Gnarra JR, Croce CM, Huebner KCancer researchLung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency. Cancer Res. 2005 Aug 01; 65(15):6576-82.Cancer Res2005-08-01T00:00:002005Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.16330098Calin GA, Garzon R, Cimmino A, Fabbri M, Croce CMLeukemia researchMicroRNAs and leukemias: how strong is the connection? Leuk Res. 2006 Jun; 30(6):653-5.Leuk Res2005-12-02T00:00:002005MicroRNAs and leukemias: how strong is the connection?17563749Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco AOncogeneSpecific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2007 Nov 29; 26(54):7590-5.Oncogene2007-06-11T00:00:002007Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.17665990Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GAExpert opinion on biological therapyRegulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther. 2007 Jul; 7(7):1009-19.Expert Opin Biol Ther2007-07-01T00:00:002007Regulatory mechanisms of microRNAs involvement in cancer.18158129Liu CG, Spizzo R, Calin GA, Croce CMMethods (San Diego, Calif.)Expression profiling of microRNA using oligo DNA arrays. Methods. 2008 Jan; 44(1):22-30.Methods2008-01-01T00:00:002008Expression profiling of microRNA using oligo DNA arrays.18373886Negrini M, Calin GABreast cancer research : BCRBreast cancer metastasis: a microRNA story. Breast Cancer Res. 2008; 10(2):203.Breast Cancer Res2008-03-26T00:00:002008Breast cancer metastasis: a microRNA story.18375053Yendamuri S, Trapasso F, Calin GACancer lettersARLTS1 - a novel tumor suppressor gene. Cancer Lett. 2008 Jun 08; 264(1):11-20.Cancer Lett2008-03-28T00:00:002008ARLTS1 - a novel tumor suppressor gene.19671845Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M, Dinney CClinical cancer research : an official journal of the American Association for Cancer ResearchmiR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res. 2009 Aug 15; 15(16):5060-72.Clin Cancer Res2009-08-11T00:00:002009miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.19826008Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M, Capogrossi MC, Martelli FThe Journal of biological chemistryAn integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem. 2009 Dec 11; 284(50):35134-43.J Biol Chem2009-10-13T00:00:002009An integrated approach for experimental target identification of hypoxia-induced miR-210.19926640Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, Keating MJ, Croce CM, Calin GACarcinogenesisNon-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis. 2010 Feb; 31(2):208-15.Carcinogenesis2009-11-19T00:00:002009Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.20466868Sampath D, Calin GABloodCoding and noncoding: the CLL mix. Blood. 2010 May 13; 115(19):3858-9.Blood2010-05-13T00:00:002010Coding and noncoding: the CLL mix.20665731Cortez MA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR, Carlotti C, Tirapelli D, Neder L, Brassesco MS, Scrideli CA, Tone LG, Georgescu MM, Zhang W, Puduvalli V, Calin GAGenes, chromosomes & cancermiR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer. 2010 Nov; 49(11):981-90.Genes Chromosomes Cancer2010-11-01T00:00:002010miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.20802525Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller MOncogeneCpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene. 2010 Dec 02; 29(48):6390-401.Oncogene2010-08-30T00:00:002010CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.20974243Rossi S, Tsirigos A, Amoroso A, Mascellani N, Rigoutsos I, Calin GA, Volinia SGenomicsOMiR: Identification of associations between OMIM diseases and microRNAs. Genomics. 2011 Feb; 97(2):71-6.Genomics2010-10-23T00:00:002010OMiR: Identification of associations between OMIM diseases and microRNAs.21264920Yang H, Fang Z, Wei Y, Hu Y, Calin GA, Kantarjian HM, Garcia-Manero GAmerican journal of hematologyLevels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA. Am J Hematol. 2011 Feb; 86(2):237-8.Am J Hematol2011-02-01T00:00:002011Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRA.21270524Almeida MI, Reis RM, Calin GACell cycle (Georgetown, Tex.)BRCA1, microRNAs and cancer predisposition: challenging the dogma. Cell Cycle. 2011 Feb 01; 10(3):377.Cell Cycle2011-02-01T00:00:002011BRCA1, microRNAs and cancer predisposition: challenging the dogma.21816909Setoyama T, Zhang X, Natsugoe S, Calin GAClinical cancer research : an official journal of the American Association for Cancer ResearchmicroRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma? Clin Cancer Res. 2011 Sep 01; 17(17):5527-9.Clin Cancer Res2011-08-04T00:00:002011microRNA-10b: a new marker or the marker of pancreatic ductal adenocarcinoma?22213511Redis RS, Berindan-Neagoe I, Pop VI, Calin GAJournal of cellular biochemistryNon-coding RNAs as theranostics in human cancers. J Cell Biochem. 2012 May; 113(5):1451-9.J Cell Biochem2012-05-01T00:00:002012Non-coding RNAs as theranostics in human cancers.22791772Calin GA, Konopleva MBloodSmall gene, big number, many effects. Blood. 2012 Jul 12; 120(2):240-1.Blood2012-07-12T00:00:002012Small gene, big number, many effects.22947071Chen L, Calin GA, Zhang SJournal of chemical information and modelingNovel insights of structure-based modeling for RNA-targeted drug discovery. J Chem Inf Model. 2012 Oct 22; 52(10):2741-53.J Chem Inf Model2012-09-21T00:00:002012Novel insights of structure-based modeling for RNA-targeted drug discovery.23835474Nishida N, Mimori K, Mori M, Calin GACell researchEGFR gets in the way of microRNA biogenesis. Cell Res. 2013 Oct; 23(10):1157-8.Cell Res2013-07-09T00:00:002013EGFR gets in the way of microRNA biogenesis.24416156Anfossi S, Giordano A, Gao H, Cohen EN, Tin S, Wu Q, Garza RJ, Debeb BG, Alvarez RH, Valero V, Hortobagyi GN, Calin GA, Ueno NT, Woodward WA, Reuben JMPloS oneHigh serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer. PLoS One. 2014; 9(1):e83113.PLoS One2014-01-08T00:00:002014High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.24906400Pichler M, Calin GAJournal of the National Cancer InstituteLong noncoding RNA in neuroblastoma: new light on the (old) N-Myc story. J Natl Cancer Inst. 2014 Jul; 106(7).J Natl Cancer Inst2014-06-06T00:00:002014Long noncoding RNA in neuroblastoma: new light on the (old) N-Myc story.Authorship 2725641Authorship 2733621Authorship 2735391Authorship 2735512Authorship 2737237Authorship 2737325Authorship 2741818Authorship 2742134Authorship 2744603Authorship 2747174Authorship 27474523Authorship 2750463Authorship 27516111Authorship 2751702Authorship 2752873Authorship 27529823Authorship 2753287Authorship 2753773Authorship 276300110439970Calin G, Wijnen J, van der Klift H, Ionita A, Mulder A, Breukel C, Smits R, Dauwerse H, Hansson K, Calin S, Stefanescu D, Oproiu A, Fodde REuropean journal of human genetics : EJHGMarfan-like habitus and familial adenomatous polyposis in two unrelated males: a significant association? Eur J Hum Genet. 1999 Jul; 7(5):609-14.Eur J Hum Genet1999-07-01T00:00:001999Marfan-like habitus and familial adenomatous polyposis in two unrelated males: a significant association?16251535Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CMThe New England journal of medicineA MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005 Oct 27; 353(17):1793-801.N Engl J Med2005-10-27T00:00:002005A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.17707831Calin GA, Pekarsky Y, Croce CMBest practice & research. Clinical haematologyThe role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol. 2007 Sep; 20(3):425-37.Best Pract Res Clin Haematol2007-09-01T00:00:002007The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.17785203Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CMCancer cellUltraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007 Sep; 12(3):215-29.Cancer Cell2007-09-01T00:00:002007Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.19148134Yendamuri S, Calin GALeukemiaThe role of microRNA in human leukemia: a review. Leukemia. 2009 Jul; 23(7):1257-63.Leukemia2009-01-15T00:00:002009The role of microRNA in human leukemia: a review.19262572Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GANature reviews. CancerMicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009 04; 9(4):293-302.Nat Rev Cancer2009-03-05T00:00:002009MicroRNAs--the micro steering wheel of tumour metastases.19584283Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi LCancer researchMiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009 Jul 15; 69(14):5761-7.Cancer Res2009-07-07T00:00:002009MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.20553595Felli N, Cianetti L, Pelosi E, Car? A, Liu CG, Calin GA, Rossi S, Peschle C, Marziali G, Giuliani ABMC systems biologyHematopoietic differentiation: a coordinated dynamical process towards attractor stable states. BMC Syst Biol. 2010 Jun 16; 4:85.BMC Syst Biol2010-06-16T00:00:002010Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states.21318219Zheng H, Song F, Zhang L, Yang D, Ji P, Wang Y, Almeida M, Calin GA, Hao X, Wei Q, Zhang W, Chen KInternational journal of oncologyGenetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer. Int J Oncol. 2011 Apr; 38(4):1153-61.Int J Oncol2011-02-11T00:00:002011Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer.22266873Spizzo R, Almeida MI, Colombatti A, Calin GAOncogeneLong non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012 Oct 25; 31(43):4577-87.Oncogene2012-01-23T00:00:002012Long non-coding RNAs and cancer: a new frontier of translational research?22527502Cortez MA, Welsh JW, Calin GARecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancerCirculating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res. 2012; 195:151-61.Recent Results Cancer Res2012-01-01T00:00:002012Circulating microRNAs as noninvasive biomarkers in breast cancer.23409773Hudson RS, Yi M, Volfovsky N, Prueitt RL, Esposito D, Volinia S, Liu CG, Schetter AJ, Van Roosbroeck K, Stephens RM, Calin GA, Croce CM, Ambs SMolecular cancerTranscription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer. 2013 Feb 14; 12:13.Mol Cancer2013-02-14T00:00:002013Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer.23725032Rozovski U, Calin GA, Setoyama T, D'Abundo L, Harris DM, Li P, Liu Z, Grgurevic S, Ferrajoli A, Faderl S, Burger JA, O'Brien S, Wierda WG, Keating MJ, Estrov ZMolecular cancerSignal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer. 2013 Jun 01; 12:50.Mol Cancer2013-06-01T00:00:002013Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.24002999Nishimura M, Jung EJ, Shah MY, Lu C, Spizzo R, Shimizu M, Han HD, Ivan C, Rossi S, Zhang X, Nicoloso MS, Wu SY, Almeida MI, Bottsford-Miller J, Pecot CV, Zand B, Matsuo K, Shahzad MM, Jennings NB, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Calin GACancer discoveryTherapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov. 2013 Nov; 3(11):1302-15.Cancer Discov2013-09-03T00:00:002013Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.24013925Manyam G, Ivan C, Calin GA, Coombes KRBioinformatics (Oxford, England)targetHub: a programmable interface for miRNA-gene interactions. Bioinformatics. 2013 Oct 15; 29(20):2657-8.Bioinformatics2013-09-06T00:00:002013targetHub: a programmable interface for miRNA-gene interactions.24037088Ferdin J, Nishida N, Wu X, Nicoloso MS, Shah MY, Devlin C, Ling H, Shimizu M, Kumar K, Cortez MA, Ferracin M, Bi Y, Yang D, Czerniak B, Zhang W, Schmittgen TD, Voorhoeve MP, Reginato MJ, Negrini M, Davuluri RV, Kunej T, Ivan M, Calin GACell death and differentiationHINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ. 2013 Dec; 20(12):1675-87.Cell Death Differ2013-09-13T00:00:002013HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts.24212084Rayner K, Dimmeler S, Calin GA, Thum T, Raizman JE, Diamandis EPClinical chemistryNovel biomarkers for acute myocardial infarction: is microRNA the new kid on the block? Clin Chem. 2014 Jun; 60(6):812-7.Clin Chem2013-11-08T00:00:002013Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block?24373626Wang LQ, Kwong YL, Kho CS, Wong KF, Wong KY, Ferracin M, Calin GA, Chim CSMolecular cancerEpigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NF?B pathway. Mol Cancer. 2013 Dec 27; 12:173.Mol Cancer2013-12-27T00:00:002013Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NF?B pathway.24492836Schwarzenbach H, Nishida N, Calin GA, Pantel KNature reviews. Clinical oncologyClinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014 Mar; 11(3):145-56.Nat Rev Clin Oncol2014-02-04T00:00:002014Clinical relevance of circulating cell-free microRNAs in cancer.Authorship 27888230Authorship 27894013Authorship 2790179Authorship 27930319Authorship 2819796Authorship 2820815Authorship 2830897Authorship 2840995Authorship 2847703Authorship 2848331Authorship 2848403Authorship 2849551Authorship 2879333Authorship 2879413Authorship 2881675Authorship 2889955Authorship 28901715Authorship 2895382Authorship 2896259Authorship 2898636Authorship 29002913Authorship 2900753Authorship 2903045Authorship 2903203Authorship 2905419Authorship 2905502Authorship 2906133Authorship 2910063Authorship 2910982Authorship 2912165Authorship 29132410Authorship 2913286Authorship 2913304Authorship 2916715Authorship 2918723Authorship 2919089Authorship 2920968Authorship 2922326Authorship 2923383Authorship 29236126Authorship 2927002Authorship 2928077Authorship 29314724Authorship 2932554Authorship 29366316Authorship 2937367Authorship 2938434Authorship 29479613Authorship 29526224Authorship 2954452Authorship 2959512Authorship 2960209Authorship 2960557Authorship 2962473Authorship 29671013Authorship 2975094Authorship 29892228Authorship 2996485Authorship 2999679Authorship 3000043Authorship 3002532Authorship 30065816Authorship 3008839Authorship 30094225Authorship 3012903Authorship 3016962Authorship 30177819Authorship 3018744Authorship 3023863Authorship 3024378Authorship 3025052Authorship 30308313Authorship 3046061Authorship 30522510Authorship 30551319Authorship 30552528Authorship 3055623Authorship 3059272Authorship 3078141Authorship 3080124Authorship 3081581Authorship 3081702Authorship 3082501Authorship 3082671Authorship 3084972Authorship 3088503Authorship 3131832Authorship 31330324578083Calin GFtiziologia[Value and role of cyto-histo-bacteriological studies in making the diagnosis of the nature and stage of extrarespiratory tuberculosis]. Ftiziologia. 1972 Jan-Feb; 21(1):59-66.Ftiziologia1972-01-01T00:00:001972[Value and role of cyto-histo-bacteriological studies in making the diagnosis of the nature and stage of extrarespiratory tuberculosis].5055735Calin GFtiziologia[Atypical characteristics of present-day osteoarticular tuberculosis]. Ftiziologia. 1972 Mar-Apr; 21(2):167-76.Ftiziologia1972-03-01T00:00:001972[Atypical characteristics of present-day osteoarticular tuberculosis].5164534Calin G, Macovei D, Teodoru ARevista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi[Progesterone deficiency in cervical isthmic incompetence]. Rev Med Chir Soc Med Nat Iasi. 1971 Oct-Dec; 75(4):933-8.Rev Med Chir Soc Med Nat Iasi1971-10-01T00:00:001971[Progesterone deficiency in cervical isthmic incompetence].5364540Calin GRomanian medical reviewIntraabdominal tuberculosis--surgical findings. Rom Med Rev. 1969; 13(4):62-9.Rom Med Rev1969-01-01T00:00:001969Intraabdominal tuberculosis--surgical findings.5589311Olanescu G, Popescu E, Ivanovici F, Calin GDer Urologe[Colocystoplasty for enlargement of urine capacity of the bladder. Indications and results]. Urologe. 1967 May-Jun; 6(3):145-53.Urologe1967-05-01T00:00:001967[Colocystoplasty for enlargement of urine capacity of the bladder. Indications and results].6151721Proca E, Calin GRevista de chirurgie, oncologie, radiologie, o.r.l., oftalmologie, stomatologie. Chirurgie[Medical treatment of complete urinary retention with alpha blockaders]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1983 May-Jun; 32(3):161-8.Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir1983-05-01T00:00:001983[Medical treatment of complete urinary retention with alpha blockaders].6450968Proca E, Calin G, Popescu ARevista de chirurgie, oncologie, radiologie, o.r.l., oftalmologie, stomatologie. Chirurgie[Glenn-Cohen-Anderson operation in the treatment of vesico-renal reflux]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1980 May-Jun; 29(3):183-91.Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir1980-05-01T00:00:001980[Glenn-Cohen-Anderson operation in the treatment of vesico-renal reflux].7146760Proca E, Calin C, Calin G, Gurtavenco ARevista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Bacteriologia, virusologia, parazitologia, epidemiologia[Bacteriological study of patients treated with urethro-vesical catheterization]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1982 Apr-Jun; 27(2):73-80.Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol1982-04-01T00:00:001982[Bacteriological study of patients treated with urethro-vesical catheterization].14301261GAVRILESCU C, CALIN G, ALTARESCU M, NADOLU G, ZAMFIR MRevista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi[GENITAL HEMATOMA, A GRAVE APOPLECTIC DISORDER OF LATE PREGNANCY TOXEMIA]. Rev Med Chir Soc Med Nat Iasi. 1964 Apr-Jun; 68:375-9.Rev Med Chir Soc Med Nat Iasi1964-04-01T00:00:001964[GENITAL HEMATOMA, A GRAVE APOPLECTIC DISORDER OF LATE PREGNANCY TOXEMIA].14398881HAIMOVICI-HANES N, CALIN GArchives des maladies professionnelles de medecine du travail et de securite sociale[The education, re-education and readaption to work, during hospitalization, of extra-pulmonary tuberculotics]. Arch Mal Prof. 1959 Sep-Oct; 20:548-51.Arch Mal Prof1959-09-01T00:00:001959[The education, re-education and readaption to work, during hospitalization, of extra-pulmonary tuberculotics].17914491Georgescu EF, Stanescu L, Georgescu AC, Dumitrescu D, Foarfa C, Calin GRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieBone abnormalities occurring in the follow-up of the patients with neurofibromatosis type 1. Rom J Morphol Embryol. 2007; 48(3):249-56.Rom J Morphol Embryol2007-01-01T00:00:002007Bone abnormalities occurring in the follow-up of the patients with neurofibromatosis type 1.18060199Stanescu L, Georgescu CV, Georgescu AC, Georgescu I, Calin GRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieErythrokeratodermia variabilis - variant with circumscribed variable erythema and periorificial fixed Bazex Dupr? erythema. Rom J Morphol Embryol. 2007; 48(4):443-7.Rom J Morphol Embryol2007-01-01T00:00:002007Erythrokeratodermia variabilis - variant with circumscribed variable erythema and periorificial fixed Bazex Dupr? erythema.19434323Stanescu L, Popescu CF, Georgescu I, Georgescu CV, Anghelina L, Petrescu I, Calin GRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieSpitz nevus with an uncertain malignant potential. Rom J Morphol Embryol. 2009; 50(2):275-82.Rom J Morphol Embryol2009-01-01T00:00:002009Spitz nevus with an uncertain malignant potential.20809038Stanescu L, V?lcea A, Popescu CF, Niculescu CE, Ciobanu O, Calin GRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologiePlaque-type morphea in children. Rom J Morphol Embryol. 2010; 51(3):559-63.Rom J Morphol Embryol2010-01-01T00:00:002010Plaque-type morphea in children.21430351Ferdin J, Kunej T, Calin GAJournal of the Association of Genetic TechnologistsMicroRNA: Genomic Association with Cancer Predisposition. J Assoc Genet Technol. 2011; 37(1):11-9.J Assoc Genet Technol2011-01-01T00:00:002011MicroRNA: Genomic Association with Cancer Predisposition.21597834Calin G, Stefanescu DOncology reportsCan the loss of negative regulation theory be compatible with the development of hematological malignancies - (review). Oncol Rep. 1995 Sep; 2(5):875-8.Oncol Rep1995-09-01T00:00:001995Can the loss of negative regulation theory be compatible with the development of hematological malignancies - (review).21607451Stefanescu D, Colita D, Calin GOncology reportsA complex translocation t(1-12-11) in a patient with hodgkins-disease. Oncol Rep. 1994 Jul; 1(4):837-9.Oncol Rep1994-07-01T00:00:001994A complex translocation t(1-12-11) in a patient with hodgkins-disease.21607481Calin GOncology reportsOncogenes and tumor-suppressor genes - 2 different looks of the same gene. Oncol Rep. 1994 Sep; 1(5):987-91.Oncol Rep1994-09-01T00:00:001994Oncogenes and tumor-suppressor genes - 2 different looks of the same gene.24111776Gee HE, Ivan C, Calin GA, Ivan MAntioxidants & redox signalingHypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal. 2014 Sep 10; 21(8):1220-38.Antioxid Redox Signal2013-11-22T00:00:002013HypoxamiRs and cancer: from biology to targeted therapy.24121593Maia BM, Rocha RM, Calin GAEpigeneticsClinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology. Epigenetics. 2014 Jan; 9(1):75-80.Epigenetics2013-10-11T00:00:002013Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology.24373479Martens-Uzunova ES, B?ttcher R, Croce CM, Jenster G, Visakorpi T, Calin GAEuropean urologyLong noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014 Jun; 65(6):1140-51.Eur Urol2013-12-14T00:00:002013Long noncoding RNA in prostate, bladder, and kidney cancer.24687772Shah MY, Calin GAWiley interdisciplinary reviews. RNAMicroRNAs as therapeutic targets in human cancers. Wiley Interdiscip Rev RNA. 2014 Jul-Aug; 5(4):537-48.Wiley Interdiscip Rev RNA2014-03-28T00:00:002014MicroRNAs as therapeutic targets in human cancers.24690917Ga??n-G?mez I, Wei Y, Yang H, Pierce S, Bueso-Ramos C, Calin G, Boyano-Ad?nez Mdel C, Garc?a-Manero GPloS oneOverexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-?B activation and enhances erythroid differentiation arrest. PLoS One. 2014; 9(4):e93404.PLoS One2014-04-01T00:00:002014Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-?B activation and enhances erythroid differentiation arrest.24710569Liu X, Robinson SN, Setoyama T, Tung SS, D'Abundo L, Shah MY, Yang H, Yvon E, Shah N, Yang H, Konopleva M, Garcia-Manero G, McNiece I, Rezvani K, Calin GA, Shpall EJ, Parmar SBone marrow transplantationFOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. Bone Marrow Transplant. 2014 Jun; 49(6):793-9.Bone Marrow Transplant2014-04-07T00:00:002014FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells.24727437Armenia J, Fabris L, Lovat F, Berton S, Segatto I, D'Andrea S, Ivan C, Cascione L, Calin GA, Croce CM, Colombatti A, Vecchione A, Belletti B, Baldassarre GOncotargetContact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget. 2014 Mar 15; 5(5):1185-97.Oncotarget2014-03-15T00:00:002014Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.24791940Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, Komaki R, Giri DK, Quini CC, Wolfe T, Peltier HJ, Bader AG, Heymach JV, Meyn RE, Welsh JWMolecular therapy : the journal of the American Society of Gene TherapyTherapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther. 2014 Aug; 22(8):1494-1503.Mol Ther2014-05-05T00:00:002014Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.24914586Kita Y, Vincent K, Natsugoe S, Berindan-Neagoe I, Calin GAExpert review of molecular diagnosticsEpigenetically regulated microRNAs and their prospect in cancer diagnosis. Expert Rev Mol Diagn. 2014 Jul; 14(6):673-83.Expert Rev Mol Diagn2014-06-10T00:00:002014Epigenetically regulated microRNAs and their prospect in cancer diagnosis.24916701Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, Ferracin M, D'Abundo L, Saccenti E, Matis S, Lionetti M, Agnelli L, Gentile M, Recchia AG, Bossio S, Reverberi D, Rigolin G, Calin GA, Sabbioni S, Russo G, Tassone P, Morabito F, Ferrarini M, Neri AClinical cancer research : an official journal of the American Association for Cancer ResearchmicroRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters. Clin Cancer Res. 2014 Aug 01; 20(15):4141-53.Clin Cancer Res2014-06-10T00:00:002014microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.24920658Wu SY, Lopez-Berestein G, Calin GA, Sood AKScience translational medicineRNAi therapies: drugging the undruggable. Sci Transl Med. 2014 Jun 11; 6(240):240ps7.Sci Transl Med2014-06-11T00:00:002014RNAi therapies: drugging the undruggable.24941322Giza DE, Vasilescu C, Calin GAExpert opinion on biological therapyMicroRNAs and ceRNAs: therapeutic implications of RNA networks. Expert Opin Biol Ther. 2014 Sep; 14(9):1285-93.Expert Opin Biol Ther2014-06-18T00:00:002014MicroRNAs and ceRNAs: therapeutic implications of RNA networks.25063298Ru Y, Kechris KJ, Tabakoff B, Hoffman P, Radcliffe RA, Bowler R, Mahaffey S, Rossi S, Calin GA, Bemis L, Theodorescu DNucleic acids researchThe multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014; 42(17):e133.Nucleic Acids Res2014-07-24T00:00:002014The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations.25069439Bottoni A, Calin GAMicroRNA (Shariqah, United Arab Emirates)MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia. Microrna. 2014; 2(3):158-64.Microrna2014-01-01T00:00:002014MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia.25070780Nouraee N, Calin GAMicroRNA (Shariqah, United Arab Emirates)MicroRNAs as cancer biomarkers. Microrna. 2013; 2(2):102-17.Microrna2013-01-01T00:00:002013MicroRNAs as cancer biomarkers.25093380Van Roosbroeck K, Verstovsek S, Calin GALeukemia & lymphomaLong non-coding RNAs in primary myelofibrosis: the dark matter in hematopoietic progenitor cells? Leuk Lymphoma. 2015 Feb; 56(2):281-2.Leuk Lymphoma2015-02-01T00:00:002015Long non-coding RNAs in primary myelofibrosis: the dark matter in hematopoietic progenitor cells?25123609Kunej T, Obsteter J, Pogacar Z, Horvat S, Calin GACritical reviews in clinical laboratory sciencesThe decalog of long non-coding RNA involvement in cancer diagnosis and monitoring. Crit Rev Clin Lab Sci. 2014 Dec; 51(6):344-57.Crit Rev Clin Lab Sci2014-08-15T00:00:002014The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.25190496Bottai G, Pasculli B, Calin GA, Santarpia LExpert opinion on biological therapyTargeting the microRNA-regulating DNA damage/repair pathways in cancer. Expert Opin Biol Ther. 2014 Nov; 14(11):1667-83.Expert Opin Biol Ther2014-09-05T00:00:002014Targeting the microRNA-regulating DNA damage/repair pathways in cancer.25216221Zuo Z, Maiti S, Hu S, Loghavi S, Calin GA, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Cooper LJ, Bueso-Ramos CEModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPlasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes. Mod Pathol. 2015 Mar; 28(3):373-82.Mod Pathol2014-09-12T00:00:002014Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes.25232827Nassar FJ, El Sabban M, Zgheib NK, Tfayli A, Boulos F, Jabbour M, El Saghir NS, Talhouk R, Bazarbachi A, Calin GA, Nasr RPloS onemiRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study. PLoS One. 2014; 9(9):e107566.PLoS One2014-09-18T00:00:002014miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study.25236394Braicu C, Tomuleasa C, Monroig P, Cucuianu A, Berindan-Neagoe I, Calin GACell death and differentiationExosomes as divine messengers: are they the Hermes of modern molecular oncology? Cell Death Differ. 2015 Jan; 22(1):34-45.Cell Death Differ2014-09-19T00:00:002014Exosomes as divine messengers: are they the Hermes of modern molecular oncology?25239236Monroig Pdel C, Chen L, Zhang S, Calin GAAdvanced drug delivery reviewsSmall molecule compounds targeting miRNAs for cancer therapy. Adv Drug Deliv Rev. 2015 Jan; 81:104-16.Adv Drug Deliv Rev2014-09-17T00:00:002014Small molecule compounds targeting miRNAs for cancer therapy.25261368Ress AL, Stiegelbauer V, Schwarzenbacher D, Deutsch A, Perakis S, Ling H, Ivan C, Calin GA, Rinner B, Gerger A, Pichler MOncotargetSpinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget. 2014 Sep 30; 5(18):8492-502.Oncotarget2014-09-30T00:00:002014Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.25304686Zhang S, Lu Z, Unruh AK, Ivan C, Baggerly KA, Calin GA, Li Z, Bast RC, Le XFMolecular cancer research : MCRClinically relevant microRNAs in ovarian cancer. Mol Cancer Res. 2015 Mar; 13(3):393-401.Mol Cancer Res2014-10-10T00:00:002014Clinically relevant microRNAs in ovarian cancer.25338714Sato-Kuwabara Y, Melo SA, Soares FA, Calin GAInternational journal of oncologyThe fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol. 2015 Jan; 46(1):17-27.Int J Oncol2014-10-17T00:00:002014The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review).25341933Braicu C, Catana C, Calin GA, Berindan-Neagoe ICurrent pharmaceutical designNCRNA combined therapy as future treatment option for cancer. Curr Pharm Des. 2014; 20(42):6565-74.Curr Pharm Des2014-01-01T00:00:002014NCRNA combined therapy as future treatment option for cancer.25351346Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand B, Dalton HJ, Filant J, Miller JB, Lu C, Sadaoui NC, Mangala LS, Taylor M, van den Beucken T, Koch E, Rodriguez-Aguayo C, Huang L, Bar-Eli M, Wouters BG, Radovich M, Ivan M, Calin GA, Zhang W, Lopez-Berestein G, Sood AKNature communicationsHypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun. 2014 Oct 29; 5:5202.Nat Commun2014-10-29T00:00:002014Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.25352916Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, Volinia SGenome medicineA large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Med. 2014; 6(10):76.Genome Med2014-10-02T00:00:002014A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma.25369454Silla T, Kepp K, Tai ES, Goh L, Davila S, Catela Ivkovic T, Calin GA, Voorhoeve PMPloS oneAllele frequencies of variants in ultra conserved elements identify selective pressure on transcription factor binding. PLoS One. 2014; 9(11):e110692.PLoS One2014-11-04T00:00:002014Allele frequencies of variants in ultra conserved elements identify selective pressure on transcription factor binding.25476907Tudor S, Giza DE, Lin HY, Fabris L, Yoshiaki K, D'Abundo L, Toale KM, Shimizu M, Ferracin M, Challagundla KB, Cortez MA, Fuentes-Mattei E, Tulbure D, Gonzalez C, Henderson J, Row M, Rice TW, Ivan C, Negrini M, Fabbri M, Morris JS, Yeung SC, Vasilescu C, Calin GACell death & diseaseCellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis. 2014 Dec 04; 5:e1559.Cell Death Dis2014-12-04T00:00:002014Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma.25512634Berindan-Neagoe I, Calin GAClinical cancer research : an official journal of the American Association for Cancer ResearchMolecular pathways: microRNAs, cancer cells, and microenvironment. Clin Cancer Res. 2014 Dec 15; 20(24):6247-53.Clin Cancer Res2014-12-15T00:00:002014Molecular pathways: microRNAs, cancer cells, and microenvironment.25517752Ciccone M, Ferrajoli A, Keating MJ, Calin GACancer cellSnapShot: chronic lymphocytic leukemia. Cancer Cell. 2014 Nov 10; 26(5):770-770.e1.Cancer Cell2014-11-10T00:00:002014SnapShot: chronic lymphocytic leukemia.25547678Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, B?rresen-Dale AL, Santarpia LClinical cancer research : an official journal of the American Association for Cancer ResearchA serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients. Clin Cancer Res. 2015 Mar 01; 21(5):1207-14.Clin Cancer Res2014-12-29T00:00:002014A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.25595279Gonzalez-Villasana V, Fuentes-Mattei E, Ivan C, Dalton HJ, Rodriguez-Aguayo C, Fernandez-de Thomas RJ, Aslan B, Del C Monroig P, Velazquez-Torres G, Previs RA, Pradeep S, Kahraman N, Wang H, Kanlikilicer P, Ozpolat B, Calin G, Sood AK, Lopez-Berestein GClinical cancer research : an official journal of the American Association for Cancer ResearchRac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer. Clin Cancer Res. 2015 May 01; 21(9):2127-37.Clin Cancer Res2015-01-16T00:00:002015Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer.25619839Ling H, Vincent K, Pichler M, Fodde R, Berindan-Neagoe I, Slack FJ, Calin GAOncogeneJunk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. 2015 Sep 24; 34(39):5003-11.Oncogene2015-01-26T00:00:002015Junk DNA and the long non-coding RNA twist in cancer genetics.25686251Shoshan E, Mobley AK, Braeuer RR, Kamiya T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, Velazquez-Torres G, Nip KM, Zhu K, Brooks D, Jones SJ, Birol I, Mosqueda M, Wen YY, Eterovic AK, Sood AK, Hwu P, Gershenwald JE, Robertson AG, Calin GA, Markel G, Fidler IJ, Bar-Eli MNature cell biologyReduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol. 2015 Mar; 17(3):311-21.Nat Cell Biol2015-02-16T00:00:002015Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.25735862Chen M, Calin GA, Meng QHAdvances in clinical chemistryCirculating microRNAs as Promising Tumor Biomarkers. Adv Clin Chem. 2014; 67:189-214.Adv Clin Chem2014-11-04T00:00:002014Circulating microRNAs as Promising Tumor Biomarkers.25763353Ciccone M, Calin GA, Perrotti DFrontiers in oncologyFrom the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies. Front Oncol. 2015; 5:21.Front Oncol2015-02-16T00:00:002015From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies.25775553Nunes DN, Dias-Neto E, Card?-Vila M, Edwards JK, Dobroff AS, Giordano RJ, Mandelin J, Brentani HP, Hasselgren C, Yao VJ, Marchi? S, Pereira CA, Passetti F, Calin GA, Sidman RL, Arap W, Pasqualini RProceedings of the National Academy of Sciences of the United States of AmericaSynchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch. Proc Natl Acad Sci U S A. 2015 Mar 24; 112(12):3770-5.Proc Natl Acad Sci U S A2015-03-09T00:00:002015Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch.25779950Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Card?-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini RClinical cancer research : an official journal of the American Association for Cancer ResearchTargeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens. Clin Cancer Res. 2015 Jul 01; 21(13):3041-51.Clin Cancer Res2015-03-16T00:00:002015Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.25788261Bullock MD, Pickard K, Mitter R, Sayan AE, Primrose JN, Ivan C, Calin GA, Thomas GJ, Packham GK, Mirnezami AHOncotargetStratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget. 2015 Mar 30; 6(9):7262-79.Oncotarget2015-03-30T00:00:002015Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.25832733Nouraee N, Mowla SJ, Calin GAGenes, chromosomes & cancerTracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy. Genes Chromosomes Cancer. 2015 Jun; 54(6):335-52.Genes Chromosomes Cancer2015-03-31T00:00:002015Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.25857299Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, Wagner K, Langsenlehner T, Resel M, Gerger A, Ling H, Ivan C, Calin GA, Hoefler G, Rinner B, Pichler MOncotargetLow spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget. 2015 May 10; 6(13):11191-202.Oncotarget2015-05-10T00:00:002015Low spinophilin expression enhances aggressive biological behavior of breast cancer.25972604Challagundla KB, Wise PM, Neviani P, Chava H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, Fanini F, Amadori D, Calin GA, Hadjidaniel M, Shimada H, Jong A, Seeger RC, Asgharzadeh S, Goldkorn A, Fabbri MJournal of the National Cancer InstituteExosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015 Jul; 107(7).J Natl Cancer Inst2015-05-13T00:00:002015Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.26041938Ye X, Fan F, Bhattacharya R, Bellister S, Boulbes DR, Wang R, Xia L, Ivan C, Zheng X, Calin GA, Wang J, Lu X, Ellis LMMolecular cancer research : MCRVEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells. Mol Cancer Res. 2015 Sep; 13(9):1274-82.Mol Cancer Res2015-06-03T00:00:002015VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells.26080435Salameh A, Lee AK, Card?-Vila M, Nunes DN, Efstathiou E, Staquicini FI, Dobroff AS, Marchi? S, Navone NM, Hosoya H, Lauer RC, Wen S, Salmeron CC, Hoang A, Newsham I, Lima LA, Carraro DM, Oliviero S, Kolonin MG, Sidman RL, Do KA, Troncoso P, Logothetis CJ, Brentani RR, Calin GA, Cavenee WK, Dias-Neto E, Pasqualini R, Arap WProceedings of the National Academy of Sciences of the United States of AmericaPRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A. 2015 Jul 07; 112(27):8403-8.Proc Natl Acad Sci U S A2015-06-15T00:00:002015PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.26081979Aslan B, Monroig P, Hsu MC, Pena GA, Rodriguez-Aguayo C, Gonzalez-Villasana V, Rupaimoole R, Nagaraja AS, Mangala S, Han HD, Yuca E, Wu SY, Ivan C, Moss TJ, Ram PT, Wang H, Gol-Chambers A, Ozkayar O, Kanlikilicer P, Fuentes-Mattei E, Kahraman N, Pradeep S, Ozpolat B, Tucker S, Hung MC, Baggerly K, Bartholomeusz G, Calin G, Sood AK, Lopez-Berestein GNature communicationsThe ZNF304-integrin axis protects against anoikis in cancer. Nat Commun. 2015 Jun 17; 6:7351.Nat Commun2015-06-17T00:00:002015The ZNF304-integrin axis protects against anoikis in cancer.26090587Bullock MD, Silva AM, Calin GACell cycle (Georgetown, Tex.)Estrogen and breast cancer: can less mean more? Cell Cycle. 2015; 14(14):2197-8.Cell Cycle2015-06-19T00:00:002015Estrogen and breast cancer: can less mean more?26138095Garc?a-Cruz R, Camats M, Calin GA, Liu CG, Volinia S, Taccioli C, Croce CM, Bach-Elias MBMC medical geneticsThe role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model. BMC Med Genet. 2015 Jul 03; 16:46.BMC Med Genet2015-07-03T00:00:002015The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.26158421Pichler M, Calin GABritish journal of cancerMicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015 Aug 11; 113(4):569-73.Br J Cancer2015-07-09T00:00:002015MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients.26288818Ferrajoli A, Ivan C, Ciccone M, Shimizu M, Kita Y, Ohtsuka M, D'Abundo L, Qiang J, Lerner S, Nouraee N, Rabe KG, Rassenti LZ, Van Roosbroeck K, Manning JT, Yuan Y, Zhang X, Shanafelt TD, Wierda WG, Sabbioni S, Tarrand JJ, Estrov Z, Radovich M, Liang H, Negrini M, Kipps TJ, Kay NE, Keating M, Calin GAEBioMedicineEpstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine. 2015 Jun; 2(6):572-82.EBioMedicine2015-04-29T00:00:002015Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.26297962de Melo Maia B, Ling H, Monroig P, Ciccone M, Soares FA, Calin GA, Rocha RMMolecular and cellular probesDesign of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. Mol Cell Probes. 2015 Dec; 29(6):420-426.Mol Cell Probes2015-08-20T00:00:002015Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma.26308063Ohtsuka M, Ling H, Doki Y, Mori M, Calin GAJournal of clinical medicineMicroRNA Processing and Human Cancer. J Clin Med. 2015 Aug 21; 4(8):1651-67.J Clin Med2015-08-21T00:00:002015MicroRNA Processing and Human Cancer.26362400Chira S, Jackson CS, Oprea I, Ozturk F, Pepper MS, Diaconu I, Braicu C, Raduly LZ, Calin GA, Berindan-Neagoe IOncotargetProgresses towards safe and efficient gene therapy vectors. Oncotarget. 2015 Oct 13; 6(31):30675-703.Oncotarget2015-10-13T00:00:002015Progresses towards safe and efficient gene therapy vectors.26372796Monroig-Bosque Pdel C, Rivera CA, Calin GAExpert opinion on biological therapyMicroRNAs in cancer therapeutics: "from the bench to the bedside". Expert Opin Biol Ther. 2015; 15(10):1381-5.Expert Opin Biol Ther2015-01-01T00:00:002015MicroRNAs in cancer therapeutics: "from the bench to the bedside".26408530Schwarzenbach H, da Silva AM, Calin G, Pantel KClinical chemistryData Normalization Strategies for MicroRNA Quantification. Clin Chem. 2015 Nov; 61(11):1333-42.Clin Chem2015-09-25T00:00:002015Data Normalization Strategies for MicroRNA Quantification.26452030De Mattos-Arruda L, Bottai G, Nuciforo PG, Di Tommaso L, Giovannetti E, Peg V, Losurdo A, P?rez-Garcia J, Masci G, Corsi F, Cort?s J, Seoane J, Calin GA, Santarpia LOncotargetMicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 2015 Nov 10; 6(35):37269-80.Oncotarget2015-11-10T00:00:002015MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.26465158Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori KPloS oneAn Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma. PLoS One. 2015; 10(10):e0139808.PLoS One2015-10-14T00:00:002015An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.26516918Silva A, Bullock M, Calin GCancersThe Clinical Relevance of Long Non-Coding RNAs in Cancer. Cancers (Basel). 2015 Oct 27; 7(4):2169-82.Cancers (Basel)2015-10-27T00:00:002015The Clinical Relevance of Long Non-Coding RNAs in Cancer.26577528Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, Araujo L, Carbone DP, Shilo K, Giri DK, Kelnar K, Martin D, Komaki R, Gomez DR, Krishnan S, Calin GA, Bader AG, Welsh JWJournal of the National Cancer InstitutePDL1 Regulation by p53 via miR-34. J Natl Cancer Inst. 2016 Jan; 108(1).J Natl Cancer Inst2015-11-17T00:00:002015PDL1 Regulation by p53 via miR-34.26651018Tuna M, Machado AS, Calin GAGenes, chromosomes & cancerGenetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes Chromosomes Cancer. 2016 Mar; 55(3):193-214.Genes Chromosomes Cancer2015-12-09T00:00:002015Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.26658994Giza DE, Calin GAAdvances in experimental medicine and biologymicroRNA and Chronic Lymphocytic Leukemia. Adv Exp Med Biol. 2015; 889:23-40.Adv Exp Med Biol2015-01-01T00:00:002015microRNA and Chronic Lymphocytic Leukemia.26670277Cortez MA, Valdecanas D, Niknam S, Peltier HJ, Diao L, Giri U, Komaki R, Calin GA, Gomez DR, Chang JY, Heymach JV, Bader AG, Welsh JWMolecular therapy. Nucleic acidsIn Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation. Mol Ther Nucleic Acids. 2015 Dec 15; 4:e270.Mol Ther Nucleic Acids2015-12-15T00:00:002015In Vivo Delivery of miR-34a Sensitizes Lung Tumors to Radiation Through RAD51 Regulation.26686630Rupaimoole R, Lee J, Haemmerle M, Ling H, Previs RA, Pradeep S, Wu SY, Ivan C, Ferracin M, Dennison JB, Millward NMZ, Nagaraja AS, Gharpure KM, McGuire M, Sam N, Armaiz-Pena GN, Sadaoui NC, Rodriguez-Aguayo C, Calin GA, Drapkin RI, Kovacs J, Mills GB, Zhang W, Lopez-Berestein G, Bhattacharya PK, Sood AKCell reportsLong Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Rep. 2015 Dec 22; 13(11):2395-2402.Cell Rep2015-12-10T00:00:002015Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis.26697428Catana CS, Calin GA, Berindan-Neagoe IFrontiers in medicineInflamma-miRs in Aging and Breast Cancer: Are They Reliable Players? Front Med (Lausanne). 2015; 2:85.Front Med (Lausanne)2015-12-15T00:00:002015Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?26721482Zhang X, Lopez-Berestein G, Sood AK, Calin GAMethods in molecular biology (Clifton, N.J.)Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray. Methods Mol Biol. 2016; 1402:33-41.Methods Mol Biol2016-01-01T00:00:002016Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray.26504901Bucur O, Almasan A, Zubarev R, Friedman M, Nicolson GL, Sumazin P, Leabu M, Nikolajczyk BS, Avram D, Kunej T, Calin GA, Godwin AK, Adami HO, Zaphiropoulos PG, Richardson DR, Schmitt-Ulms G, Westerblad H, Keniry M, Grau GE, Carbonetto S, Stan RV, Popa-Wagner A, Takhar K, Baron BW, Galardy PJ, Yang F, Data D, Fadare O, Yeo KJ, Gabreanu GR, Andrei S, Soare GR, Nelson MA, Liehn EADiscoveries (Craiova, Romania)An updated h-index measures both the primary and total scientific output of a researcher. Discoveries (Craiova). 2015 Jul-Sep; 3(3).Discoveries (Craiova)2015-09-30T00:00:002015An updated h-index measures both the primary and total scientific output of a researcher.27075851Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WAJournal of the National Cancer InstitutemiR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst. 2016 08; 108(8).J Natl Cancer Inst2016-04-13T00:00:002016miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.74Professor10Assistant Professor54InstructorMARIA ANGELICA ABDALLACORTEZMARIA ANGELICA ABDALLA CORTEZ11775CORTEZ, MARIA ANGELICA ABDALLAInstructorCRISTINAIVANCRISTINA IVAN11810IVAN, CRISTINAAssistant ProfessorHUILINGHUI LING11812LING, HUIAssistant ProfessorKATRIENVAN ROOSBROECKKATRIEN VAN ROOSBROECK11829VAN ROOSBROECK, KATRIENInstructor26733610Vitale C, Falchi L, Ten Hacken E, Gao H, Shaim H, Van Roosbroeck K, Calin G, O'Brien S, Faderl S, Wang X, Wierda WG, Rezvani K, Reuben JM, Burger JA, Keating MJ, Ferrajoli AClinical cancer research : an official journal of the American Association for Cancer ResearchOfatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics. Clin Cancer Res. 2016 05 15; 22(10):2359-67.Clin Cancer Res2016-01-05T00:00:002016Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics.26853146Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gaf? R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio ALB, Gomes Dias SM, Calin GAMolecular cellAllele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.Mol Cell2016-02-04T00:00:002016Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.Authorship 37455640Authorship 84116722350414Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev DCancer researchMiR-155 is a liposarcoma oncogene that targets casein kinase-1a and enhances ?-catenin signaling. Cancer Res. 2012 Apr 01; 72(7):1751-62.Cancer Res2012-02-20T00:00:002012MiR-155 is a liposarcoma oncogene that targets casein kinase-1a and enhances ?-catenin signaling.Authorship 841387Authorship 841732Authorship 841931Authorship 842250Authorship 842713Authorship 842914Authorship 843684Authorship 843894Authorship 845525Authorship 845603Authorship 845753Authorship 846449Authorship 846835Authorship 847193Authorship 847463Authorship 848043Authorship 848337Authorship 848466Authorship 848831Authorship 848841Authorship 848902Authorship 848965Authorship 849314Authorship 849796Authorship 849965Authorship 850119Authorship 850248Authorship 850393Authorship 850600Authorship 850935Authorship 851080Authorship 851625Authorship 851782Authorship 852027Authorship 852046Authorship 852421Authorship 853220Authorship 853306Authorship 853566Authorship 854057Authorship 854154Authorship 854788Authorship 854856Authorship 854935Authorship 855103Authorship 855168Authorship 855747Authorship 855749Authorship 856790Authorship 857204Authorship 857249Authorship 857278Authorship 857357Authorship 857542Authorship 857626Authorship 857720Authorship 858020Authorship 858687Authorship 858767Authorship 859086Authorship 859414Authorship 859770Authorship 859892Authorship 860163Authorship 860247Authorship 860725Authorship 860871Authorship 860986Authorship 861266Authorship 861376Authorship 861411Authorship 861555Authorship 861611Authorship 861786Authorship 861900Authorship 862001Authorship 862150Authorship 862583Authorship 863216Authorship 863279Authorship 863496Authorship 863919Authorship 863999Authorship 864109Authorship 864339Authorship 864981Authorship 865220Authorship 865315Authorship 865364Authorship 865597Authorship 865865Authorship 865990Authorship 865996Authorship 866310Authorship 866549Authorship 867045Authorship 867211Authorship 867227Authorship 867607Authorship 867837Clinical Cancer ResearchTargeting IL11 receptor in leukemia and lymphoma. Clinical Cancer Research. 21:3041-3051.Targeting IL11 receptor in leukemia and lymphomaOncoImmunologyFrom cell biology to immunology. OncoImmunology. 5.From cell biology to immunologyModern PathologyPlasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes. Modern Pathology. Plasma circulating-microRNA profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromesHigh throughput microRNAs profiling in cancers. 309-321.High throughput microRNAs profiling in cancersMolecular OncologyCirculating free xeno-microRNAs - The new kids on the block. Molecular Oncology. 10:503-508.Circulating free xeno-microRNAs - The new kids on the blockNature CommunicationsThe ZNF304-integrin axis protects against anoikis in cancer. Nature Communications. 6.The ZNF304-integrin axis protects against anoikis in cancerCell MetabolismSnapShot. Cell Metabolism. 25:220-220.e1.SnapShotPLoS OneAn integrative analysis to identify driver genes in esophageal squamous cell carcinoma. PLoS One. 10.An integrative analysis to identify driver genes in esophageal squamous cell carcinomaOncogeneJunk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. Junk DNA and the long non-coding RNA twist in cancer geneticsInternational Journal of Molecular SciencesCurrent status of long non-coding RNAs in human breast cancer. International Journal of Molecular Sciences. 17.Current status of long non-coding RNAs in human breast cancerMolecular Cancer ResearchVEGFR-1 pseudogene expression and regulatory function in human colorectal cancer cells. Molecular Cancer Research. 13:1274-1282.VEGFR-1 pseudogene expression and regulatory function in human colorectal cancer cellsMolecular Therapy - Nucleic AcidsIn vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Molecular Therapy - Nucleic Acids. 4.In vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulationCell Death and DifferentiationCellular and viral microRNAs in sepsis. Cell Death and Differentiation. Cellular and viral microRNAs in sepsisMinerva BiotecnologicaInvestigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways. Minerva Biotecnologica. 20:13-21.Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathwaysProfiling long noncoding RNA expression using custom-designed microarray. 33-41.Profiling long noncoding RNA expression using custom-designed microarrayOncotargetOver-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget. 7:31361-31371.Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinomaIn silico prediction of target SNPs affecting miR-mRNA interaction. 211-214.In silico prediction of target SNPs affecting miR-mRNA interactionCell ReportsDirect Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Reports. 15:1493-1504.Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian CancerOncology ReportsOncogenes and tumor suppressor genes - two different looks of the same gene?. Oncology Reports. 1:987-991.Oncogenes and tumor suppressor genes - two different looks of the same gene?Molecular CellCorrection to Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 [Molecular Cell 61, 520-534, (2016)]. Molecular Cell. 61:640.Correction to Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2 [Molecular Cell 61, 520-534, (2016)]MicroRNAs and drug resistance. 257-270.MicroRNAs and drug resistanceJournal of Experimental and Clinical Cancer ResearchTargeting microRNAs as key modulators of tumor immune response. Journal of Experimental and Clinical Cancer Research. 35.Targeting microRNAs as key modulators of tumor immune responseNew England Journal of MedicineThe authors reply [3]. New England Journal of Medicine. 354:525.The authors reply [3]OncotargetLong non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget. 7:20636-20654.Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesisClinical LeukemiaMicroRNAs. Clinical Leukemia. 3:20-32.MicroRNAsMicroRNAs as Drugs and Drug Targets in Cancer. 97-111.MicroRNAs as Drugs and Drug Targets in CancerOncogeneRadiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. Oncogene. Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathwayCell ReportsLong Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis. Cell Reports. 13:2395-2402.Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering GlycolysisOncotargetMicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients. Oncotarget. 6:37269-37280.MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patientsOncotargetGlobally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget. 7:53165-53177.Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinomaBeyond Mirnas. 247-264.Beyond MirnasEBioMedicineEBioMedicine. 12:34-42.EBioMedicineNature GeneticsErratum. Nature Genetics. 42:464.ErratumOncotargetExamining plasma microRNA markers for colorectal cancer at different stages. Oncotarget. 7:11434-11449.Examining plasma microRNA markers for colorectal cancer at different stagesEBioMedicineH19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer. EBioMedicine. 13:113-124.H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal CancerFrontiers in OncologyFrom the biology of PP2A to the PADs for therapy of hematologic malignancies. Frontiers in Oncology. 4 AUG.From the biology of PP2A to the PADs for therapy of hematologic malignanciesAmerican Journal of PathologyHodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression Pattern. American Journal of Pathology. 186:2251-2253.Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression PatternMolecular Cancer ResearchClinically relevant microRNAs in ovarian cancer. Molecular Cancer Research. 13:393-401.Clinically relevant microRNAs in ovarian cancerOncology ReportsCan the loss of negative regulation theory be compatible with the development of hematological malignancies?. Oncology Reports. 2:875-878.Can the loss of negative regulation theory be compatible with the development of hematological malignancies?OncotargetMiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget. 7:49217-49231.MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppressionLeukemia and LymphomaLong non-coding RNAs in primary myelofibrosis. Leukemia and Lymphoma. 56:281-282.Long non-coding RNAs in primary myelofibrosisMathematical BiosciencesFrom mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localization. Mathematical Biosciences. 280:50-61.From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localizationThe Role of MicroRNAs and Ultraconserved Non-Coding RNAs in Cancer. 435-447.The Role of MicroRNAs and Ultraconserved Non-Coding RNAs in CancerGenome MedicineA large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Medicine. 6.A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human gliomaClinical Cancer ResearchOfatumumab and lenalidomide for patients with relapsed or refractory chronic lymphocytic leukemia. Clinical Cancer Research. 22:2359-2367.Ofatumumab and lenalidomide for patients with relapsed or refractory chronic lymphocytic leukemiaProceedings of the National Academy of Sciences of the United States of AmericaAnalysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs. Proceedings of the National Academy of Sciences of the United States of America. 112:E1106-E1115.Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAsBioinformatics, non-coding RNAs and its possible application in personalized medicine. 21-37.Bioinformatics, non-coding RNAs and its possible application in personalized medicineNew England Journal of MedicineThe authors reply [12]. New England Journal of Medicine. 354:1205.The authors reply [12]GutThe clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasisCancer ResearchUbiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells. Cancer Research. 76:7194-7207.Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cellsOncogeneMicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. Oncogene. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancerDrug-MicroRNA Cross-Talk. 991-1016.Drug-MicroRNA Cross-TalkNature GeneticsErratum. Nature Genetics. 48:221.ErratumJournal of Nucleic Acids InvestigationNon-coding RNAs and cancer. Journal of Nucleic Acids Investigation. 2:27-30.Non-coding RNAs and cancerJournal of Cellular BiochemistryErratum. Journal of Cellular Biochemistry. 115:2045.ErratumBreast DiseasesPrinciples of MicroRNA involvement in breast cancer. Breast Diseases. 22:238-243.Principles of MicroRNA involvement in breast cancerBMC CancerMALAT1 promoted invasiveness of gastric adenocarcinoma. BMC Cancer. 17.MALAT1 promoted invasiveness of gastric adenocarcinomaCancer DiscoveryMiRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discovery. 6:235-246.MiRNA deregulation in cancer cells and the tumor microenvironmentNew England Journal of MedicineFamilial cancer and ARLTS1 [1] (multiple letters). New England Journal of Medicine. 353:313-314.Familial cancer and ARLTS1 [1] (multiple letters)MicroRNAs in cancer (an overview). 1-71.MicroRNAs in cancer (an overview)Breast DiseasesIdentification of circulating MicroRNA signatures for breast cancer detection. Breast Diseases. 25:31-33.Identification of circulating MicroRNA signatures for breast cancer detectionBloodWhen kissing (disease) counts. Blood. 127:1947-1948.When kissing (disease) countsMicroRNAs and other non-coding RNAs. 1-12.MicroRNAs and other non-coding RNAsCancer CellGenetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell. 29:607-608.Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene ExpressionJournal of Visualized ExperimentsDescribing a transcription factor dependent regulation of the micro RNA transcriptome. Journal of Visualized Experiments. 2016.Describing a transcription factor dependent regulation of the micro RNA transcriptomeMicroRNA involvement in intestinal tumorigenesis. 169-188.MicroRNA involvement in intestinal tumorigenesisClinical Cancer ResearchRac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer. Clinical Cancer Research. 21:2127-2137.Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancerJournal of Nucleic Acids InvestigationMicroRNAs in mouse models of lymphoid malignancies. Journal of Nucleic Acids Investigation. 1:36-40.MicroRNAs in mouse models of lymphoid malignanciesNutrition and CancerSoy isoflavone genistein-mediated downregulation of miR-155 contributes to the anticancer effects of genistein. Nutrition and Cancer. 68:154-164.Soy isoflavone genistein-mediated downregulation of miR-155 contributes to the anticancer effects of genisteinRNA as a Therapeutic Molecule. RNA as a Therapeutic MoleculeBlood Cells, Molecules, and DiseasesCorrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doi. Blood Cells, Molecules, and Diseases. 55:420.Corrigendum to "ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance" [Blood Cells Mol. Dis. 53, (1-2), (June-August 2014) 47-55], doiMicrornas and cancer therapeutics. 637-645.Micrornas and cancer therapeuticsBreast DiseasesBreast Diseases. 27:44-45.Breast DiseasesCurrent GenomicsMicroRNAs in myeloid hematological malignancies. Current Genomics. 16:336-348.MicroRNAs in myeloid hematological malignanciesMolecular and Cellular ProbesDesign of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. Molecular and Cellular Probes. Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinomaJournal of Translational Medicine and ResearchHuman cancers. Journal of Translational Medicine and Research. 21:168-172.Human cancersOncoImmunologyTipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. OncoImmunology. Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppressionOral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyThe emerging role of long noncoding RNAs in oral cancer. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 123:235-241.The emerging role of long noncoding RNAs in oral cancerCancersThe clinical relevance of long non-coding RNAs in cancer. Cancers. 7:2169-2182.The clinical relevance of long non-coding RNAs in cancerPersonalized MedicineUse of miRNA expression profiling to identify novel biomarkers. Personalized Medicine. 4:147-155.Use of miRNA expression profiling to identify novel biomarkersOncotargetStratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget. 6:7262-7279.Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAsNeuro-OncologyMiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro-Oncology. 18:639-648.MiR-138 exerts anti-glioma efficacy by targeting immune checkpointsChirurgia (Romania)Patients after splenectomy. Chirurgia (Romania). 111:393-399.Patients after splenectomyGenome MedicineThe miR-143/miR-145 cluster and the tumor microenvironment. Genome Medicine. 8.The miR-143/miR-145 cluster and the tumor microenvironmentInvolvement of MicroRNAs in human cancer. 69-104.Involvement of MicroRNAs in human cancerLecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)Bigger data is better for molecular diagnosis tests based on decision trees. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 9714:288-295.Bigger data is better for molecular diagnosis tests based on decision treesFrontiers in OncologyFrom the biology of PP2A to the PADs for therapy of hematologic malignancies. Frontiers in Oncology. 5.From the biology of PP2A to the PADs for therapy of hematologic malignanciesEBioMedicineEpstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine. Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall SurvivalNeuro-OncologyPD-L1 expression and prognostic impact in glioblastoma. Neuro-Oncology. 18:195-205.PD-L1 expression and prognostic impact in glioblastomaJournal of the National Cancer InstitutemiR-141-mediated regulation of brain metastasis from breast cancer. Journal of the National Cancer Institute. 108.miR-141-mediated regulation of brain metastasis from breast cancerProceedings of the National Academy of Sciences of the United States of AmericaErratum. Proceedings of the National Academy of Sciences of the United States of America. 103:2464.ErratumSmall silencing non-coding RNAs. 481-496.Small silencing non-coding RNAsMicrornas as therapeutic targets. 683-697.Micrornas as therapeutic targetsOncogeneHypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene. Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progressionOncotargetTherapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 7:15093-15104.Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancerCancer ResearchIn response [2]. Cancer Research. 67:4534.In response [2]Genes Chromosomes and CancerGenetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases. Genes Chromosomes and Cancer. 55:193-214.Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseasesOncotargetProgresses towards safe and efficient gene therapy vectors. Oncotarget. 6:30675-30703.Progresses towards safe and efficient gene therapy vectorsOncotargetLow spinophilin expression enhances aggressive biological behavior of breast cancer. Oncotarget. 6:11191-11202.Low spinophilin expression enhances aggressive biological behavior of breast cancerEuropean UrologyThe Potential of MicroRNAs as Prostate Cancer Biomarkers. European Urology. The Potential of MicroRNAs as Prostate Cancer BiomarkersRNA as a Therapeutic Molecule. 691-699.RNA as a Therapeutic Molecule22935643Tsongalis GJ, Calin G, Cordelier P, Croce C, Monzon F, Szafranska-Schwarzbach AEClinical chemistryMicroRNA analysis: is it ready for prime time? Clin Chem. 2013 Feb; 59(2):343-7.Clin Chem2012-08-30T00:00:002012MicroRNA analysis: is it ready for prime time?28926136Shen J, Hodges TR, Song R, Gong Y, Calin GA, Heimberger AB, Zhao HMolecular carcinogenesisSerum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma. Mol Carcinog. 2018 Jan; 57(1):137-141.Mol Carcinog2017-10-10T00:00:002017Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.28855213Figueroa J, Phillips LM, Shahar T, Hossain A, Gumin J, Kim H, Bean AJ, Calin GA, Fueyo J, Walters ET, Kalluri R, Verhaak RG, Lang FFCancer researchExosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. Cancer Res. 2017 11 01; 77(21):5808-5819.Cancer Res2017-08-30T00:00:002017Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587.28965162Jacobs DI, Liu Y, Gabrusiewicz K, Tsavachidis S, Armstrong GN, Zhou R, Wei J, Ivan C, Calin G, Molinaro AM, Rice T, Bracci PM, Hansen HM, Wiencke JK, Wrensch MR, Heimberger AB, Bondy MLJournal of neuro-oncologyGermline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients. J Neurooncol. 2018 Jan; 136(1):33-39.J Neurooncol2017-09-30T00:00:002017Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.Authorship 8872627Authorship 88759611Authorship 8884779Authorship 8886098Authorship 88879417Authorship 8900045D015972Physiology125688690.314255Gene Expression Regulation, NeoplasticD022661Chemicals & Drugs1172370.840342RNA, UntranslatedAuthorship 9005584D009369Disorders2056151140.155158NeoplasmsAuthorship 9019642Authorship 90237538Authorship 9042318Authorship 9043956Authorship 9046202Authorship 9046254Authorship 9046632Authorship 90469615Authorship 9049378Authorship 9053543Authorship 9053715Authorship 90564514Authorship 9059274Authorship 9060782Authorship 9062533Authorship 90625613Authorship 9070039Authorship 90729314Authorship 9078544Authorship 9081683Authorship 90817412Authorship 9082063Authorship 9086282Authorship 9091212Authorship 9091762Authorship 9092822Authorship 90977914Authorship 90985118Authorship 9098738Authorship 91038618Authorship 91043015Authorship 91054710Authorship 9108101Authorship 91087025Authorship 9112491Authorship 91132018Authorship 9113524Authorship 9113642Authorship 9117802Authorship 91194510Authorship 9121685Authorship 91289511Authorship 9131373Authorship 9132974Authorship 91342918Authorship 9136287Authorship 9146685Authorship 9152931Authorship 91572744Authorship 91616513Authorship 91633524Authorship 9166645Authorship 91712714Authorship 9173544Authorship 91767824Authorship 9179187Authorship 91793744Authorship 9183889Authorship 9191401Authorship 9199292Authorship 91998113Authorship 91998814Authorship 9201651Authorship 9203823Authorship 9204912Authorship 9205515Authorship 9205544Authorship 9208848Authorship 92119711Authorship 9214011Authorship 9215817Authorship 92162813Authorship 92184040Authorship 92198020Authorship 9227453Authorship 9229313Authorship 9231764Authorship 9232183Authorship 92338513Authorship 9235318Authorship 9235845Authorship 9236501Authorship 92382633Authorship 9239332Authorship 9241756Authorship 92428814Authorship 92525812Authorship 9263314Authorship 9265042Authorship 92691427Authorship 9271332Authorship 92723217Authorship 92728546Authorship 9282946Authorship 92849333Authorship 9289622Authorship 9297144Authorship 9298364Authorship 9305694Authorship 9306463Authorship 9307747Authorship 93112316Authorship 9323836Authorship 9325413D035683Chemicals & Drugs75129430.373492MicroRNAsAuthorship 9335671Authorship 9339771Authorship 9342532Authorship 93484618Authorship 93544613Authorship 9357918Authorship 9358701Authorship 9361212Authorship 9362761Authorship 9365127Authorship 93661110Authorship 9366412Authorship 9367837Authorship 9369727Authorship 9385382Authorship 93890715Authorship 9397314Authorship 94041519Authorship 9405328Authorship 9405681721666870Zanesi N, Pekarsky Y, Trapasso F, Calin G, Croce CMJournal of nucleic acids investigationMicroRNAs in mouse models of lymphoid malignancies. J Nucleic Acids Investig. 2010; 1(1):36-40.J Nucleic Acids Investig2010-01-01T00:00:002010MicroRNAs in mouse models of lymphoid malignancies.23515489Monroig PD, Calin GACurrent pathobiology reportsMicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities. Curr Pathobiol Rep. 2013 Mar; 1(1):43-52.Curr Pathobiol Rep2013-03-01T00:00:002013MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities.25804630Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose J, Packham G, Liu K, Bojja K, Gaf? R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami A, Calin GA, Nicoloso MSGutThe clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut. 2016 06; 65(6):977-989.Gut2015-03-24T00:00:002015The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.26317116Giza DE, Vasilescu C, Calin GADiscoveries (Craiova, Romania)Key principles of miRNA involvement in human diseases. Discoveries (Craiova). 2014 Oct-Dec; 2(4):e34.Discoveries (Craiova)2014-10-01T00:00:002014Key principles of miRNA involvement in human diseases.26323609Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K, Ling X, Zhou S, Ivan C, Chen JQ, Burks JK, Fuller GN, Calin GA, Conrad CA, Creasy C, Ritthipichai K, Radvanyi L, Heimberger ABNeuro-oncologyPD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 2016 Feb; 18(2):195-205.Neuro Oncol2015-08-30T00:00:002015PD-L1 expression and prognostic impact in glioblastoma.26771440de la Parra C, Castillo-Pichardo L, Cruz-Collazo A, Cubano L, Redis R, Calin GA, Dharmawardhane SNutrition and cancerSoy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein. Nutr Cancer. 2016; 68(1):154-64.Nutr Cancer2016-01-15T00:00:002016Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.26683705Almeida MI, Silva AM, Vasconcelos DM, Almeida CR, Caires H, Pinto MT, Calin GA, Santos SG, Barbosa MAOncotargetmiR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis. Oncotarget. 2016 Jan 05; 7(1):7-22.Oncotarget2016-01-05T00:00:002016miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis.26658052Wei J, Nduom EK, Kong LY, Hashimoto Y, Xu S, Gabrusiewicz K, Ling X, Huang N, Qiao W, Zhou S, Ivan C, Fuller GN, Gilbert MR, Overwijk W, Calin GA, Heimberger ABNeuro-oncologyMiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro Oncol. 2016 05; 18(5):639-48.Neuro Oncol2015-12-11T00:00:002015MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.26725326Rupaimoole R, Ivan C, Yang D, Gharpure KM, Wu SY, Pecot CV, Previs RA, Nagaraja AS, Armaiz-Pena GN, McGuire M, Pradeep S, Mangala LS, Rodriguez-Aguayo C, Huang L, Bar-Eli M, Zhang W, Lopez-Berestein G, Calin GA, Sood AKOncogeneHypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression. Oncogene. 2016 08 18; 35(33):4312-20.Oncogene2016-01-04T00:00:002016Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.26806656Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GAEuropean urologyThe Potential of MicroRNAs as Prostate Cancer Biomarkers. Eur Urol. 2016 08; 70(2):312-22.Eur Urol2016-01-22T00:00:002016The Potential of MicroRNAs as Prostate Cancer Biomarkers.26863633Sun Y, Liu Y, Cogdell D, Calin GA, Sun B, Kopetz S, Hamilton SR, Zhang WOncotargetExamining plasma microRNA markers for colorectal cancer at different stages. Oncotarget. 2016 Mar 08; 7(10):11434-49.Oncotarget2016-03-08T00:00:002016Examining plasma microRNA markers for colorectal cancer at different stages.26865249Rupaimoole R, Calin GA, Lopez-Berestein G, Sood AKCancer discoverymiRNA Deregulation in Cancer Cells and the Tumor Microenvironment. Cancer Discov. 2016 Mar; 6(3):235-46.Cancer Discov2016-02-10T00:00:002016miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.26876200Fabris L, Berton S, Citron F, D'Andrea S, Segatto I, Nicoloso MS, Massarut S, Armenia J, Zafarana G, Rossi S, Ivan C, Perin T, Vaidya JS, Avanzo M, Roncadin M, Schiappacassi M, Bristow RG, Calin G, Baldassarre G, Belletti BOncogeneRadiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. Oncogene. 2016 09 15; 35(37):4914-26.Oncogene2016-02-15T00:00:002016Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.26943042Olivieri M, Ferro M, Terreri S, Durso M, Romanelli A, Avitabile C, De Cobelli O, Messere A, Bruzzese D, Vannini I, Marinelli L, Novellino E, Zhang W, Incoronato M, Ilardi G, Staibano S, Marra L, Franco R, Perdon? S, Terracciano D, Czerniak B, Liguori GL, Colonna V, Fabbri M, Febbraio F, Calin GA, Cimmino AOncotargetLong non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget. 2016 Apr 12; 7(15):20636-54.Oncotarget2016-04-12T00:00:002016Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis.26860056Fabris L, Calin GAMolecular oncologyCirculating free xeno-microRNAs - The new kids on the block. Mol Oncol. 2016 Mar; 10(3):503-8.Mol Oncol2016-01-21T00:00:002016Circulating free xeno-microRNAs - The new kids on the block.26918603Dwivedi SK, Mustafi SB, Mangala LS, Jiang D, Pradeep S, Rodriguez-Aguayo C, Ling H, Ivan C, Mukherjee P, Calin GA, Lopez-Berestein G, Sood AK, Bhattacharya ROncotargetTherapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer. Oncotarget. 2016 Mar 22; 7(12):15093-104.Oncotarget2016-03-22T00:00:002016Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.27040698Van Roosbroeck K, Calin GASeminars in oncologyMicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies? Semin Oncol. 2016 Apr; 43(2):209-14.Semin Oncol2016-02-08T00:00:002016MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?27160903Chaluvally-Raghavan P, Jeong KJ, Pradeep S, Silva AM, Yu S, Liu W, Moss T, Rodriguez-Aguayo C, Zhang D, Ram P, Liu J, Lu Y, Lopez-Berestein G, Calin GA, Sood AK, Mills GBCell reportsDirect Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Rep. 2016 05 17; 15(7):1493-1504.Cell Rep2016-05-05T00:00:002016Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.27456130Anfossi S, Calin GAThe American journal of pathologyHodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression Pattern. Am J Pathol. 2016 Sep; 186(9):2251-3.Am J Pathol2016-07-25T00:00:002016Hodgkin Lymphoma Cells Have a Specific Long Noncoding RNA Expression Pattern.27359057de Melo Maia B, Rodrigues IS, Akagi EM, Soares do Amaral N, Ling H, Monroig P, Soares FA, Calin GA, Rocha RMOncotargetMiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget. 2016 08 02; 7(31):49217-49231.Oncotarget2016-08-02T00:00:002016MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression.27363020Jiang J, Azevedo-Pouly AC, Redis RS, Lee EJ, Gusev Y, Allard D, Sutaria DS, Badawi M, Elgamal OA, Lerner MR, Brackett DJ, Calin GA, Schmittgen TDOncotargetGlobally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma. Oncotarget. 2016 Aug 16; 7(33):53165-53177.Oncotarget2016-08-16T00:00:002016Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinoma.27447964Marini A, Lena AM, Panatta E, Ivan C, Han L, Liang H, Annicchiarico-Petruzzelli M, Di Daniele N, Calin GA, Candi E, Melino GOncotargetUltraconserved long non-coding RNA uc.63 in breast cancer. Oncotarget. 2017 May 30; 8(22):35669-35680.Oncotarget2017-05-30T00:00:002017Ultraconserved long non-coding RNA uc.63 in breast cancer.27498347Vasilescu C, Tanase M, Dragomir M, Calin GAMathematical biosciencesFrom mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localization. Math Biosci. 2016 10; 280:50-61.Math Biosci2016-08-04T00:00:002016From mobility to crosstalk. A model of intracellular miRNAs motion may explain the RNAs interaction mechanism on the basis of target subcellular localization.27568792Ciccone M, Calin GAMicroRNA (Shariqah, United Arab Emirates)MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights. Microrna. 2016; 5(2):106-112.Microrna2016-01-01T00:00:002016MicroRNAs in Chronic Lymphocytic Leukemia: An Old Disease with New Genetic Insights.27652320Redis RS, Calin GAMolecular & cellular oncologyThe interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism? Mol Cell Oncol. 2016 Jul; 3(4):e1166308.Mol Cell Oncol2016-03-30T00:00:002016The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism?27070707Bueno MJ, P?rez de Castro I, G?mez de Cedr?n M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fern?ndez-Piqueras J, Malumbres MCancer cellGenetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell. 2016 Apr 11; 29(4):607-608.Cancer Cell2016-04-11T00:00:002016Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression.27120784Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini MOncotargetOver-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget. 2016 May 24; 7(21):31361-71.Oncotarget2016-05-24T00:00:002016Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.27341356Rozovski U, Hazan-Halevy I, Calin G, Harris D, Li P, Liu Z, Keating MJ, Estrov ZJournal of visualized experiments : JoVEDescribing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome. J Vis Exp. 2016 06 15; (112).J Vis Exp2016-06-15T00:00:002016Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome.27345412Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco AOncogeneSpecific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2016 09 29; 35(39):5214.Oncogene2016-06-27T00:00:002016Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.27349385Paladini L, Fabris L, Bottai G, Raschioni C, Calin GA, Santarpia LJournal of experimental & clinical cancer research : CRTargeting microRNAs as key modulators of tumor immune response. J Exp Clin Cancer Res. 2016 Jun 27; 35:103.J Exp Clin Cancer Res2016-06-27T00:00:002016Targeting microRNAs as key modulators of tumor immune response.26988859Almeida MI, Calin GAGenome medicineThe miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles. Genome Med. 2016 Mar 17; 8(1):29.Genome Med2016-03-17T00:00:002016The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles.27047254Ciccone M, Calin GACurrent genomicsMicroRNAs in Myeloid Hematological Malignancies. Curr Genomics. 2015 Oct; 16(5):336-48.Curr Genomics2015-10-01T00:00:002015MicroRNAs in Myeloid Hematological Malignancies.27103742Van Roosbroeck K, Calin GABloodWhen kissing (disease) counts. Blood. 2016 Apr 21; 127(16):1947-8.Blood2016-04-21T00:00:002016When kissing (disease) counts.27467917Kong LY, Wei J, Fuller GN, Schrand B, Gabrusiewicz K, Zhou S, Rao G, Calin G, Gilboa E, Heimberger ABOncoimmunologyTipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. Oncoimmunology. 2016 May; 5(5):e1117739.Oncoimmunology2015-12-21T00:00:002015Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression.27742688Kanlikilicer P, Rashed MH, Bayraktar R, Mitra R, Ivan C, Aslan B, Zhang X, Filant J, Silva AM, Rodriguez-Aguayo C, Bayraktar E, Pichler M, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein GCancer researchUbiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells. Cancer Res. 2016 12 15; 76(24):7194-7207.Cancer Res2016-10-14T00:00:002016Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.27819637Dragomir M, Petrescu DGE, Manga GE, Calin GA, Vasilescu C, -Chirurgia (Bucharest, Romania : 1990)Patients After Splenectomy: Old Risks and New Perspectives. Chirurgia (Bucur). 2016 Sept-Oct; 111(5):393-399.Chirurgia (Bucur)2016-09-01T00:00:002016Patients After Splenectomy: Old Risks and New Perspectives.27893706Bucay N, Sekhon K, Yang T, Majid S, Shahryari V, Hsieh C, Mitsui Y, Deng G, Tabatabai ZL, Yamamura S, Calin GA, Dahiya R, Tanaka Y, Saini SOncogeneMicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. Oncogene. 2017 05 11; 36(19):2667-2679.Oncogene2016-11-28T00:00:002016MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.27988500Ling H, Girnita L, Buda O, Calin GAClinical chemistry and laboratory medicineNon-coding RNAs: the cancer genome dark matter that matters! Clin Chem Lab Med. 2017 May 01; 55(5):705-714.Clin Chem Lab Med2017-05-01T00:00:002017Non-coding RNAs: the cancer genome dark matter that matters!27989708Gomes CC, de Sousa SF, Calin GA, Gomez RSOral surgery, oral medicine, oral pathology and oral radiologyThe emerging role of long noncoding RNAs in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Feb; 123(2):235-241.Oral Surg Oral Med Oral Pathol Oral Radiol2016-10-13T00:00:002016The emerging role of long noncoding RNAs in oral cancer.27999740Park JH, Theodoratou E, Calin GA, Shin JIOncoimmunologyFrom cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks. Oncoimmunology. 2016; 5(11):e1230579.Oncoimmunology2016-09-09T00:00:002016From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks.28076764Redis RS, Calin GACell metabolismSnapShot: Non-coding RNAs and Metabolism. Cell Metab. 2017 01 10; 25(1):220-220.e1.Cell Metab2017-01-10T00:00:002017SnapShot: Non-coding RNAs and Metabolism.28077118Lee NK, Lee JH, Ivan C, Ling H, Zhang X, Park CH, Calin GA, Lee SKBMC cancerMALAT1 promoted invasiveness of gastric adenocarcinoma. BMC Cancer. 2017 01 11; 17(1):46.BMC Cancer2017-01-11T00:00:002017MALAT1 promoted invasiveness of gastric adenocarcinoma.28132417Smolle MA, Calin HN, Pichler M, Calin GAThe FEBS journalNoncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics. FEBS J. 2017 07; 284(13):1952-1966.FEBS J2017-02-17T00:00:002017Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.27720213Shah MY, Ferrajoli A, Sood AK, Lopez-Berestein G, Calin GAEBioMedicinemicroRNA Therapeutics in Cancer - An Emerging Concept. EBioMedicine. 2016 Oct; 12:34-42.EBioMedicine2016-09-20T00:00:002016microRNA Therapeutics in Cancer - An Emerging Concept.27740627Giza DE, Fuentes-Mattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C, Calin GACell death and differentiationCellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ. 2016 12; 23(12):1906-1918.Cell Death Differ2016-10-14T00:00:002016Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications.27789274Ohtsuka M, Ling H, Ivan C, Pichler M, Matsushita D, Goblirsch M, Stiegelbauer V, Shigeyasu K, Zhang X, Chen M, Vidhu F, Bartholomeusz GA, Toiyama Y, Kusunoki M, Doki Y, Mori M, Song S, Gunther JR, Krishnan S, Slaby O, Goel A, Ajani JA, Radovich M, Calin GAEBioMedicineH19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-?-Catenin Signaling in Colorectal Cancer. EBioMedicine. 2016 Nov; 13:113-124.EBioMedicine2016-10-19T00:00:002016H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-?-Catenin Signaling in Colorectal Cancer.28036267Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat BOncotargetMicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget. 2017 Feb 14; 8(7):11641-11658.Oncotarget2017-02-14T00:00:002017MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.28106823Bottai G, Diao L, Baggerly KA, Paladini L, Gyorffy B, Raschioni C, Pusztai L, Calin GA, Santarpia LInternational journal of molecular sciencesIntegrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. Int J Mol Sci. 2017 Jan 19; 18(1).Int J Mol Sci2017-01-19T00:00:002017Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.27601590Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X, Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, Haybaeck J, Svoboda M, Okugawa Y, Gerger A, Hoefler G, Goel A, Slaby O, Calin GAClinical cancer research : an official journal of the American Association for Cancer ResearchGenome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis. Clin Cancer Res. 2017 Mar 01; 23(5):1323-1333.Clin Cancer Res2016-09-06T00:00:002016Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.27608009Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler MInternational journal of molecular sciencesCurrent Status of Long Non-Coding RNAs in Human Breast Cancer. Int J Mol Sci. 2016 Sep 06; 17(9).Int J Mol Sci2016-09-06T00:00:002016Current Status of Long Non-Coding RNAs in Human Breast Cancer.27903673Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis RS, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GAClinical cancer research : an official journal of the American Association for Cancer ResearchCombining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clin Cancer Res. 2017 06 01; 23(11):2891-2904.Clin Cancer Res2016-11-30T00:00:002016Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.28280276Yuan T, Yang Y, Chen J, Li W, Li W, Zhang Q, Mi Y, Goswami RS, You JQ, Lin D, Qian MD, Calin S, Liang Y, Miranda RN, Calin GA, Zhou X, Ma L, Zweidler-McKay PA, Liu B, Weng AP, Medeiros LJ, Zhang Y, You MJLeukemiaRegulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD. Leukemia. 2017 11; 31(11):2355-2364.Leukemia2017-03-10T00:00:002017Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.28490808Silva AM, Almeida MI, Teixeira JH, Maia AF, Calin GA, Barbosa MA, Santos SGScientific reportsDendritic Cell-derived Extracellular Vesicles mediate Mesenchymal Stem/Stromal Cell recruitment. Sci Rep. 2017 05 10; 7(1):1667.Sci Rep2017-05-10T00:00:002017Dendritic Cell-derived Extracellular Vesicles mediate Mesenchymal Stem/Stromal Cell recruitment.28423620Rashed MH, Kanlikilicer P, Rodriguez-Aguayo C, Pichler M, Bayraktar R, Bayraktar E, Ivan C, Filant J, Silva A, Aslan B, Denizli M, Mitra R, Ozpolat B, Calin GA, Sood AK, Abd-Ellah MF, Helal GK, Berestein GLOncotargetExosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs. Oncotarget. 2017 Mar 21; 8(12):20145-20164.Oncotarget2017-03-21T00:00:002017Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.28533224Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, Pehserl AM, Reicher A, Resel M, Heitzer E, Ivan C, Bullock M, Ling H, Deutsch A, Wulf-Goldenberg A, Adiprasito JB, Stoeger H, Haybaeck J, Svoboda M, Stotz M, Hoefler G, Slaby O, Calin GA, Gerger A, Pichler MClinical cancer research : an official journal of the American Association for Cancer ResearchmiR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017 Sep 01; 23(17):5255-5266.Clin Cancer Res2017-05-22T00:00:002017miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.28535802Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gaf? R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GAGenome biologyN-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol. 2017 05 24; 18(1):98.Genome Biol2017-05-24T00:00:002017N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.28729024Fabris L, Calin GAInternational review of cell and molecular biologyUnderstanding the Genomic Ultraconservations: T-UCRs and Cancer. Int Rev Cell Mol Biol. 2017; 333:159-172.Int Rev Cell Mol Biol2017-06-07T00:00:002017Understanding the Genomic Ultraconservations: T-UCRs and Cancer.28465156Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, Ciccone M, Kargin OA, Zhang X, Mur P, do Amaral NS, Chen M, Tarrand JJ, Lupu F, Ferrajoli A, Keating MJ, Vasilescu C, Yeung SJ, Calin GAEBioMedicinePlasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections. EBioMedicine. 2017 Jun; 20:182-192.EBioMedicine2017-04-19T00:00:002017Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections.28581517Suleymanova N, Crudden C, Shibano T, Worrall C, Oprea I, Tica A, Calin GA, Girnita A, Girnita LOncogeneFunctional antagonism of ?-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes. Oncogene. 2017 10 12; 36(41):5734-5744.Oncogene2017-06-05T00:00:002017Functional antagonism of ?-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes.28165644Gladek I, Ferdin J, Horvat S, Calin GA, Kunej TGenes, chromosomes & cancerHIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies. Genes Chromosomes Cancer. 2017 06; 56(6):439-452.Genes Chromosomes Cancer2017-03-31T00:00:002017HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies.28241429Smolle MA, Bauernhofer T, Pummer K, Calin GA, Pichler MInternational journal of molecular sciencesCurrent Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer. Int J Mol Sci. 2017 Feb 22; 18(2).Int J Mol Sci2017-02-22T00:00:002017Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.28934601Redis RS, Vela LE, Lu W, Ferreira de Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B, Taguchi A, Chen Y, Fernandez AF, Valledor L, Van Roosbroeck K, Chang S, Shah M, Kinnebrew G, Han L, Atlasi Y, Cheung LH, Huang GY, Monroig P, Ramirez MS, Catela Ivkovic T, Van L, Ling H, Gaf? R, Kapitanovic S, Lanza G, Bankson JA, Huang P, Lai SY, Bast RC, Rosenblum MG, Radovich M, Ivan M, Bartholomeusz G, Liang H, Fraga MF, Widger WR, Hanash S, Berindan-Neagoe I, Lopez-Berestein G, Ambrosio ALB, Gomes Dias SM, Calin GAMolecular cellAllele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):640.Mol Cell2016-02-18T00:00:002016Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2.28783166D'Abundo L, Callegari E, Bresin A, Chillemi A, Elamin BK, Guerriero P, Huang X, Saccenti E, Hussein EMAA, Casciano F, Secchiero P, Zauli G, Calin GA, Russo G, Lee LJ, Croce CM, Marcucci G, Sabbioni S, Malavasi F, Negrini MOncogeneAnti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model. Oncogene. 2017 11 23; 36(47):6617-6626.Oncogene2017-08-07T00:00:002017Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.28793797Wu X, Tudoran OM, Calin GA, Ivan MAntioxidants & redox signalingThe Many Faces of Long Noncoding RNAs in Cancer. Antioxid Redox Signal. 2018 09 20; 29(9):922-935.Antioxid Redox Signal2017-10-20T00:00:002017The Many Faces of Long Noncoding RNAs in Cancer.28838211Ozawa T, Matsuyama T, Toiyama Y, Takahashi N, Ishikawa T, Uetake H, Yamada Y, Kusunoki M, Calin G, Goel AAnnals of oncology : official journal of the European Society for Medical OncologyCCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer. Ann Oncol. 2017 Aug 01; 28(8):1882-1888.Ann Oncol2017-08-01T00:00:002017CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.28930145Shen P, Pichler M, Chen M, Calin GA, Ling HInternational journal of molecular sciencesTo Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer. Int J Mol Sci. 2017 Sep 20; 18(9).Int J Mol Sci2017-09-20T00:00:002017To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer.29180617Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri MNature communicationsTranscribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2017 11 27; 8(1):1801.Nat Commun2017-11-27T00:00:002017Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.28904816Rodriguez-Aguayo C, Monroig PDC, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein GCell discoveryRegulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov. 2017; 3:17029.Cell Discov2017-09-12T00:00:002017Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer.28912018Bellido F, Sowada N, Mur P, L?zaro C, Pons T, Vald?s-Mas R, Pineda M, Aiza G, Iglesias S, Soto JL, Urioste M, Cald?s T, Balb?n M, Blay P, Rueda D, Dur?n M, Valencia A, Moreno V, Brunet J, Blanco I, Navarro M, Calin GA, Borck G, Puente XS, Capell? G, Valle LGastroenterologyAssociation Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer. Gastroenterology. 2018 01; 154(1):181-194.e20.Gastroenterology2017-09-12T00:00:002017Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.28916343Terracciano D, Terreri S, de Nigris F, Costa V, Calin GA, Cimmino ABiochimica et biophysica acta. Reviews on cancerThe role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer. Biochim Biophys Acta Rev Cancer. 2017 Dec; 1868(2):449-455.Biochim Biophys Acta Rev Cancer2017-09-13T00:00:002017The role of a new class of long noncoding RNAs transcribed from ultraconserved regions in cancer.29038531Berrout J, Kyriakopoulou E, Moparthi L, Hogea AS, Berrout L, Ivan C, Lorger M, Boyle J, Peers C, Muench S, Gomez JE, Hu X, Hurst C, Hall T, Umamaheswaran S, Wesley L, Gagea M, Shires M, Manfield I, Knowles MA, Davies S, Suhling K, Gonzalez YT, Carragher N, Macleod K, Abbott NJ, Calin GA, Gamper N, Zygmunt PM, Timsah ZNature communicationsTRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p. Nat Commun. 2017 10 16; 8(1):947.Nat Commun2017-10-16T00:00:002017TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p.29166412Bras JP, Silva AM, Calin GA, Barbosa MA, Santos SG, Almeida MIPloS onemiR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells. PLoS One. 2017; 12(11):e0188530.PLoS One2017-11-22T00:00:002017miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells.28820886Vasilescu C, Dragomir M, Tanase M, Giza D, Purnichescu-Purtan R, Chen M, Yeung SJ, Calin GAPloS oneCirculating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis. PLoS One. 2017; 12(8):e0183334.PLoS One2017-08-18T00:00:002017Circulating miRNAs in sepsis-A network under attack: An in-silico prediction of the potential existence of miRNA sponges in sepsis.28882220Van Roosbroeck K, Calin GAAdvances in cancer researchCancer Hallmarks and MicroRNAs: The Therapeutic Connection. Adv Cancer Res. 2017; 135:119-149.Adv Cancer Res2017-08-12T00:00:002017Cancer Hallmarks and MicroRNAs: The Therapeutic Connection.28945717Kalariya N, Brassil K, Calin GClinical journal of oncology nursingMicroRNAs: Clinical Trials and Potential Applications?. Clin J Oncol Nurs. 2017 Oct 01; 21(5):554-559.Clin J Oncol Nurs2017-10-01T00:00:002017MicroRNAs: Clinical Trials and Potential Applications?.29024380Bayraktar R, Van Roosbroeck K, Calin GAMolecular oncologyCell-to-cell communication: microRNAs as hormones. Mol Oncol. 2017 12; 11(12):1673-1686.Mol Oncol2017-10-26T00:00:002017Cell-to-cell communication: microRNAs as hormones.29089558Amorim MG, Valieris R, Drummond RD, Pizzi MP, Freitas VM, Sinigaglia-Coimbra R, Calin GA, Pasqualini R, Arap W, Silva IT, Dias-Neto E, Nunes DNScientific reportsA total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies. Sci Rep. 2017 10 31; 7(1):14395.Sci Rep2017-10-31T00:00:002017A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies.29203780Nassar FJ, Talhouk R, Zgheib NK, Tfayli A, El Sabban M, El Saghir NS, Boulos F, Jabbour MN, Chalala C, Boustany RM, Kadara H, Zhang Z, Zheng Y, Joyce B, Hou L, Bazarbachi A, Calin G, Nasr RScientific reportsmicroRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis. Sci Rep. 2017 12 04; 7(1):16829.Sci Rep2017-12-04T00:00:002017microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis.29311577Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri MNature communicationsPublisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2018 01 08; 9(1):160.Nat Commun2018-01-08T00:00:002018Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.29330106Calin GACancer lettersFeaturing the special issue Guest Editor. Cancer Lett. 2018 06 01; 423:27.Cancer Lett2018-01-09T00:00:002018Featuring the special issue Guest Editor.29467236Ferreira AF, Calin GA, Pican?o-Castro V, Kashima S, Covas DT, de Castro FAJournal of cell scienceHematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator. J Cell Sci. 2018 02 21; 131(4).J Cell Sci2018-02-21T00:00:002018Hematopoietic stem cells from induced pluripotent stem cells - considering the role of microRNA as a cell differentiation regulator.29386624Velazquez-Torres G, Shoshan E, Ivan C, Huang L, Fuentes-Mattei E, Paret H, Kim SJ, Rodriguez-Aguayo C, Xie V, Brooks D, Jones SJM, Robertson AG, Calin G, Lopez-Berenstein G, Sood A, Bar-Eli MNature communicationsA-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun. 2018 01 31; 9(1):461.Nat Commun2018-01-31T00:00:002018A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.29458141Del Vecchio F, Lee GH, Hawezi J, Bhome R, Pugh S, Sayan E, Thomas G, Packham G, Primrose J, Pichler M, Mirnezami A, Calin G, Bullock MCancer lettersLong non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk. Cancer Lett. 2018 05 01; 421:94-102.Cancer Lett2018-02-17T00:00:002018Long non-coding RNAs within the tumour microenvironment and their role in tumour-stroma cross-talk.29746929Chaganty BKR, Qiu S, Gest A, Lu Y, Ivan C, Calin GA, Weiner LM, Fan ZCancer lettersTrastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN? secretion. Cancer Lett. 2018 08 28; 430:47-56.Cancer Lett2018-05-08T00:00:002018Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFN? secretion.29748184Bayraktar R, Ivan C, Bayraktar E, Kanlikilicer P, Kabil NN, Kahraman N, Mokhlis HA, Karakas D, Rodriguez-Aguayo C, Arslan A, Sheng J, Wong S, Lopez-Berestein G, Calin GA, Ozpolat BClinical cancer research : an official journal of the American Association for Cancer ResearchDual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion. Clin Cancer Res. 2018 09 01; 24(17):4225-4241.Clin Cancer Res2018-05-10T00:00:002018Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.29567676Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GAGenome researchCancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 04; 28(4):432-447.Genome Res2018-03-22T00:00:002018Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.29154447Ultimo S, Martelli AM, Zauli G, Vitale M, Calin GA, Neri LMJournal of cellular physiologyRoles and clinical implications of microRNAs in acute lymphoblastic leukemia. J Cell Physiol. 2018 08; 233(8):5642-5654.J Cell Physiol2018-02-28T00:00:002018Roles and clinical implications of microRNAs in acute lymphoblastic leukemia.29425682Peng Y, Calin GACancer lettersCrucial role of non-coding RNAs in disease. Cancer Lett. 2018 04 28; 420:127-128.Cancer Lett2018-02-06T00:00:002018Crucial role of non-coding RNAs in disease.29754176Anfossi S, Fu X, Nagvekar R, Calin GAAdvances in experimental medicine and biologyMicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells. Adv Exp Med Biol. 2018; 1056:87-108.Adv Exp Med Biol2018-01-01T00:00:002018MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells.29861415Bullock MD, Silva AM, Kanlikilicer-Unaldi P, Filant J, Rashed MH, Sood AK, Lopez-Berestein G, Calin GANon-coding RNAExosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer. Noncoding RNA. 2015 Jun 03; 1(1):53-68.Noncoding RNA2015-06-03T00:00:002015Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer.30083269Silva AM, Almeida MI, Teixeira JH, Ivan C, Oliveira J, Vasconcelos D, Neves N, Ribeiro-Machado C, Cunha C, Barbosa MA, Calin GA, Santos SGTheranosticsProfiling the circulating miRnome reveals a temporal regulation of the bone injury response. Theranostics. 2018; 8(14):3902-3917.Theranostics2018-06-24T00:00:002018Profiling the circulating miRnome reveals a temporal regulation of the bone injury response.30148073Dragomir M, Chen B, Calin GATranslational cancer researchExosomal lncRNAs as new players in cell-to-cell communication. Transl Cancer Res. 2018 Mar; 7(Suppl 2):S243-S252.Transl Cancer Res2018-03-01T00:00:002018Exosomal lncRNAs as new players in cell-to-cell communication.30280089Dragomir M, Calin GAFrontiers in oncologyCorrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs. Front Oncol. 2018; 8:307.Front Oncol2018-09-21T00:00:002018Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs.29911069Dragomir M, Calin GAFrontiers in oncologyCircular RNAs in Cancer - Lessons Learned From microRNAs. Front Oncol. 2018; 8:179.Front Oncol2018-05-28T00:00:002018Circular RNAs in Cancer - Lessons Learned From microRNAs.30056798Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico MEEpigeneticsEpigenetics of gastrointestinal diseases: notes from a workshop. Epigenetics. 2018; 13(4):449-457.Epigenetics2018-07-30T00:00:002018Epigenetics of gastrointestinal diseases: notes from a workshop.30337246Fu X, Calin GAEBioMedicinemiR-122 and hepatocellular carcinoma: from molecular biology to therapeutics. EBioMedicine. 2018 11; 37:17-18.EBioMedicine2018-10-15T00:00:002018miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics.30397238Lujambio A, Portela A, Liz J, Melo SA, Rossi S, Spizzo R, Croce CM, Calin GA, Esteller MOncogeneCorrection: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene. 2019 01; 38(5):765-766.Oncogene2019-01-01T00:00:002019Correction: CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer.30409799Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GAHaematologicaThe involvement of microRNA in the pathogenesis of Richter syndrome. Haematologica. 2019 05; 104(5):1004-1015.Haematologica2018-11-08T00:00:002018The involvement of microRNA in the pathogenesis of Richter syndrome.29784926Anfossi S, Babayan A, Pantel K, Calin GANature reviews. Clinical oncologyClinical utility of circulating non-coding RNAs - an update. Nat Rev Clin Oncol. 2018 09; 15(9):541-563.Nat Rev Clin Oncol2018-09-01T00:00:002018Clinical utility of circulating non-coding RNAs - an update.29788626Sever NI, Younan S, E Wojcik S, Spizzo R, Fabbri M, Calin GAPersonalized medicineUse of miRNA expression profiling to identify novel biomarkers. Per Med. 2007 May; 4(2):147-155.Per Med2007-05-01T00:00:002007Use of miRNA expression profiling to identify novel biomarkers.29971628Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat BBreast cancer research and treatmentThymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Breast Cancer Res Treat. 2018 Oct; 171(3):593-605.Breast Cancer Res Treat2018-07-03T00:00:002018Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.30038718Malpeli G, Barbi S, Tosadori G, Greco C, Zupo S, Pedron S, Brunelli M, Bertolaso A, Scupoli MT, Krampera M, Kamga PT, Croce CM, Calin GA, Scarpa A, Zam? AOncotargetMYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways. Oncotarget. 2018 Jul 03; 9(51):29753-29771.Oncotarget2018-07-03T00:00:002018MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.30102929Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MAMolecular aspects of medicineMicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2019 12; 70:3-20.Mol Aspects Med2018-08-18T00:00:002018MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.30183576Manga G, Calin GA, Manuc M, Droc G, Tudor SChirurgia (Bucharest, Romania : 1990)New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer? Chirurgia (Bucur). 2018 Jul-Aug; 113(4):464-468.Chirurgia (Bucur)2018-07-01T00:00:002018New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?30237846Dragomir MP, Calin GAOncotargetCpG island hypermethylation go circular (RNA). Oncotarget. 2018 Sep 04; 9(69):33052-33053.Oncotarget2018-09-04T00:00:002018CpG island hypermethylation go circular (RNA).29949872Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GAInternational journal of molecular sciencesUsing microRNA Networks to Understand Cancer. Int J Mol Sci. 2018 Jun 26; 19(7).Int J Mol Sci2018-06-26T00:00:002018Using microRNA Networks to Understand Cancer.29951335Dragomir M, Chen B, Fu X, Calin GACancer biology & medicineKey questions about the checkpoint blockade-are microRNAs an answer? Cancer Biol Med. 2018 May; 15(2):103-115.Cancer Biol Med2018-05-01T00:00:002018Key questions about the checkpoint blockade-are microRNAs an answer?30096304Dragomir MP, Knutsen E, Calin GACellSnapShot: Unconventional miRNA Functions. Cell. 2018 08 09; 174(4):1038-1038.e1.Cell2018-08-09T00:00:002018SnapShot: Unconventional miRNA Functions.30166612Monroig-Bosque PDC, Shah MY, Fu X, Fuentes-Mattei E, Ling H, Ivan C, Nouraee N, Huang B, Chen L, Pileczki V, Redis RS, Jung EJ, Zhang X, Lehrer M, Nagvekar R, Mafra ACP, Monroig-Bosque MDM, Irimie A, Rivera C, Dan Dumitru C, Berindan-Neagoe I, Nikonowicz EP, Zhang S, Calin GAScientific reportsOncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers. Sci Rep. 2018 08 30; 8(1):13106.Sci Rep2018-08-30T00:00:002018OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.30221473Shen P, Reineke LC, Knutsen E, Chen M, Pichler M, Ling H, Calin GAMolecular oncologyMetformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling. Mol Oncol. 2018 11; 12(11):1856-1870.Mol Oncol2018-10-15T00:00:002018Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.30231579Xiao H, Shiu PKT, Shu J, Santulli G, Gheybi MK, Conn SJ, Bogard B, Hub? F, Taube JH, Mani SA, Song L, Calin GA, Zhang SNon-coding RNAThe Non-Coding RNA Journal Club: Highlights on Recent Papers-6. Noncoding RNA. 2018 Sep 18; 4(3).Noncoding RNA2018-09-18T00:00:002018The Non-Coding RNA Journal Club: Highlights on Recent Papers-6.30350212Van Roosbroeck K, Bayraktar R, Calin GAMethods in molecular biology (Clifton, N.J.)Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR. Methods Mol Biol. 2019; 1881:267-276.Methods Mol Biol2019-01-01T00:00:002019Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.30595406Diniz MG, Fran?a JA, Vilas-Boas FAS, de Souza FTA, Calin GA, Gomez RS, de Sousa SF, Gomes CCPathology, research and practiceThe long noncoding RNA KIAA0125 is upregulated in ameloblastomas. Pathol Res Pract. 2019 Mar; 215(3):466-469.Pathol Res Pract2018-12-26T00:00:002018The long noncoding RNA KIAA0125 is upregulated in ameloblastomas.30654191Mokhlis HA, Bayraktar R, Kabil NN, Caner A, Kahraman N, Rodriguez-Aguayo C, Zambalde EP, Sheng J, Karagoz K, Kanlikilicer P, Abdel Aziz AAH, Abdelghany TM, Ashour AA, Wong S, Gatza ML, Calin GA, Lopez-Berestein G, Ozpolat BMolecular therapy. Nucleic acidsThe Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers. Mol Ther Nucleic Acids. 2019 Mar 01; 14:301-317.Mol Ther Nucleic Acids2018-12-13T00:00:002018The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers.30742906Farooqi AA, Fuentes-Mattei E, Fayyaz S, Raj P, Goblirsch M, Poltronieri P, Calin GASeminars in cancer biologyInterplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer. Semin Cancer Biol. 2019 10; 58:47-55.Semin Cancer Biol2019-02-08T00:00:002019Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer.30487062Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein GEBioMedicineExosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine. 2018 Dec; 38:100-112.EBioMedicine2018-11-25T00:00:002018Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.30578699Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GAGenes, chromosomes & cancerRole of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer. 2019 04; 58(4):244-253.Genes Chromosomes Cancer2019-04-01T00:00:002019Role of miRNAs in immune responses and immunotherapy in cancer.30636774Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz SBritish journal of cancerCirculating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer. 2019 02; 120(3):340-345.Br J Cancer2019-01-14T00:00:002019Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.30709367Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler MBreast cancer research : BCRMiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast Cancer Res. 2019 02 01; 21(1):20.Breast Cancer Res2019-02-01T00:00:002019MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.30474323Calin GAGenes, chromosomes & cancerPreface for GCC Special Issue on noncoding RNAs, noncoding DNAs, and genome editing. Genes Chromosomes Cancer. 2019 04; 58(4):189-190.Genes Chromosomes Cancer2019-01-07T00:00:002019Preface for GCC Special Issue on noncoding RNAs, noncoding DNAs, and genome editing.30632384Gulei D, Raduly L, Berindan-Neagoe I, Calin GAExpert review of molecular diagnosticsCRISPR-based RNA editing: diagnostic applications and therapeutic options. Expert Rev Mol Diagn. 2019 02; 19(2):83-88.Expert Rev Mol Diagn2019-01-21T00:00:002019CRISPR-based RNA editing: diagnostic applications and therapeutic options.30365347Fo?elteder J, Calin GA, Pichler MExpert opinion on therapeutic targetsLong non-coding RNA CCAT2 as a therapeutic target in colorectal cancer. Expert Opin Ther Targets. 2018 12; 22(12):973-976.Expert Opin Ther Targets2018-10-30T00:00:002018Long non-coding RNA CCAT2 as a therapeutic target in colorectal cancer.30550267Mitra K, Feist WN, Anfossi S, Fuentes-Mattei E, Almeida MI, Kim JJ, Calin GA, Warmflash AACS synthetic biologyS-MiRAGE: A Quantitative, Secreted RNA-Based Reporter of Gene Expression and Cell Persistence. ACS Synth Biol. 2019 01 18; 8(1):25-33.ACS Synth Biol2018-12-21T00:00:002018S-MiRAGE: A Quantitative, Secreted RNA-Based Reporter of Gene Expression and Cell Persistence.30548184Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe IMolecular oncologymiR-181a/b therapy in lung cancer: reality or myth? Mol Oncol. 2019 01; 13(1):9-25.Mol Oncol2019-01-03T00:00:002019miR-181a/b therapy in lung cancer: reality or myth?30614645Calin GAMolecular oncologyThe noncoding RNA revolution-three decades and still going strong! Mol Oncol. 2019 01; 13(1):3.Mol Oncol2019-01-01T00:00:002019The noncoding RNA revolution-three decades and still going strong!Authorship 942972230884898Pardini B, Calin GACancersMicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer. Cancers (Basel). 2019 Mar 17; 11(3).Cancers (Basel)2019-03-17T00:00:002019MicroRNAs and Long Non-Coding RNAs and Their Hormone-Like Activities in Cancer.Authorship 9439473Authorship 9439621Authorship 9441721029327093Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GACancer metastasis reviewsMiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Rev. 2018 03; 37(1):17-32.Cancer Metastasis Rev2018-03-01T00:00:002018MiR-181 family-specific behavior in different cancers: a meta-analysis view.29285656Calin GA, Van Roosbroeck KCancer metastasis reviewsPreface. Cancer Metastasis Rev. 2018 03; 37(1):3-4.Cancer Metastasis Rev2018-03-01T00:00:002018Preface.29976738Abruzzo LV, Herling CD, Calin GA, Oakes C, Barron LL, Banks HE, Katju V, Keating MJ, Coombes KRHaematologicaTrisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways. Haematologica. 2018 12; 103(12):2069-2078.Haematologica2018-07-05T00:00:002018Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways.Authorship 946636331064412Li Z, Wong KY, Calin GA, Chng WJ, Chan GC, Chim CSClinical epigeneticsEpigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact. Clin Epigenetics. 2019 05 07; 11(1):71.Clin Epigenetics2019-05-07T00:00:002019Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.D062085Chemicals & Drugs2725980.648717RNA, Long Noncoding23636127Wei J, Wang F, Kong LY, Xu S, Doucette T, Ferguson SD, Yang Y, McEnery K, Jethwa K, Gjyshi O, Qiao W, Levine NB, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger ABCancer researchmiR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013 Jul 01; 73(13):3913-26.Cancer Res2013-05-01T00:00:002013miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.23963114Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SYOncotargetCoordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget. 2013 Sep; 4(9):1388-98.Oncotarget2013-09-01T00:00:002013Coordinated targeting of the EGFR signaling axis by microRNA-27a*.24045437Taube JH, Malouf GG, Lu E, Sphyris N, Vijay V, Ramachandran PP, Ueno KR, Gaur S, Nicoloso MS, Rossi S, Herschkowitz JI, Rosen JM, Issa JP, Calin GA, Chang JT, Mani SAScientific reportsEpigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep. 2013; 3:2687.Sci Rep2013-01-01T00:00:002013Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties.24127332Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RFEndocrine-related cancerA miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer. 2013 Dec; 20(6):809-23.Endocr Relat Cancer2013-10-14T00:00:002013A miRNA signature associated with human metastatic medullary thyroid carcinoma.Authorship 94754713Authorship 9477933Authorship 9478124Authorship 9482193231124563Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SYJournal of the National Cancer InstituteDisruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer. J Natl Cancer Inst. 2020 03 01; 112(3):266-277.J Natl Cancer Inst2020-03-01T00:00:002020Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.31142339Petrescu GED, Sabo AA, Torsin LI, Calin GA, Dragomir MPJournal of experimental & clinical cancer research : CRMicroRNA based theranostics for brain cancer: basic principles. J Exp Clin Cancer Res. 2019 May 29; 38(1):231.J Exp Clin Cancer Res2019-05-29T00:00:002019MicroRNA based theranostics for brain cancer: basic principles.31139186Bayraktar R, Bertilaccio MTS, Calin GAFrontiers in immunologyThe Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors. Front Immunol. 2019; 10:1053.Front Immunol2019-05-14T00:00:002019The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors.31171626Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JAGutMultiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut. 2020 01; 69(1):18-31.Gut2019-06-06T00:00:002019Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.Authorship 953900431416190Pardini B, Sabo AA, Birolo G, Calin GACancersNoncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies. Cancers (Basel). 2019 Aug 14; 11(8).Cancers (Basel)2019-08-14T00:00:002019Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies.Authorship 954222431434680Fabbri M, Girnita L, Varani G, Calin GAGenome researchDecrypting noncoding RNA interactions, structures, and functional networks. Genome Res. 2019 09; 29(9):1377-1388.Genome Res2019-08-21T00:00:002019Decrypting noncoding RNA interactions, structures, and functional networks.Authorship 955013131489780Pereira Zambalde E, Mathias C, Rodrigues AC, de Souza Fonseca Ribeiro EM, Fiori Gradia D, Calin GA, Carvalho de Oliveira JWiley interdisciplinary reviews. RNAHighlighting transcribed ultraconserved regions in human diseases. Wiley Interdiscip Rev RNA. 2020 03; 11(2):e1567.Wiley Interdiscip Rev RNA2019-09-05T00:00:002019Highlighting transcribed ultraconserved regions in human diseases.Authorship 955146931496026Dragomir MP, Tudor S, Okubo K, Shimizu M, Chen M, Giza DE, He WR, Ivan C, Calin GA, Vasilescu CJournal of cellular and molecular medicineThe non-coding RNome after splenectomy. J Cell Mol Med. 2019 11; 23(11):7844-7858.J Cell Mol Med2019-09-08T00:00:002019The non-coding RNome after splenectomy.Authorship 9558341531541193Dias MM, Adamoski D, Dos Reis LM, Ascen??o CFR, de Oliveira KRS, Mafra ACP, da Silva Bastos AC, Quintero M, de G Cassago C, Ferreira IM, Fidelis CHV, Rocco SA, Bajgelman MC, Stine Z, Berindan-Neagoe I, Calin GA, Ambrosio ALB, Dias SMGOncogeneGLS2 is protumorigenic in breast cancers. Oncogene. 2020 01; 39(3):690-702.Oncogene2019-09-20T00:00:002019GLS2 is protumorigenic in breast cancers.Authorship 9559206Authorship 956084731547814Li Y, Chen M, Pardini B, Dragomir MP, Lucci A, Calin GAJournal of translational medicineThe role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database. J Transl Med. 2019 09 23; 17(1):318.J Transl Med2019-09-23T00:00:002019The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.31558294Huang GL, Sun J, Lu Y, Liu Y, Cao H, Zhang H, Calin GAMolecular aspects of medicineMiR-200 family and cancer: From a meta-analysis view. Mol Aspects Med. 2019 12; 70:57-71.Mol Aspects Med2019-09-23T00:00:002019MiR-200 family and cancer: From a meta-analysis view.Authorship 956391331582259Smolle MA, Prinz F, Calin GA, Pichler MMolecular aspects of medicineCurrent concepts of non-coding RNA regulation of immune checkpoints in cancer. Mol Aspects Med. 2019 12; 70:117-126.Mol Aspects Med2019-09-30T00:00:002019Current concepts of non-coding RNA regulation of immune checkpoints in cancer.Authorship 9569945Authorship 957042431600876Crudden C, Song D, Cismas S, Trocm? E, Pasca S, Calin GA, Girnita A, Girnita LCellsBelow the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey. Cells. 2019 10 09; 8(10).Cells2019-10-09T00:00:002019Below the Surface: IGF-1R Therapeutic Targeting and Its Endocytic Journey.31603768Butner JD, Fuentes D, Ozpolat B, Calin GA, Zhou X, Lowengrub J, Cristini V, Wang ZIEEE transactions on bio-medical engineeringA Multiscale Agent-Based Model of Ductal Carcinoma In Situ. IEEE Trans Biomed Eng. 2020 05; 67(5):1450-1461.IEEE Trans Biomed Eng2019-10-08T00:00:002019A Multiscale Agent-Based Model of Ductal Carcinoma In Situ.Authorship 957444631627266Barth DA, Slaby O, Klec C, Juracek J, Drula R, Calin GA, Pichler MCancersCurrent Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2019 Oct 17; 11(10).Cancers (Basel)2019-10-17T00:00:002019Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.Authorship 9604534Authorship 960568331689173Habic A, Mattick JS, Calin GA, Krese R, Konc J, Kunej TOmics : a journal of integrative biologyGenetic Variations of Ultraconserved Elements in the Human Genome. OMICS. 2019 11; 23(11):549-559.OMICS2019-11-01T00:00:002019Genetic Variations of Ultraconserved Elements in the Human Genome.31681586Zimta AA, Tomuleasa C, Sahnoune I, Calin GA, Berindan-Neagoe IFrontiers in oncologyLong Non-coding RNAs in Myeloid Malignancies. Front Oncol. 2019; 9:1048.Front Oncol2019-10-18T00:00:002019Long Non-coding RNAs in Myeloid Malignancies.Authorship 961192131735351Calin GA, Fabris LMolecular aspects of medicineMolecular aspects of medicine - Editorial 2019. Mol Aspects Med. 2019 12; 70:1-2.Mol Aspects Med2019-11-14T00:00:002019Molecular aspects of medicine - Editorial 2019.Authorship 961619331767626Rezaeian AH, Khanbabaei H, Calin GACancer researchTherapeutic Potential of the miRNA-ATM Axis in the Management of Tumor Radioresistance. Cancer Res. 2020 01 15; 80(2):139-150.Cancer Res2019-11-25T00:00:002019Therapeutic Potential of the miRNA-ATM Axis in the Management of Tumor Radioresistance.Authorship 9627417Authorship 962747431847392Chen B, Li J, Chi D, Sahnoune I, Calin S, Girnita L, Calin GACellsNon-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer. Cells. 2019 12 14; 8(12).Cells2019-12-14T00:00:002019Non-Coding RNAs in IGF-1R Signaling Regulation: The Underlying Pathophysiological Link between Diabetes and Cancer.31847695Oncul S, Amero P, Rodriguez-Aguayo C, Calin GA, Sood AK, Lopez-Berestein GRNA biologyLong non-coding RNAs in ovarian cancer: expression profile and functional spectrum. RNA Biol. 2020 11; 17(11):1523-1534.RNA Biol2019-12-17T00:00:002019Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.Authorship 974574331867576De Los Santos MC, Dragomir MP, Calin GACancer drug resistance (Alhambra, Calif.)The role of exosomal long non-coding RNAs in cancer drug resistance. Cancer Drug Resist. 2019 Dec 19; 2:1178-1192.Cancer Drug Resist2019-12-19T00:00:002019The role of exosomal long non-coding RNAs in cancer drug resistance.Authorship 9757549Authorship 9758532931935430El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, Abd-Allah AR, Sood AK, Lopez-Berestein GCellular signallingGATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2020 04; 68:109539.Cell Signal2020-01-11T00:00:002020GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.31941838Fuentes-Mattei E, Bayraktar R, Manshouri T, Silva AM, Ivan C, Gulei D, Fabris L, Soares do Amaral N, Mur P, Perez C, Torres-Claudio E, Dragomir MP, Badillo-Perez A, Knutsen E, Narayanan P, Golfman L, Shimizu M, Zhang X, Zhao W, Ho WT, Estecio MR, Bartholomeusz G, Tomuleasa C, Berindan-Neagoe I, Zweidler-McKay PA, Estrov Z, Zhao ZJ, Verstovsek S, Calin GA, Redis RSJCI insightmiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2. JCI Insight. 2020 01 16; 5(1).JCI Insight2020-01-16T00:00:002020miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.Authorship 9761607Authorship 9762521831972470Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein GEBioMedicineCorrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]. EBioMedicine. 2020 Feb; 52:102630.EBioMedicine2020-01-20T00:00:002020Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112].31963578Pellecchia S, Sepe R, Decaussin-Petrucci M, Ivan C, Shimizu M, Coppola C, Testa D, Calin GA, Fusco A, Pallante PCancersThe Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity. Cancers (Basel). 2020 Jan 17; 12(1).Cancers (Basel)2020-01-17T00:00:002020The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity.Authorship 9765783831988194Pichler M, Rodriguez-Aguayo C, Nam SY, Dragomir MP, Bayraktar R, Anfossi S, Knutsen E, Ivan C, Fuentes-Mattei E, Lee SK, Ling H, Catela Ivkovic T, Huang G, Huang L, Okugawa Y, Katayama H, Taguchi A, Bayraktar E, Bhattacharya R, Amero P, He WR, Tran AM, Vychytilova-Faltejskova P, Klec C, Bonilla DL, Zhang X, Kapitanovic S, Loncar B, Gaf? R, Wang Z, Cristini V, Hanash SM, Bar-Eli M, Lanza G, Slaby O, Goel A, Rigoutsos I, Lopez-Berestein G, Calin GAGutTherapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer. Gut. 2020 10; 69(10):1818-1831.Gut2020-01-27T00:00:002020Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.Authorship 9773422Authorship 97738311Authorship 9774312Authorship 977608432014474das Chagas PF, de Sousa GR, Kodama MH, de Biagi Junior CAO, Yunes JA, Brandalise SR, Calin GA, Tone LG, Scrideli CA, de Oliveira JCHematology, transfusion and cell therapyUltraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematol Transfus Cell Ther. 2021 Jan-Mar; 43(1):28-34.Hematol Transfus Cell Ther2020-01-30T00:00:002020Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia.32017402Panatta E, Lena AM, Mancini M, Smirnov A, Marini A, Delli Ponti R, Botta-Orfila T, Tartaglia GG, Mauriello A, Zhang X, Calin GA, Melino G, Candi EEMBO reportsLong non-coding RNA uc.291 controls epithelial differentiation by interfering with the ACTL6A/BAF complex. EMBO Rep. 2020 03 04; 21(3):e46734.EMBO Rep2020-02-04T00:00:002020Long non-coding RNA uc.291 controls epithelial differentiation by interfering with the ACTL6A/BAF complex.32023341Anfossi S, Calin GAThe Journal of experimental medicineWhen non-coding is not enough. J Exp Med. 2020 03 02; 217(3).J Exp Med2020-03-02T00:00:002020When non-coding is not enough.32034004Dragomir MP, Kopetz S, Ajani JA, Calin GAGutNon-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut. 2020 04; 69(4):748-763.Gut2020-02-07T00:00:002020Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility.Authorship 9778762432051587Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, Knutsen E, Shimizu M, Ivan C, Rao X, Wang J, Silverman DA, Tam S, Zhao M, Caulin C, Zinger A, Tasciotti E, Dougherty PM, El-Naggar A, Calin GA, Myers JNNatureLoss of p53 drives neuron reprogramming in head and neck cancer. Nature. 2020 02; 578(7795):449-454.Nature2020-02-12T00:00:002020Loss of p53 drives neuron reprogramming in head and neck cancer.Authorship 978131332079038Wang LQ, Kumar S, Calin GA, Li Z, Chim CSBritish journal of haematologyFrequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification. Br J Haematol. 2020 07; 190(2):249-261.Br J Haematol2020-02-20T00:00:002020Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.Authorship 9800521032211400Tran AM, Chalbatani GM, Berland L, Cruz De Los Santos M, Raj P, Jalali SA, Gharagouzloo E, Ivan C, Dragomir MP, Calin GAFrontiers in cell and developmental biologyA New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs. Front Cell Dev Biol. 2020; 8:50.Front Cell Dev Biol2020-03-09T00:00:002020A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs.Authorship 98769412Authorship 987773132309535Bucur O, Almasan A, Nikolajczyk BS, Nicolson GL, Lawler J, Velculescu VE, Draghici S, Leabu M, Avram D, Bucur I, Calautti E, Calin GA, Chauhan SC, Ciubotaru M, Constantinescu SN, Datta D, Duda DG, Friedman MT, Galardy PJ, Harris BT, Huarte M, Khalil AM, Marchetti D, Movileanu L, Nat R, Nucera C, Popa-Wagner A, Stancu AL, Zhu S, Liehn EADiscoveries (Craiova, Romania)Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry. Discoveries (Craiova). 2013 Dec 31; 1(1):e1.Discoveries (Craiova)2013-12-31T00:00:002013Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry.32314733Calin GAeLifePseudogenes, RNAs and new reproducibility norms. Elife. 2020 04 21; 9.Elife2020-04-21T00:00:002020Pseudogenes, RNAs and new reproducibility norms.Authorship 9881672Authorship 9882782332340118Jonas K, Calin GA, Pichler MInternational journal of molecular sciencesRNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer. Int J Mol Sci. 2020 Apr 23; 21(8).Int J Mol Sci2020-04-23T00:00:002020RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer.32345613Ajani JA, Xu Y, Huo L, Wang R, Li Y, Wang Y, Pizzi MP, Scott A, Harada K, Ma L, Yao X, Jin J, Zhao W, Dong X, Badgwell BD, Shanbhag N, Tatlonghari G, Estrella JS, Roy-Chowdhuri S, Kobayashi M, Vykoukal JV, Hanash SM, Calin GA, Peng G, Lee JS, Johnson RL, Wang Z, Wang L, Song SGutYAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut. 2021 01; 70(1):55-66.Gut2020-04-27T00:00:002020YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition.Authorship 989387432403283El-Daly SM, Bayraktar R, Anfossi S, Calin GAInternational journal of molecular sciencesThe Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies. Int J Mol Sci. 2020 May 11; 21(9).Int J Mol Sci2020-05-11T00:00:002020The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies.Authorship 9901821032450611Chen F, Wu X, Niculite C, Gilca M, Petrusca D, Rogozea A, Rice S, Guo B, Griffin S, Calin GA, Boswell HS, Konig HJournal of cellular and molecular medicineClassic and targeted anti-leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications. J Cell Mol Med. 2020 07; 24(13):7378-7392.J Cell Mol Med2020-05-25T00:00:002020Classic and targeted anti-leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications.Authorship 9909522632493919Rupaimoole R, Wu SY, Pradeep S, Ivan C, Pecot CV, Gharpure KM, Nagaraja AS, Armaiz-Pena GN, McGuire M, Zand B, Dalton HJ, Filant J, Miller JB, Lu C, Sadaoui NC, Mangala LS, Taylor M, van den Beucken T, Koch E, Rodriguez-Aguayo C, Huang L, Bar-Eli M, Wouters BG, Radovich M, Ivan M, Calin GA, Zhang W, Lopez-Berestein G, Sood AKNature communicationsAuthor Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat Commun. 2020 06 03; 11(1):2867.Nat Commun2020-06-03T00:00:002020Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Authorship 992527732575430De Luca G, Cardinali B, Del Mastro L, Lastraioli S, Carli F, Ferrarini M, Calin GA, Garuti A, Mazzitelli C, Zupo S, Dono MInternational journal of molecular sciencesOptimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling. Int J Mol Sci. 2020 Jun 19; 21(12).Int J Mol Sci2020-06-19T00:00:002020Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling.Authorship 9949981Authorship 995180532707943Drula R, Ott LF, Berindan-Neagoe I, Pantel K, Calin GACancersMicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods. Cancers (Basel). 2020 Jul 22; 12(8).Cancers (Basel)2020-07-22T00:00:002020MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods.32694876Calin GA, Pardini BNature metabolismMir-roring hypoxia in EGFR-TKI tolerance. Nat Metab. 2019 04; 1(4):418-419.Nat Metab2019-04-01T00:00:002019Mir-roring hypoxia in EGFR-TKI tolerance.Authorship 9961645Authorship 996330432756406Barth DA, Juracek J, Slaby O, Pichler M, Calin GACancerslncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System. Cancers (Basel). 2020 Aug 03; 12(8).Cancers (Basel)2020-08-03T00:00:002020lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.32738290Farooqi AA, Fayyaz S, Poltronieri P, Calin G, Mallardo MSeminars in cancer biologyEpigenetic deregulation in cancer: Enzyme players and non-coding RNAs. Semin Cancer Biol. 2022 08; 83:197-207.Semin Cancer Biol2020-07-30T00:00:002020Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs.Authorship 9973364732805281Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, Tang C, Li Y, Shimura T, Ivkovic TC, De Los Santos MC, Anfossi S, Shimizu M, Shah MY, Ling H, Shen P, Multani AS, Pardini B, Burks JK, Katayama H, Reineke LC, Huo L, Syed M, Song S, Ferracin M, Oki E, Fromm B, Ivan C, Bhuvaneshwar K, Gusev Y, Mimori K, Menter D, Sen S, Matsuyama T, Uetake H, Vasilescu C, Kopetz S, Parker-Thornburg J, Taguchi A, Hanash SM, Girnita L, Slaby O, Goel A, Varani G, Gagea M, Li C, Ajani JA, Calin GAGastroenterologyThe Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling. Gastroenterology. 2020 12; 159(6):2146-2162.e33.Gastroenterology2020-08-15T00:00:002020The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.Authorship 998152432855620Li Z, Kumar S, Jin DY, Calin GA, Chng WJ, Siu KL, Poon MW, Chim CSCancer cell internationalEpigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination. Cancer Cell Int. 2020; 20:403.Cancer Cell Int2020-08-25T00:00:002020Epigenetic silencing of long non-coding RNA BM742401 in multiple myeloma: impact on prognosis and myeloma dissemination.Authorship 9988513Authorship 998924232937758Fabris L, Juracek J, Calin GInternational journal of molecular sciencesNon-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia. Int J Mol Sci. 2020 Sep 14; 21(18).Int J Mol Sci2020-09-14T00:00:002020Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic Leukemia.32944617Silverman DA, Calin GA, Myers JN, Amit MMolecular & cellular oncologyNeural reprogramming via microRNAs: the new kid on the p53-deficient block. Mol Cell Oncol. 2020; 7(4):1756723.Mol Cell Oncol2020-05-07T00:00:002020Neural reprogramming via microRNAs: the new kid on the p53-deficient block.Authorship 100006116Authorship 1000139832973129Cortez MA, Masrorpour F, Ivan C, Zhang J, Younes AI, Lu Y, Estecio MR, Barsoumian HB, Menon H, Caetano MDS, Ramapriyan R, Schoenhals JE, Wang X, Skoulidis F, Wasley MD, Calin G, Hwu P, Welsh JWNature communicationsBone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020 09 24; 11(1):4840.Nat Commun2020-09-24T00:00:002020Bone morphogenetic protein 7 promotes resistance to immunotherapy.32977531Dragomir MP, Manyam GC, Ott LF, Berland L, Knutsen E, Ivan C, Lipovich L, Broom BM, Calin GANon-coding RNAFuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs. Noncoding RNA. 2020 Sep 23; 6(4).Noncoding RNA2020-09-23T00:00:002020FuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs.Authorship 1000963532984015Terracciano D, Buonerba C, Scafuri L, De Berardinis P, Calin GA, Ferrajoli A, Fabbri M, Cimmino AFrontiers in oncologyPerspective: Cancer Patient Management Challenges During the COVID-19 Pandemic. Front Oncol. 2020; 10:1556.Front Oncol2020-08-18T00:00:002020Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic.Authorship 10023261633033261Cortez MA, Masrorpour F, Ivan C, Zhang J, Younes AI, Lu Y, Estecio MR, Barsoumian HB, Menon H, da Silva Caetano M, Ramapriyan R, Schoenhals JE, Wang X, Skoulidis F, Wasley MD, Calin G, Hwu P, Welsh JWNature communicationsAuthor Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy. Nat Commun. 2020 Oct 08; 11(1):5144.Nat Commun2020-10-08T00:00:002020Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy.Authorship 10026526Authorship 1002900233062956Anfossi S, Calin GACancer drug resistance (Alhambra, Calif.)Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy. Cancer Drug Resist. 2020; 3:356-370.Cancer Drug Resist2020-03-21T00:00:002020Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy.33042985Barth DA, Drula R, Ott L, Fabris L, Slaby O, Calin GA, Pichler MFrontiers in cell and developmental biologyCirculating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers. Front Cell Dev Biol. 2020; 8:828.Front Cell Dev Biol2020-09-15T00:00:002020Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical Biomarkers.Authorship 1003133233076962Zhang MY, Calin GA, Yuen KS, Jin DY, Chim CSClinical epigeneticsEpigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy. Clin Epigenetics. 2020 10 19; 12(1):150.Clin Epigenetics2020-10-19T00:00:002020Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.Authorship 10044137Authorship 10046431033158816Crudden C, Shibano T, Song D, Dragomir MP, Cismas S, Serly J, Nedelcu D, Fuentes-Mattei E, Tica A, Calin GA, Girnita A, Girnita LCancer researchInhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth. Cancer Res. 2021 01 15; 81(2):501-514.Cancer Res2020-11-06T00:00:002020Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth.33142779Dragomir MP, Moisoiu V, Manaila R, Pardini B, Knutsen E, Anfossi S, Amit M, Calin GAJournal of clinical medicineA Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment. J Clin Med. 2020 Oct 31; 9(11).J Clin Med2020-10-31T00:00:002020A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment.Authorship 1006711533304384Evangelista AF, de Menezes WP, Berardinelli GN, Dos Santos W, Scapulatempo-Neto C, Guimar?es DP, Calin GA, Reis RMFrontiers in geneticsPyknon-Containing Transcripts Are Downregulated in Colorectal Cancer Tumors, and Loss of PYK44 Is Associated With Worse Patient Outcome. Front Genet. 2020; 11:581454.Front Genet2020-11-12T00:00:002020Pyknon-Containing Transcripts Are Downregulated in Colorectal Cancer Tumors, and Loss of PYK44 Is Associated With Worse Patient Outcome.Authorship 10069203Authorship 10070955Authorship 10070982633322770Hunt PJ, Kabotyanski KE, Calin GA, Xie T, Myers JN, Amit MCancersInterrupting Neuron-Tumor Interactions to Overcome Treatment Resistance. Cancers (Basel). 2020 Dec 12; 12(12).Cancers (Basel)2020-12-12T00:00:002020Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance.33334813Silverman DA, Martinez VK, Dougherty PM, Myers JN, Calin GA, Amit MCancer researchCancer-Associated Neurogenesis and Nerve-Cancer Cross-talk. Cancer Res. 2021 03 15; 81(6):1431-1440.Cancer Res2020-12-17T00:00:002020Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.33334899Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Blum Murphy M, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Song S, Wang L, Ajani JAGutIntegrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut. 2021 11; 70(11):2055-2065.Gut2020-12-17T00:00:002020Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.Authorship 1007660133353258Calin GA, Vazquez FNon-coding RNAWelcome to the New Journal Non-Coding RNA! Noncoding RNA. 2014 Nov 21; 1(1):1-3.Noncoding RNA2014-11-21T00:00:002014Welcome to the New Journal Non-Coding RNA!Authorship 10082186Authorship 10082252233398132Butner JD, Wang Z, Elganainy D, Al Feghali KA, Plodinec M, Calin GA, Dogra P, Nizzero S, Ruiz-Ram?rez J, Martin GV, Tawbi HA, Chung C, Koay EJ, Welsh JW, Hong DS, Cristini VNature biomedical engineeringA mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden. Nat Biomed Eng. 2021 04; 5(4):297-308.Nat Biomed Eng2021-01-04T00:00:002021A mathematical model for the quantification of a patient's sensitivity to checkpoint inhibitors and long-term tumour burden.33398161Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Abdelhakeem AAF, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal A, Song S, Ajani JA, Wang LNature medicineSingle-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat Med. 2021 01; 27(1):141-151.Nat Med2021-01-04T00:00:002021Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.Authorship 1008709533430133Torsin LI, Petrescu GED, Sabo AA, Chen B, Brehar FM, Dragomir MP, Calin GAInternational journal of molecular sciencesEditing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance. Int J Mol Sci. 2021 Jan 08; 22(2).Int J Mol Sci2021-01-08T00:00:002021Editing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance.Authorship 1009280433476261Butner JD, Fuentes D, Ozpolat B, Calin GA, Zhou X, Lowengrub J, Cristini V, Wang ZIEEE transactions on bio-medical engineeringCorrections to "A multiscale Agent-Based Model of Ductal Carcinoma in Situ". IEEE Trans Biomed Eng. 2021 02; 68(2):736.IEEE Trans Biomed Eng2021-02-01T00:00:002021Corrections to "A multiscale Agent-Based Model of Ductal Carcinoma in Situ".Authorship 1010382433522932Mohapatra S, Pioppini C, Ozpolat B, Calin GAMolecular cancerNon-coding RNAs regulation of macrophage polarization in cancer. Mol Cancer. 2021 02 01; 20(1):24.Mol Cancer2021-02-01T00:00:002021Non-coding RNAs regulation of macrophage polarization in cancer.Authorship 101111716Authorship 1011284233567603Terreri S, Mancinelli S, Ferro M, Vitale MC, Perdon? S, Castaldo L, Gigantino V, Mercadante V, De Cecio R, Aquino G, Montella M, Angelini C, Del Prete E, Aprile M, Ciaramella A, Liguori GL, Costa V, Calin GA, La Civita E, Terracciano D, Febbraio F, Cimmino ACancersSubcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue. Cancers (Basel). 2021 Feb 08; 13(4).Cancers (Basel)2021-02-08T00:00:002021Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue.33577974Tortora F, Calin GA, Cimmino AMolecular and cellular endocrinologyEffects of long non-coding RNAs on androgen signaling pathways in genitourinary malignancies. Mol Cell Endocrinol. 2021 04 15; 526:111197.Mol Cell Endocrinol2021-02-09T00:00:002021Effects of long non-coding RNAs on androgen signaling pathways in genitourinary malignancies.Authorship 10120891633614241Gorur A, Bayraktar R, Ivan C, Mokhlis HA, Bayraktar E, Kahraman N, Karakas D, Karamil S, Kabil NN, Kanlikilicer P, Aslan B, Tamer L, Wang Z, Cristini V, Lopez-Berestein G, Calin G, Ozpolat BMolecular therapy. Nucleic acidsncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer. Mol Ther Nucleic Acids. 2021 Mar 05; 23:930-943.Mol Ther Nucleic Acids2021-01-20T00:00:002021ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer.Authorship 1014518133764431Calin GABloodQuicker and digital: the way on protein biomarkers? Blood. 2021 03 25; 137(12):1564-1565.Blood2021-03-25T00:00:002021Quicker and digital: the way on protein biomarkers?Authorship 1015086133822742Calin GACancer researchBeing Small and Intronic: miRNAs That Count! Cancer Res. 2021 03 01; 81(5):1212-1213.Cancer Res2021-03-01T00:00:002021Being Small and Intronic: miRNAs That Count!Authorship 10168281133886417Dragomir MP, Tudor S, Lacatus M, Stanciulea O, Trandafir B, Diaconu A, Coriu D, Colita A, Droc G, Purnichescu-Purtan R, Calin G, Vasilescu CActa chirurgica BelgicaTNF-alpha releasing capacity of the whole blood drops after open total splenectomy, but increases after partial/subtotal or minimally invasive splenectomy. Acta Chir Belg. 2022 Oct; 122(5):346-356.Acta Chir Belg2021-04-30T00:00:002021TNF-alpha releasing capacity of the whole blood drops after open total splenectomy, but increases after partial/subtotal or minimally invasive splenectomy.Authorship 10172121133911148Yeh M, Wang YY, Yoo JY, Oh C, Otani Y, Kang JM, Park ES, Kim E, Chung S, Jeon YJ, Calin GA, Kaur B, Zhao Z, Lee TJScientific reportsMicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Sci Rep. 2021 04 28; 11(1):9219.Sci Rep2021-04-28T00:00:002021MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.Authorship 1021413434145432Winkle M, El-Daly SM, Fabbri M, Calin GANature reviews. Drug discoveryNoncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021 08; 20(8):629-651.Nat Rev Drug Discov2021-06-18T00:00:002021Noncoding RNA therapeutics - challenges and potential solutions.Authorship 10237951Authorship 1024525234160807Rosenlund IA, Calin GA, Dragomir MP, Knutsen EMethods in molecular biology (Clifton, N.J.)CRISPR/Cas9 to Silence Long Non-Coding RNAs. Methods Mol Biol. 2021; 2348:175-187.Methods Mol Biol2021-01-01T00:00:002021CRISPR/Cas9 to Silence Long Non-Coding RNAs.34226679Mohapatra S, Calin GCell death and differentiationJAM-ming miR-21. Cell Death Differ. 2021 10; 28(10):2837-2839.Cell Death Differ2021-07-05T00:00:002021JAM-ming miR-21.Authorship 10248444Authorship 10250461434247567Li Y, Chen D, Xuan H, Dragomir MP, Calin GA, Meng X, Chen M, Jin HBosnian journal of basic medical sciencesConstruction and validation of prognostic nomogram for metaplastic breast cancer. Bosn J Basic Med Sci. 2022 Feb 01; 22(1):131-139.Bosn J Basic Med Sci2022-02-01T00:00:002022Construction and validation of prognostic nomogram for metaplastic breast cancer.34259445Vicente D, Schobel SA, Anfossi S, Hensman H, Lisboa F, Robertson H, Khatri V, Bradley MJ, Shimizu M, Buchman TG, Davis TA, Dente CJ, Kirk AD, Calin GA, Elster EACritical care medicineViral Micro-RNAs Are Detected in the Early Systemic Response to Injury and Are Associated With Outcomes in Polytrauma Patients. Crit Care Med. 2022 02 01; 50(2):296-306.Crit Care Med2022-02-01T00:00:002022Viral Micro-RNAs Are Detected in the Early Systemic Response to Injury and Are Associated With Outcomes in Polytrauma Patients.Authorship 10268292634353949Li Y, Tan Z, Zhang Y, Zhang Z, Hu Q, Liang K, Jun Y, Ye Y, Li YC, Li C, Liao L, Xu J, Xing Z, Pan Y, Chatterjee SS, Nguyen TK, Hsiao H, Egranov SD, Putluri N, Coarfa C, Hawke DH, Gunaratne PH, Tsai KL, Han L, Hung MC, Calin GA, Namour F, Gu?ant JL, Muntau AC, Blau N, Sutton VR, Schiff M, Feillet F, Zhang S, Lin C, Yang LScience (New York, N.Y.)A noncoding RNA modulator potentiates phenylalanine metabolism in mice. Science. 2021 08 06; 373(6555):662-673.Science2021-08-06T00:00:002021A noncoding RNA modulator potentiates phenylalanine metabolism in mice.Authorship 1028093234417742Zhang X, Calin GAMethods in molecular biology (Clifton, N.J.)Profiling Long Non-coding RNA expression Using Custom-Designed Microarray. Methods Mol Biol. 2021; 2372:43-51.Methods Mol Biol2021-01-01T00:00:002021Profiling Long Non-coding RNA expression Using Custom-Designed Microarray.Authorship 1028449934439240Chaftari P, Qdaisat A, Chaftari AM, Maamari J, Li Z, Lupu F, Raad I, Hachem R, Calin G, Yeung SJCancersPrognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection. Cancers (Basel). 2021 Aug 13; 13(16).Cancers (Basel)2021-08-13T00:00:002021Prognostic Value of Procalcitonin, C-Reactive Protein, and Lactate Levels in Emergency Evaluation of Cancer Patients with Suspected Infection.Authorship 1029930334532286Wei J, Gilboa E, Calin GA, Heimberger ABFrontiers in oncologyImmune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment. Front Oncol. 2021; 11:682129.Front Oncol2021-08-31T00:00:002021Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment.Authorship 1031920934680368Esposito CL, Van Roosbroeck K, Santamaria G, Rotoli D, Sandomenico A, Wierda WG, Ferrajoli A, Ruvo M, Calin GA, de Franciscis V, Catuogno SCancersSelection of a Nuclease-Resistant RNA Aptamer Targeting CD19. Cancers (Basel). 2021 Oct 18; 13(20).Cancers (Basel)2021-10-18T00:00:002021Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19.Authorship 10333914Authorship 10335841Authorship 10337472Authorship 1034059934772589El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, Kabil N, Ozpolat B, Calin GA, Salama SA, Abd-Allah AR, Sood AK, Lopez-Berestein GCellular signallingCORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cell Signal. 2022 Jan; 89:110147.Cell Signal2021-11-09T00:00:002021CORRIGENDUM: GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.34739825Mohapatra S, Calin GAMolecular cellAPPLE and translation: When a small peptideproduced from a "non-coding RNA" matters! Mol Cell. 2021 11 04; 81(21):4349-4351.Mol Cell2021-11-04T00:00:002021APPLE and translation: When a small peptideproduced from a "non-coding RNA" matters!34830370Pirlog R, Drula R, Nutu A, Calin GA, Berindan-Neagoe IInternational journal of molecular sciencesThe Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions. Int J Mol Sci. 2021 Nov 19; 22(22).Int J Mol Sci2021-11-19T00:00:002021The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions.34728089Dragomir MP, Knutsen E, Calin GATrends in genetics : TIGClassical and noncanonical functions of miRNAs in cancers. Trends Genet. 2022 04; 38(4):379-394.Trends Genet2021-10-30T00:00:002021Classical and noncanonical functions of miRNAs in cancers.Authorship 1035602134912071N?meth K, Calin GABritish journal of cancerStandardisation of protocols can be crucial in long non-coding RNA research. Br J Cancer. 2022 04; 126(6):833-834.Br J Cancer2021-12-15T00:00:002021Standardisation of protocols can be crucial in long non-coding RNA research.Authorship 10384128Authorship 10400149Authorship 10402302Authorship 10403402Authorship 1041034335036070Siqueira E, Obiols-Guardia A, Jorge-Torres OC, Oliveira-Mateos C, Soler M, Ramesh-Kumar D, Seti?n F, van Rossum D, Pascual-Alonso A, Xiol C, Ivan C, Shimizu M, Armstrong J, Calin GA, Pasterkamp RJ, Esteller M, Guil SMolecular therapy. Nucleic acidsAnalysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome. Mol Ther Nucleic Acids. 2022 Mar 08; 27:621-644.Mol Ther Nucleic Acids2021-12-22T00:00:002021Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome.35204715Zambalde EP, Adamoski D, Gradia DF, Rabinovich I, Rodrigues AC, Ivan C, Ribeiro EMSF, Calin GA, Carvalho de Oliveira JBiomoleculesTranscribed Ultraconserved Regions Are Associated with Clinicopathological Features in Breast Cancer. Biomolecules. 2022 01 26; 12(2).Biomolecules2022-01-26T00:00:002022Transcribed Ultraconserved Regions Are Associated with Clinicopathological Features in Breast Cancer.35294699Dogra P, Ram?rez JR, Butner JD, Pel?ez MJ, Chung C, Hooda-Nehra A, Pasqualini R, Arap W, Cristini V, Calin GA, Ozpolat B, Wang ZPharmaceutical researchTranslational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer. Pharm Res. 2022 Mar; 39(3):511-528.Pharm Res2022-03-16T00:00:002022Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer.35063535Kara G, Calin GA, Ozpolat BAdvanced drug delivery reviewsRNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev. 2022 03; 182:114113.Adv Drug Deliv Rev2022-01-19T00:00:002022RNAi-based therapeutics and tumor targeted delivery in cancer.35052468Zhang MY, Calin G, Deng MD, Au-Yeung RKH, Wang LQ, Chim CSGenesEpigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-?B Signaling in Non-Hodgkin's Lymphoma. Genes (Basel). 2022 01 11; 13(1).Genes (Basel)2022-01-11T00:00:002022Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-?B Signaling in Non-Hodgkin's Lymphoma.Authorship 10437171Authorship 10438784Authorship 1043939435418578Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GASignal transduction and targeted therapyTargeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther. 2022 04 13; 7(1):121.Signal Transduct Target Ther2022-04-13T00:00:002022Targeting non-coding RNAs to overcome cancer therapy resistance.35422492Balihodzic A, Prinz F, Dengler MA, Calin GA, Jost PJ, Pichler MCell death and differentiationNon-coding RNAs and ferroptosis: potential implications for cancer therapy. Cell Death Differ. 2022 06; 29(6):1094-1106.Cell Death Differ2022-04-14T00:00:002022Non-coding RNAs and ferroptosis: potential implications for cancer therapy.35408829Turk A, Calin GA, Kunej TInternational journal of molecular sciencesMicroRNAs in Leukemias: A Clinically Annotated Compendium. Int J Mol Sci. 2022 Mar 23; 23(7).Int J Mol Sci2022-03-23T00:00:002022MicroRNAs in Leukemias: A Clinically Annotated Compendium.Authorship 1044889535494005Tellez-Gabriel M, Tekpli X, Reine TM, Hegge B, Nielsen SR, Chen M, Moi L, Normann LS, Busund LR, Calin GA, M?landsmo GM, Perander M, Theocharis AD, Kolset SO, Knutsen EFrontiers in oncologySerglycin Is Involved in TGF-? Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue. Front Oncol. 2022; 12:868868.Front Oncol2022-04-14T00:00:002022Serglycin Is Involved in TGF-? Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue.Authorship 10458171135546352Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, Liu C-, Andreeff M, Croce CMOncogeneCorrection to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2022 Jun; 41(25):3452-3453.Oncogene2022-06-01T00:00:002022Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.Authorship 104638311Authorship 1046726435625973Yoon JH, Byun H, Ivan C, Calin GA, Jung D, Lee SCancerslncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer. Cancers (Basel). 2022 May 11; 14(10).Cancers (Basel)2022-05-11T00:00:002022lncRNAs UC.145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer.35597788Butner JD, Dogra P, Chung C, Ruiz-Ram?rez J, Nizzero S, Plodinec M, Li X, Pan PY, Chen SH, Cristini V, Ozpolat B, Calin GA, Wang ZCell death & diseaseDedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study. Cell Death Dis. 2022 May 21; 13(5):485.Cell Death Dis2022-05-21T00:00:002022Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study.Authorship 10469371835642638Lu Z, Mao W, Yang H, Santiago-O'Farrill JM, Rask PJ, Mondal J, Chen H, Ivan C, Liu X, Liu CG, Xi Y, Masuda K, Carrami EM, Chen M, Tang Y, Pang L, Lakomy DS, Calin GA, Liang H, Ahmed AA, Vankayalapati H, Bast RCThe Journal of clinical investigationSIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. J Clin Invest. 2022 06 01; 132(11).J Clin Invest2022-06-01T00:00:002022SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.Authorship 104933218Authorship 10492411135763934Chen J, Tang S, Ke S, Cai JJ, Osorio D, Golovko A, Morpurgo B, Guo S, Sun Y, Winkle M, Calin GA, Tian YRedox biologyAblation of long noncoding RNA MALAT1 activates antioxidant pathway and alleviates sepsis in mice. Redox Biol. 2022 08; 54:102377.Redox Biol2022-06-18T00:00:002022Ablation of long noncoding RNA MALAT1 activates antioxidant pathway and alleviates sepsis in mice.35776213Klec C, Knutsen E, Schwarzenbacher D, Jonas K, Pasculli B, Heitzer E, Rinner B, Krajina K, Prinz F, Gottschalk B, Ulz P, Deutsch A, Prokesch A, Jahn SW, Lellahi SM, Perander M, Barbano R, Graier WF, Parrella P, Calin GA, Pichler MCellular and molecular life sciences : CMLSALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform. Cell Mol Life Sci. 2022 Jul 01; 79(7):391.Cell Mol Life Sci2022-07-01T00:00:002022ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.Authorship 10499551435797620Vicente DA, Schobel SA, Anfossi S, Hensman H, Lisboa F, Robertson H, Khatri V, Bradley MJ, Shimizu M, Buchman TG, Davis TA, Dente CJ, Kirk AD, Calin GA, Elster EAThe journal of trauma and acute care surgeryCellular microRNAs correlate with clinical parameters in multiple injury patients. J Trauma Acute Care Surg. 2022 10 01; 93(4):427-438.J Trauma Acute Care Surg2022-07-07T00:00:002022Cellular microRNAs correlate with clinical parameters in multiple injury patients.Authorship 1050286235838046Pirlog R, Calin GAThe Journal of clinical investigationKRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer. J Clin Invest. 2022 07 15; 132(14).J Clin Invest2022-07-15T00:00:002022KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer.Authorship 10510185Authorship 1050743335841518Cismaru CA, Pirlog R, Calin GA, Berindan-Neagoe IStem cell reviews and reportsStem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding. Stem Cell Rev Rep. 2022 12; 18(8):2549-2565.Stem Cell Rev Rep2022-07-16T00:00:002022Stem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding.35860836Chen B, Yang C, Dragomir MP, Chi D, Chen W, Horst D, Calin GA, Li QTherapeutic advances in medical oncologyAssociation of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Ther Adv Med Oncol. 2022; 14:17588359221111703.Ther Adv Med Oncol2022-07-15T00:00:002022Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.Authorship 1051458435884374Giordo R, Gulsha R, Kalla S, Calin GA, Lipovich LCancersLncRNA-Associated Genetic Etiologies Are Shared between Type 2 Diabetes and Cancers in the UAE Population. Cancers (Basel). 2022 Jul 07; 14(14).Cancers (Basel)2022-07-07T00:00:002022LncRNA-Associated Genetic Etiologies Are Shared between Type 2 Diabetes and Cancers in the UAE Population.Authorship 10623385Authorship 10559613Authorship 105659319Authorship 10602412Authorship 10569117Authorship 10587664Authorship 10587553Authorship 10616912Authorship 105938812Authorship 105478520Authorship 10592891236569509Moore JA, Lehner MJ, Anfossi S, Datar S, Tidwell RS, Campbell M, Shah AY, Ward JF, Karam JA, Wood CG, Pisters LL, Calin GA, Tu SMBJUI compassPredictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries. BJUI Compass. 2023 Jan; 4(1):81-87.BJUI Compass2022-07-05T00:00:002022Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries.36322628Zhang Y, Sun C, Li Y, Qin J, Amancherla K, Jing Y, Hu Q, Liang K, Zhang Z, Ye Y, Huang LA, Nguyen TK, Egranov SD, Zhao Z, Wu A, Xi Y, Yao J, Hung MC, Calin GA, Cheng J, Lim B, Lehmann LH, Salem JE, Johnson DB, Curran MA, Yu D, Han L, Darabi R, Yang L, Moslehi JJ, Lin CScience translational medicineHormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis. Sci Transl Med. 2022 11 02; 14(669):eabo1981.Sci Transl Med2022-11-02T00:00:002022Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.36408168Tognon M, Calin GA, Del Valle LFrontiers in oncologyEditorial: Epigenetics and molecular genetics of rare tumors. Front Oncol. 2022; 12:1049140.Front Oncol2022-11-03T00:00:002022Editorial: Epigenetics and molecular genetics of rare tumors.36187924Minciuna CE, Tanase M, Manuc TE, Tudor S, Herlea V, Dragomir MP, Calin GA, Vasilescu CComputational and structural biotechnology journalThe seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers. Comput Struct Biotechnol J. 2022; 20:5065-5075.Comput Struct Biotechnol J2022-09-12T00:00:002022The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers.36456103Jurj A, Qian D, Calin GA, Litchfield KAnnals of oncology : official journal of the European Society for Medical OncologyAt the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets. Ann Oncol. 2022 12; 33(12):1214-1216.Ann Oncol2022-12-01T00:00:002022At the crossroad between checkpoint blockade and big data analyses: identification of novel biomarkers and potential targets.36082440Aprile M, Costa V, Cimmino A, Calin GAInternational journal of cancerEmerging role of oncogenic long noncoding RNA as cancer biomarkers. Int J Cancer. 2023 03 01; 152(5):822-834.Int J Cancer2022-09-26T00:00:002022Emerging role of oncogenic long noncoding RNA as cancer biomarkers.36167417Mohapatra S, Winkle M, Ton AN, Nguyen D, Calin GAThe Journal of pharmacology and experimental therapeuticsThe Role of Non-Coding RNAs in Chromosomal Instability in Cancer. J Pharmacol Exp Ther. 2023 01; 384(1):10-19.J Pharmacol Exp Ther2022-09-27T00:00:002022The Role of Non-Coding RNAs in Chromosomal Instability in Cancer.35954481Kara G, Arun B, Calin GA, Ozpolat BCancersmiRacle of microRNA-Driven Cancer Nanotherapeutics. Cancers (Basel). 2022 Aug 06; 14(15).Cancers (Basel)2022-08-06T00:00:002022miRacle of microRNA-Driven Cancer Nanotherapeutics.36002248Fan Y, Li Y, Yao X, Jin J, Scott A, Liu B, Wang S, Huo L, Wang Y, Wang R, Pool Pizzi M, Ma L, Shao S, Sewastjanow-Silva M, Waters R, Chatterjee D, Liu B, Shanbhag N, Peng G, Calin GA, Mazur PK, Hanash SM, Ishizawa J, Hirata Y, Nagano O, Wang Z, Wang L, Xian W, McKeon F, Ajani JA, Song SGutEpithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment. Gut. 2023 04; 72(4):624-637.Gut2022-08-24T00:00:002022Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.36077862Hofman P, Calin GA, Mani SA, Bontoux C, Ili? M, Wistuba IICancersThe Third Joint Meeting on Lung Cancer of the FHU OncoAge (University C?te d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. Cancers (Basel). 2022 Sep 04; 14(17).Cancers (Basel)2022-09-04T00:00:002022The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University C?te d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients.36077759Vykoukal J, Fahrmann JF, Patel N, Shimizu M, Ostrin EJ, Dennison JB, Ivan C, Goodman GE, Thornquist MD, Barnett MJ, Feng Z, Calin GA, Hanash SMCancersContributions of Circulating microRNAs for Early Detection of Lung Cancer. Cancers (Basel). 2022 Aug 30; 14(17).Cancers (Basel)2022-08-30T00:00:002022Contributions of Circulating microRNAs for Early Detection of Lung Cancer.Authorship 10632218Authorship 10630012736727622Shortridge MD, Chaubey B, Zhang HJ, Pavelitz T, Vidadala V, Tang C, Olsen GL, Calin GA, Varani GACS chemical biologyDrug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21. ACS Chem Biol. 2023 02 17; 18(2):237-250.ACS Chem Biol2023-02-02T00:00:002023Drug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21.36724291Sun C, Ye Y, Tan Z, Liu Y, Li Y, Hu W, Liang K, Egranov SD, Huang LA, Zhang Z, Zhang Y, Yao J, Nguyen TK, Zhao Z, Wu A, Marks JR, Caudle AS, Sahin AA, Gao J, Gammon ST, Piwnica-Worms D, Hu J, Chiao PJ, Yu D, Hung MC, Curran MA, Calin GA, Ying H, Han L, Lin C, Yang LScience advancesTumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Sci Adv. 2023 02 03; 9(5):eadd6995.Sci Adv2023-02-01T00:00:002023Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion.Authorship 1064368636830634Rodrigues AC, Zambalde EP, Bellan DL, Trindade EDS, Ribeiro EMSF, Calin G, Gradia DF, Carvalho de Oliveira JBiomoleculesLnc-uc.147 Is Associated with Disease Stage of Liver, Gastric, and Renal Cancer. Biomolecules. 2023 01 31; 13(2).Biomolecules2023-01-31T00:00:002023Lnc-uc.147 Is Associated with Disease Stage of Liver, Gastric, and Renal Cancer.Authorship 10659262936916500Untergasser A, Hellemans J, Pfaffl MW, Ruijter JM, van den Hoff MJB, Dragomir MP, Adamoski D, Dias SMG, Reis RM, Ferracin M, Dias-Neto E, Marsh I, Kubista M, Fabbri M, Goel A, Slab? O, Knutsen E, Chen B, Negrini M, Mimori K, Pichler M, Papatriantafyllou M, Anfossi S, Schmittgen TD, Huggett J, Bustin S, Vandesompele J, Calin GA, HEROIC (tHe initiativE gRoup On qRT dIsClosure) ConsortiumMolecular oncologyDisclosing quantitative RT-PCR raw data during manuscript submission: a call for action. Mol Oncol. 2023 05; 17(5):713-717.Mol Oncol2023-03-27T00:00:002023Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action.Authorship 10686983737100955Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Aqeilan RI, Arama E, Baehrecke EH, Balachandran S, Bano D, Barlev NA, Bartek J, Bazan NG, Becker C, Bernassola F, Bertrand MJM, Bianchi ME, Blagosklonny MV, Blander JM, Blandino G, Blomgren K, Borner C, Bortner CD, Bove P, Boya P, Brenner C, Broz P, Brunner T, Damgaard RB, Calin GA, Campanella M, Candi E, Carbone M, Carmona-Gutierrez D, Cecconi F, Chan FK, Chen GQ, Chen Q, Chen YH, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Ciliberto G, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Daugaard M, Dawson TM, Dawson VL, De Maria R, De Strooper B, Debatin KM, Deberardinis RJ, Degterev A, Del Sal G, Deshmukh M, Di Virgilio F, Diederich M, Dixon SJ, Dynlacht BD, El-Deiry WS, Elrod JW, Engeland K, Fimia GM, Galassi C, Ganini C, Garcia-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Gerlic M, Ghosh S, Green DR, Greene LA, Gronemeyer H, H?cker G, Hajn?czky G, Hardwick JM, Haupt Y, He S, Heery DM, Hengartner MO, Hetz C, Hildeman DA, Ichijo H, Inoue S, J??ttel? M, Janic A, Joseph B, Jost PJ, Kanneganti TD, Karin M, Kashkar H, Kaufmann T, Kelly GL, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Kluck R, Krysko DV, Kulms D, Kumar S, Lavandero S, Lavrik IN, Lemasters JJ, Liccardi G, Linkermann A, Lipton SA, Lockshin RA, L?pez-Ot?n C, Luedde T, MacFarlane M, Madeo F, Malorni W, Manic G, Mantovani R, Marchi S, Marine JC, Martin SJ, Martinou JC, Mastroberardino PG, Medema JP, Mehlen P, Meier P, Melino G, Melino S, Miao EA, Moll UM, Mu?oz-Pinedo C, Murphy DJ, Niklison-Chirou MV, Novelli F, N??ez G, Oberst A, Ofengeim D, Opferman JT, Oren M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pentimalli F, Pereira DM, Pervaiz S, Peter ME, Pinton P, Porta G, Prehn JHM, Puthalakath H, Rabinovich GA, Rajalingam K, Ravichandran KS, Rehm M, Ricci JE, Rizzuto R, Robinson N, Rodrigues CMP, Rotblat B, Rothlin CV, Rubinsztein DC, Rudel T, Rufini A, Ryan KM, Sarosiek KA, Sawa A, Sayan E, Schroder K, Scorrano L, Sesti F, Shao F, Shi Y, Sica GS, Silke J, Simon HU, Sistigu A, Stephanou A, Stockwell BR, Strapazzon F, Strasser A, Sun L, Sun E, Sun Q, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Troy CM, Turk B, Urbano N, Vandenabeele P, Vanden Berghe T, Vander Heiden MG, Vanderluit JL, Verkhratsky A, Villunger A, von Karstedt S, Voss AK, Vousden KH, Vucic D, Vuri D, Wagner EF, Walczak H, Wallach D, Wang R, Wang Y, Weber A, Wood W, Yamazaki T, Yang HT, Zakeri Z, Zawacka-Pankau JE, Zhang L, Zhang H, Zhivotovsky B, Zhou W, Piacentini M, Kroemer G, Galluzzi LCell death and differentiationApoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ. 2023 05; 30(5):1097-1154.Cell Death Differ2023-04-26T00:00:002023Apoptotic cell death in disease-Current understanding of the NCCD 2023.Authorship 10708421137152770Ichihara M, Takahashi H, Nishida N, Ivan C, Okuzaki D, Yokoyama Y, Ohtsuka M, Miyoshi N, Uemura M, Tanaka S, Calin GA, Mori M, Doki Y, Eguchi H, Yamamoto HAnnals of gastroenterological surgeryLong noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer. Ann Gastroenterol Surg. 2023 May; 7(3):458-470.Ann Gastroenterol Surg2022-12-29T00:00:002022Long noncoding RNA 01534 maintains cancer stemness by downregulating endoplasmic reticulum stress response in colorectal cancer.Authorship 107299431Authorship 107287716Authorship 107384411Authorship 107398532Authorship 10723421Authorship 107446511Authorship 107360439Authorship 107325313Authorship 107306111Authorship 107367719Authorship 1072059437365156Fierro C, Gatti V, La Banca V, De Domenico S, Scalera S, Corleone G, Fanciulli M, De Nicola F, Mauriello A, Montanaro M, Calin GA, Melino G, Peschiaroli ANature communicationsThe long non-coding RNA NEAT1 is a ?Np63 target gene modulating epidermal differentiation. Nat Commun. 2023 06 26; 14(1):3795.Nat Commun2023-06-26T00:00:002023The long non-coding RNA NEAT1 is a ?Np63 target gene modulating epidermal differentiation.37348162Dragomir MP, Calina TG, Perez E, Schallenberg S, Chen M, Albrecht T, Koch I, Wolkenstein P, Goeppert B, Roessler S, Calin GA, Sers C, Horst D, Ro?ner F, Capper DEBioMedicineDNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours. EBioMedicine. 2023 Jul; 93:104657.EBioMedicine2023-06-21T00:00:002023DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours.37217493Stabile R, Cabezas MR, Verhagen MP, Tucci FA, van den Bosch TPP, De Herdt MJ, van der Steen B, Nigg AL, Chen M, Ivan C, Shimizu M, Koljenovic S, Hardillo JA, Verrijzer CP, Baatenburg de Jong RJ, Calin GA, Fodde RCell death & diseaseThe deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs. Cell Death Dis. 2023 05 22; 14(5):337.Cell Death Dis2023-05-22T00:00:002023The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs.37419119Wang R, Song S, Qin J, Yoshimura K, Peng F, Chu Y, Li Y, Fan Y, Jin J, Dang M, Dai E, Pei G, Han G, Hao D, Li Y, Chatterjee D, Harada K, Pizzi MP, Scott AW, Tatlonghari G, Yan X, Xu Z, Hu C, Mo S, Shanbhag N, Lu Y, Sewastjanow-Silva M, Fouad Abdelhakeem AA, Peng G, Hanash SM, Calin GA, Yee C, Mazur P, Marsden AN, Futreal A, Wang Z, Cheng X, Ajani JA, Wang LCancer cellEvolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell. 2023 08 14; 41(8):1407-1426.e9.Cancer Cell2023-07-06T00:00:002023Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.37252969Drula R, Pardini B, Fu X, De Los Santos MC, Jurj A, Pang L, El-Daly SM, Fabris L, Knutsen E, Dragomir MP, Bayraktar R, Li Y, Chen M, Del Vecchio F, Berland L, Dae J, Fan D, Shimizu M, Tran AM, Barzi M, Pioppini C, Gutierrez AM, Ivan C, Meas S, Hall CS, Alahari SK, Berindan-Neagoe I, Fabbri M, Lucci A, Arun B, Anfossi S, Calin GAProceedings of the National Academy of Sciences of the United States of America17?-estradiol promotes extracellular vesicle release and selective miRNA loading in ERa-positive breast cancer. Proc Natl Acad Sci U S A. 2023 06 06; 120(23):e2122053120.Proc Natl Acad Sci U S A2023-05-30T00:00:00202317?-estradiol promotes extracellular vesicle release and selective miRNA loading in ERa-positive breast cancer.37283340Chira S, Ciocan C, Bica C, Calin GA, Berindan-Neagoe IFEBS lettersArtificial miRNAs derived from miR-181 family members have potential in cancer therapy due to an altered spectrum of target mRNAs. FEBS Lett. 2023 08; 597(15):1989-2005.FEBS Lett2023-07-09T00:00:002023Artificial miRNAs derived from miR-181 family members have potential in cancer therapy due to an altered spectrum of target mRNAs.37327315Niu Z, Sun P, Liu H, Wei P, Wu J, Huang Z, Gross ND, Shete S, Wei Q, Zafereo ME, Calin GA, Li GClinical cancer research : an official journal of the American Association for Cancer ResearchFunctional Genetic Variants in TGF?1 and TGF?R1 in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma. Clin Cancer Res. 2023 08 15; 29(16):3081-3091.Clin Cancer Res2023-08-15T00:00:002023Functional Genetic Variants in TGF?1 and TGF?R1 in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma.37261908Dragomir MP, Fuentes-Mattei E, Winkle M, Okubo K, Bayraktar R, Knutsen E, Qdaisat A, Chen M, Li Y, Shimizu M, Pang L, Liu K, Liu X, Anfossi S, Zhang H, Koch I, Tran AM, Mohapatra S, Ton A, Kaplan M, Anderson MW, Rothfuss SJ, Silasi R, Keshari RS, Ferracin M, Ivan C, Rodriguez-Aguayo C, Lopez-Berestein G, Georgescu C, Banerjee PP, Basar R, Li Z, Horst D, Vasilescu C, Bertilaccio MTS, Rezvani K, Lupu F, Yeung SC, Calin GAThe Journal of clinical investigationAnti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. J Clin Invest. 2023 07 17; 133(14).J Clin Invest2023-07-17T00:00:002023Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response.37263271Calin GAMolecular therapy : the journal of the American Society of Gene TherapyNoncoding RNAs: Hope and hype at 30 years. Mol Ther. 2023 06 07; 31(6):1501-1502.Mol Ther2023-05-31T00:00:002023Noncoding RNAs: Hope and hype at 30 years.37329887Zhang Y, Zhao Z, Huang LA, Liu Y, Yao J, Sun C, Li Y, Zhang Z, Ye Y, Yuan F, Nguyen TK, Garlapati NR, Wu A, Egranov SD, Caudle AS, Sahin AA, Lim B, Beretta L, Calin GA, Yu D, Hung MC, Curran MA, Rezvani K, Gan B, Tan Z, Han L, Lin C, Yang LCell metabolismMolecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. Cell Metab. 2023 08 08; 35(8):1457-1473.e13.Cell Metab2023-06-16T00:00:002023Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation.37305699Zhao S, Wang R, Song S, Hao D, Han G, Song X, Zhang J, Pizzi MP, Shanbhag N, Futreal A, Badgwell B, Harada K, Calin G, Vykoukal J, Yu CY, Katayama H, Hanash SM, Wang L, Ajani JAiScienceProteogenomic landscape of gastric adenocarcinoma peritoneal metastases. iScience. 2023 Jun 16; 26(6):106913.iScience2023-05-19T00:00:002023Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases.Authorship 107581615Authorship 10755312537503252Baruch EN, Nagarajan P, Gleber-Netto FO, Rao X, Xie T, Akhter S, Adewale A, Shajedul I, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Harwood C, Leigh I, Ajami N, Futreal A, Castillo M, Gunaratne P, Goepfert RP, Khushalani N, Wang J, Watowich S, Calin GA, Migden MR, Vermeer P, D'Silva N, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo J, Myers JN, Gross ND, Amit MResearch squareInflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Res Sq. 2023 Jul 18.Res Sq2023-07-18T00:00:002023Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade.37507791Blandino G, Dinami R, Marcia M, Anastasiadou E, Ryan BM, Palcau AC, Fattore L, Regazzo G, Sestito R, Loria R, D?az M?ndez AB, Cappelletto MC, Pulito C, Monteonofrio L, Calin GA, Sozzi G, Cheong JK, Aharonov R, Ciliberto GJournal of experimental & clinical cancer research : CRThe new world of RNA diagnostics and therapeutics. J Exp Clin Cancer Res. 2023 Jul 29; 42(1):189.J Exp Clin Cancer Res2023-07-29T00:00:002023The new world of RNA diagnostics and therapeutics.Authorship 107909913Authorship 107953712Authorship 1079554637738407Fan Y, Song S, Li Y, Dhar SS, Jin J, Yoshimura K, Yao X, Wang R, Scott AW, Pizzi MP, Wu J, Ma L, Calin GA, Hanash S, Wang L, Curran M, Ajani JACancer researchGalectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Res. 2023 11 15; 83(22):3726-3738.Cancer Res2023-11-15T00:00:002023Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases.37584671Cismas S, Pasca S, Crudden C, Trocoli Drakensjo I, Suleymanova N, Zhang S, Gebhard B, Song D, Neo S, Shibano T, Smith TJ, Calin GA, Girnita A, Girnita LMolecular cancer research : MCRCompeting Engagement of ?-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness. Mol Cancer Res. 2023 12 01; 21(12):1288-1302.Mol Cancer Res2023-12-01T00:00:002023Competing Engagement of ?-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma Cell Chemotherapeutic Responsiveness.37587333Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GAOncogeneGoing circular: history, present, and future of circRNAs in cancer. Oncogene. 2023 09; 42(38):2783-2800.Oncogene2023-08-16T00:00:002023Going circular: history, present, and future of circRNAs in cancer.Authorship 1081285337822601Pirlog R, Nemeth K, Calin GAFrontiers in endocrinologyEditorial: Non-coding genome and endocrinology: from bench to bedside. Front Endocrinol (Lausanne). 2023; 14:1264302.Front Endocrinol (Lausanne)2023-09-26T00:00:002023Editorial: Non-coding genome and endocrinology: from bench to bedside.37921671Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat BOncotargetCorrection: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget. 2023 Oct 31; 14:908-909.Oncotarget2023-10-31T00:00:002023Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.Authorship 108297611Authorship 10831091337940695Rodriguez-Aguayo C, Del C Monroig P, Redis RS, Bayraktar E, Almeida MI, Ivan C, Fuentes-Mattei E, Rashed MH, Chavez-Reyes A, Ozpolat B, Mitra R, Sood AK, Calin GA, Lopez-Berestein GCell discoveryAuthor Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov. 2023 Nov 08; 9(1):111.Cell Discov2023-11-08T00:00:002023Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer.Authorship 108469113Authorship 1084006437968332Nemeth K, Bayraktar R, Ferracin M, Calin GANature reviews. GeneticsNon-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024 Mar; 25(3):211-232.Nat Rev Genet2023-11-15T00:00:002023Non-coding RNAs in disease: from mechanisms to therapeutics.37990493Arasi MB, De Luca G, Chronopoulou L, Pedini F, Petrucci E, Flego M, Stringaro A, Colone M, Pasquini L, Spada M, Lulli V, Perrotta MC, Calin GA, Palocci C, Biffoni M, Felicetti F, Felli NMolecular therapy : the journal of the American Society of Gene TherapyMiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance. Mol Ther. 2024 Jan 03; 32(1):152-167.Mol Ther2023-11-21T00:00:002023MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.Authorship 1085303638083518Cave J, Shinglot V, Butner JD, Cristini V, Ozpolat B, Calin GA, Dogra P, Wang ZAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International ConferenceMechanistic modeling of anti-microRNA-155 therapy combinations in lung cancer. Annu Int Conf IEEE Eng Med Biol Soc. 2023 07; 2023:1-4.Annu Int Conf IEEE Eng Med Biol Soc2023-07-01T00:00:002023Mechanistic modeling of anti-microRNA-155 therapy combinations in lung cancer.Authorship 1086743338201290Huang W, Paul D, Calin GA, Bayraktar RCellsmiR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. Cells. 2023 12 30; 13(1).Cells2023-12-30T00:00:002023miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.Authorship 10886342938329131Fuentes-Mattei E, Bayraktar R, Manshouri T, Silva AM, Ivan C, Gulei D, Fabris L, Soares do Amaral N, Mur P, Perez C, Torres-Claudio E, Dragomir MP, Badillo-Perez A, Knutsen E, Narayanan P, Golfman L, Shimizu M, Zhang X, Zhao W, Ho WT, Estecio MR, Bartholomeusz G, Tomuleasa C, Berindan-Neagoe I, Zweidler-McKay PA, Estrov Z, Zhao ZJ, Verstovsek S, Calin GA, Redis RSJCI insightmiR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2. JCI Insight. 2024 Feb 08; 9(3).JCI Insight2024-02-08T00:00:002024miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1InstructorInstructortrue1InstructorInstructortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professor24974128Xu S, Wei J, Wang F, Kong LY, Ling XY, Nduom E, Gabrusiewicz K, Doucette T, Yang Y, Yaghi NK, Fajt V, Levine JM, Qiao W, Li XG, Lang FF, Rao G, Fuller GN, Calin GA, Heimberger ABJournal of the National Cancer InstituteEffect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. J Natl Cancer Inst. 2014 Aug; 106(8).J Natl Cancer Inst2014-06-28T00:00:002014Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.21368194Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, Rossi S, Setien F, Casanovas O, Simo-Riudalbas L, Carmona J, Carrere J, Vidal A, Aytes A, Puertas S, Ropero S, Kalluri R, Croce CM, Calin GA, Esteller MProceedings of the National Academy of Sciences of the United States of AmericaSmall molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A. 2011 Mar 15; 108(11):4394-9.Proc Natl Acad Sci U S A2011-02-28T00:00:002011Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.23796952Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gaf? R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GAGenome researchCCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013 Sep; 23(9):1446-61.Genome Res2013-06-24T00:00:002013CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.